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SUMMARY 
 
 
This study describes: 
 
1. The isolation and the purification of tissue type plasminogen activator and 
urokinase plasminogen activator in bovine milk. 
 
2. The biochemical characterisation of tissue type plasminogen activator in 
bovine milk.  
 
3. An investigation of the influence of the addition of purified tissue type 
plasminogen activator to ultra high temperature milk, Gouda cheese and 
yoghurt. 
OPSOMMING 
 
 
Hierdie studie beskryf: 
 
1. Die isolering en suiwering van weefseltipe-plasminogeenaktiveerder en 
urokinase-plasminogeenaktiveerder in beesmelk.  
 
2. Die biochemiese karakterisering van weefseltipe-plasmingeenaktiveerder 
in beesmelk.  
 
3. `n Ondersoek na die invloed van die byvoeging van gesuiwerde 
weefseltipe-plasminogeenaktiveerder by ultra hoë temperatuur melk, 
Gouda kaas en joghurt. 
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Chapter 1 
 
 
INTRODUCTION 
 
 
In 1905 “Herr Doktor” Albert Einstein, the brilliant physicist who’s legendary 
formula changed the world of physics, published four papers that were later 
described as “…the papers which, after half a century, still had a major influence 
on ongoing research” [1].  Milk was the subject of study for the scientific icon of 
the 20th century, when he formulated his theory on Brownian movement. In 
Einstein’s publication on Brownian movement in dairy research, he investigated 
the behaviour of casein particles in milk during the manufacturing of cheese, 
which is still being researched today [2]. 
 
Milk and milk constituents have always provided a model system for scientific 
investigation for numerous reasons.  Milk is a nutrient dense product which is 
secreted by the female of all mammalian species, primarily to meet the nutritional 
requirements of the neonate.  Milk contains lipids (which include essential fatty 
acids), proteins and peptides, essential amino acids, immunoglobulins, enzymes, 
enzyme inhibitors, growth factors, hormones and anti-bacterial agents, lactose, 
vitamins and inorganic elements such as calcium and water.   
 
Milk is the most nutritional and complete single food available in nature which, as 
a result, is very important in a socio-economic context in the world today. Milk 
and dairy products are important components in the human diet in many parts of 
the world, especially in developing countries such as South Africa, as it provides 
a rather inexpensive, valuable source of nutrition. It is stated by The National 
Department of Agriculture (NDA) that as much as 30% of the dietary protein in 
developed countries, such as the United States and Australia, is supplied by milk 
and dairy products.  Since milk can be converted into a wide range of products 
containing important dietary nutrients it is not only beneficial to the consumer, but 
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also to the industry.  Therefore the food industry in South Africa is faced with 
various challenges, such as providing better quality raw products and final 
product solutions to address important factors such as child nutrition, 
malnutrition, HIV-AIDS and obesity. 
 
According to the NDA primary agriculture contributes about 2.6% to the gross 
domestic product (GDP) and almost 9% to formal employment. However, there 
are strong backward and forward linkages into the economy, so that the agro-
industrial sector is estimated to comprise 15% of the GDP. In the past five years 
agricultural exports have contributed approximately 8% towards South African 
exports. The South African dairy industry is an important employer, with 4,300 
milk producers that employ about 60,000 farm workers, and indirectly providing 
employment to some 40,000 people. Milk production for 2004/2005 was 
estimated at 2.90 million tonnes. Therefore, scientific research and ultimately 
technology transfer to the primary and secondary dairy industries are key drivers 
in the expansion of a developing market within the agro-industrial sector.   
 
Milk contains approximately 30 indigenous enzymes, some of which are 
associated with the casein micelles and others that can be found in the serum 
phase of the milk [3-5].  These enzymes originate from the blood, the secretory 
cell cytoplasm or the fat globule membrane [4].  Bovine milk contains several 
endogenous proteases; these include plasmin, plasminogen, plasminogen 
activators (PA), plasmin inhibitors (PI), plasminogen activator inhibitors (PAI), 
thrombin, cathepsin D, acid milk proteases and aminopeptidases [5,6]. Several 
proteases also derive from leukocytes (somatic cells) and bacteria in milk [3]. 
 
One of the major enzymes in milk is milk alkaline protease (MAP), commonly 
referred to as plasmin.  Under certain physiological conditions, such as bacterial 
infection, the inactive precursor form of the enzyme is converted into the active 
form by self-activation (autolysis) or by limited proteolysis by another protease [7-
10].  The physiological mechanism by which the inactive precursor zymogen, 
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plasminogen, is converted to plasmin, is the result of a cascade of reactions 
producing plasmin or fibrinolysin.  In the case of plasminogen the conversion to 
the active enzyme plasmin occurs as a result of the specific action of PA [7,8]. 
Plasmin is an anti-coagulant that lyses fibrin, therefore preventing coagulation or 
clotting of blood [6,11].  
 
Protease-catalysed hydrolysis of micellular and casein dispersions in milk by the 
fibrinolytic system, of which plasmin and PA are key elements, causes multiple 
changes in the functional properties of milk and dairy products and directly 
influences the quality of milk as a base for all dairy products [12-16].  Enhanced 
proteolysis in dairy products directly influences the quality of the final product.  
Controlled proteolysis is important for the flavour development in cheese, on the 
contrary uncontrolled proteolysis can cause detrimental effects in dairy products, 
such as: the gelation of Ultra High Temperature (UHT) milk, the manufacte of 
poor quality cheeses, poor ripening of cheese, declining cheese yield, 
degradation in stored casein products (decrease in viscosity) and decreased heat 
and ethanol stability of raw and processed milks, to name but a few. 
 
The aim of the study was to purify and characterise PA from bovine milk and to 
investigate and quantify the effect of the addition of the purified PA to bovine milk 
prior to secondary processing. 
 
The mechanism of activation of the serine proteinase plasmin in the fibrinolytic 
system of human and bovine milk is described in Chapter 2. Thrombin, through 
thrombomodulin, activates protein kinase C. Activated protein kinase C increases 
the concentration of PA [17,18]. Although the physiological mechanism of PA 
function and release is still unclear, it stimulates and activates the conversion of 
plasminogen to plasmin [19]. Research also indicates that during mastitis 
(infection in the udder of the cow) there is a 10 to 20-fold increase in PA activity, 
but the mechanism causing this rapid increase in PA concentration is still 
unknown [20].  It is believed to be as a result of a second messenger system, but 
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this still remains to be proven. The increase in PA supposedly also influences the 
ratio of the different somatic cells in the milk (macrophages, neutrophils and 
lymphocytes) which is an indicator of general herd health [20,21]. 
 
Chapter 3 gives an overview of the protein composition in bovine milk. The 
activation of the plasmin results in the breakdown of several milk proteins, 
especially β- and αs- casein, yielding a number of peptides referred to as the γ-
caseins and the proteose peptones [19]. The κ-casein component is relatively 
resistant against cleavage by the enzyme [15,16,22,23].  The breakdown of the 
milk proteins will influence the textural, physical and chemical properties of milk 
and dairy products, as discussed in Chapter 4. 
 
Chapter 5 describes the isolation and characterization of plasminogen activators.  
Plasmin, plasminogen and PA are associated with the casein miscelles and the 
fat globule membranes in milk [22,23]. The PI and PAI that occur in the serum 
phase of the milk that further control the activity of PA [22,23]. There are at least 
two PAs present in bovine milk, two of which have been identified as urokinase 
plasminogen activator (u-PA) and tissue type plasminogen activator (t-PA) [22].  
Both activators have already been partially isolated and characterised and 
according to these preliminary studies also exhibit different structural, 
physiological, kinetic and immuno-chemical properties [22,24]. While it is well 
established that plasmin in milk and other dairy products occurs mainly in 
precursor form (plasminogen - activated during storage), the origin, 
characteristics and the factors affecting the activity of plasminogen activators are 
still unknown [22-28]. 
 
Chapter 6 describes the results of adding the purified PA fraction to milk and 
incubating before using the milk for the manufacturing of ultra high temperature 
(UHT) milk, Gouda cheese and yoghurt.  The hypothesis was that protease 
hydrolysis of the micellular and caseinate dispersions can cause changes in the 
functional properties and characteristics of the final products. 
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 The results of this study are discussed in Chapter 7, and the experimental 
protocols in Chapter 8.  PA was isolated and purified from bovine milk, using a 
combination of fractionation, solubilisation and chromatography steps.  Partial 
purification was done using size exclusion and metal chelate chromatography.  
Colorimetric assays were used to detect the purified PA and their activity.  The 
amino acid sequence of PA was determined by high-pressure liquid 
chromatography (HPLC) analysis with o-phthaldialdehyde (OPA) detection.  
   
In summary the elucidation of the PA system is arguably the most crucial part of 
interest to the biochemical study of milk proteases.  The elucidation can lead to 
practical applications that will be of great benefit to the primary and the 
secondary dairy industries. 
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Chapter 2 
 
 
A PHYSIOLOGICAL REVIEW OF THE FIBRINOLYTIC SYSTEM IN 
HUMAN AND BOVINE MILK 
 
2.1. Introduction 
 
Milk can be defined as the unadulterated, fresh liquid that is expressed from the 
udder of cows when milked.  This, however, excludes the liquid expressed 15 
days before and 5 days after calving, this is known as colostrum.  
 
Good quality raw milk is required to make good quality dairy products.  Once raw 
milk is defective and of inferior quality, it cannot be improved during processing, 
and defects often become more pronounced.  Mastitis, an infection of the udder 
of the cow, is one of the most common herd health concerns. Mastitis in dairy 
cows, which is most often the result of a bacterial infection or inferior milking 
practices, causes an increase in the herd Somatic Cell Count (SCC) of the milk. 
 
The SCC is the number of white blood cells, epithelial and tissue cells counted in 
1 ml of milk.  When inflammation (haemostasis and thrombosis) in the udder of 
the cow occurs, the natural defense mechanisms of the cow are activated to 
combat the infection, which leads to an increased blood supply and concentration 
of white blood cells, especially neutrophils, to the infected areas, this causing and 
increase in SCC. SCC is, therefore, an important indicator of mastitis and an 
invaluable tool for herd management and indicative of the “udder-health” of the 
cow.   
 
In South Africa the legal specification for the acceptance of raw bulk milk for 
further processing according to the ”Regulations Relating to Milk and Dairy 
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products” is 500,000 or fewer somatic cells per 1,0 ml of bovine milk (Table 2.1).  
As indicated in Table 2.2 counts exceeding 200,000 SCC.ml-1 generally indicate 
some level of mastitis (clinical or sub-clinical) in the herd and thus the potential 
for quality defects in raw milk and in processed dairy products.  Quality defects 
are generally the result of enzymes associated with infection and somatic cells 
that degrade protein, milk fats and other components resulting in reduced cheese 
yields and flavour defects (such  as bitterness, rancidity) in cheese, pasteurised 
milk and other dairy products. Table 2.3 summarises the effect of mastitis on milk 
components [29]. 
 
Table 2.1: South African Regulations Relating to Milk and Dairy products: 
Regulations regarding sale of raw milk for further processingi
 
Parameter Specification 
Antibiotics Absent 
Pathogenic organisms, extraneous matter or inflammatory products Absent 
Clot-Boil test Negative 
Standard Plate Count (cfu.ml-1) < 200,000 
Coliform bacteria (cfu.ml-1) < 10 
Escherichia coli (cfu.ml-1)ii Absent 
Escherichia coli (cfu.0.01ml-1)iii Absent 
Somatic Cell Count.ml-1 iv < 500,000 
Alcohol Test (68% ethanol v/v) Negative 
i  Published under Government Notice No. R. 1555 of 21 November 1997, As corrected by: 
Government Notice No. R.1278 of 29 October 1999, Government Notice No. R. 488 of 8 June 
2001, As amended by: Government Notice No. R.9 of 7 January 2000, Government Notice No. 
R.53 of 28 January 2000, Government Notice No. R.755 of 28 July 2000, Government Notice No. 
R.837 of 25 August 2000, Government Notice No. R.1052 of 27 October 2000, Government 
Notice No. R.489 of 8 June 2001 
ii  Modified Eijkmann Test 
iii VRB Mug Agar Method and dry hydrated film method 
iv The Standard Method for Counting Somatic Cells in Bovine Milk is set forth in International Dairy 
Federation (IDF) Bulletin No. 114 of 1979. 
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 Table 2.2: Relationship between herd Somatic Cell Count and mastitis in bovine 
milk 
 
Herd SCC / ml Mastitis 
Projected % infected 
quarters in herd 
Less than 200,000 Excellent None 
250,000 - 500,000 Good Less than 20 % 
500,000 - 750,000 Danger zone 20 - 40 % 
More than 750,000 Definite problem More than 40 % 
 
 
Table 2.3: Relationship between mastitis and milk constituents in bovine milk [29] 
 
Component Effect % Composition 
  Normal Mastitis 
Fat Decrease 3.8 3.6 
Protein 
 Casein 
 Whey Proteins 
Slight decrease 
Decrease 
Increase 
3.6 
2.8 
0.8 
3.5 
2.3 
1.2 
Lactose Decrease 4.9 4.4 
Sodium (Na+) Increase 0.05 0.08 
Chlorine (Cl-) Increase 0.10 0.18 
Calcium (Ca2+) Decrease 0.13 0.09 
 
Factors causing mastitis and an increase in SCC, such as overmilking, injury to 
the udder of the cow and infection in the teat canal resulting in inflammation, are 
discussed in more detail in Chapter 4. 
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2.2. The physiology of bovine milk synthesis 
 
In order to understand the effect of milk proteases on milk and milk composition it 
is important to have a basic understanding of the physiological process of milk 
synthesis. 
 
The udder of a full-grown cow can weigh up to 50 kilograms (kg), just prior to 
milking, and is divided in individual milk glands or quarters.  Each quarter has 
one teat, with no connection between individual quarters.   The ideal udder 
should shrink after complete milking, but still be elastic. Generally, the rear 
quarters are slightly more developed and produce 60% of the milk, whereas the 
front quarters only produce 40%. The major components of the udder are as 
follows (Fig. 2.1) [30,31]: 
 
Ligaments: Together with the skin, ligaments and connective tissue support and 
maintain the udder close to the body of the cow.  The ligaments are divided into 
the median suspensory ligaments, these divide the left and the right halves of the 
udder of the cow, and the lateral suspensory ligaments which give support to the 
outside and underside of the udder. 
 
Secretory and duct system: The udder is known as an exocrine gland because 
milk is synthesized in a specialized cell known as an alveolus (grouped in 
alveoli), and is then excreted outside the body through a duct system.  The 
alveoli are made up of a single layer of myoepithelial cells, which surround the 
lumen on the inside of each alveolus, into which the milk is secreted.  A dense 
layer of myoepithelial cells (muscle tissue) and capillary blood vessels surround 
the alveoli.  The function of the alveolus is to (i) remove nutrients from the blood, 
(ii) to transform these nutrients into milk and (iii) to discharge the milk into the 
lumen.  Each lumen drains to smaller milk collection ducts which are connected 
to the gland cistern directly above the teat of the gland.  The milk can be 
withdrawn from the gland (or quarter) via the teat and teat canal. 
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Blood supply and capillary structures: Milk production demands a lot of nutrients; 
these are brought to the udder via the bloodstream. To produce 1 kg of milk, 400 
to 500 kg of blood must pass through the udder. In addition, the blood carries 
hormones that control udder development, milk synthesis, and the regeneration 
of the secretory cells between lactations, also known as the dry period. 
 
Lymph system: Lymph is a clear fluid that comes from tissues highly irrigated by 
blood. The lymph helps to balance the fluid flowing in and out of the udder and 
helps to combat infections. Sometimes the increased blood flow at the onset of 
lactation leads to an accumulation of fluid in the udder until the lymph system is 
able to remove this extra fluid. 
   
Innervation of the udder: Nerve receptors on the surface of the udder are 
sensitive to touch and temperature. During the preparation of the udder for 
milking, these nerves are triggered which initiates the “milk let down” reflex that 
allows the release of milk. The hormone, oxytocin, and the nervous system are 
also involved in the regulation of blood flow to the udder. When a cow is startled 
or feels physical pain, the concerted action of adrenaline and the nervous system 
decreases blood flow to the udder, thus inhibiting the “milk let down” reflex and 
as a result milk production is lowered.  
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Figure 2.1: Alveoli and ducts of the milk secretory system [31]. 
 
 
Milk secretion by the secretory cells is a continuous process that involves 
intricate biochemical reactions as diagrammatically summarised in Fig. 2.2.  
Nutritional factors which influence rumen fermentation and the end products of 
fermentation such as volatile fatty acids, ammonia and peptides, influence milk 
composition since microbial protein and volatile fatty acids are precursors for milk 
component synthesis. The principle nutrients available to the udder for synthesis 
of milk solids are glucose, acetate, β-hydroxy butyrate, long chain fatty acids and 
amino acids. As molecules of lactose are produced, water moves into the cell to 
equalise osmotic pressure, the same is true for the ash or minerals component. 
The rate of lactose synthesis and secretion therefore regulates milk yield.  
Lactose is produced from glucose, most of which is synthesised in the liver from 
propionate, a ruminally derived volatile fatty acid. Under some circumstances 
glucose can also be synthesised from amino acids and starch.  
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Figure 2.2: Milk secretion in the secretory cells (crossed circles indicate key 
regulatory steps) [31]. 
 
Milk protein is synthesised in the mammary gland from amino acids extracted 
from blood as it flows through the mammary gland. The amino acids are supplied 
by ruminally synthesised microbial protein (MCP) and ruminally undegraded 
dietary protein (UDP). Colostrum milk contains extensive amounts of globulin 
proteins which move directly from blood to milk.  
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Milk fat is synthesised in the mammary gland from two basic types of precursors. 
Short chain fatty acids are synthesised primarily from acetate and β-hydroxy-
butyrate which are derived from the rumen as a result of carbohydrate digestion 
by microbes. The longer chain fatty acids are extracted from the circulating blood 
by the mammary gland. These fatty acids are primarily of dietary origin but may 
also be derived from body fat mobilisation or by liver metabolism. About 50% of 
total fatty acids are synthesised in the mammary gland while the remaining 50% 
are derived directly from the blood.  
 
The energy required by the udder for synthesis of milk solids is derived largely 
from the oxidation of acetate, the volatile fatty acids produced in the largest 
quantity in the rumen. Smaller amounts of energy are derived from the oxidation 
of β-hydroxy-butyrate (synthesised in the liver from butyrate, the volatile fatty acid 
produced in the third largest quantity in the rumen), amino acids and glucose 
[31,32]. 
 
2.3. The fibrinolytic system 
 
The fibrinolytic system acts as an anti-coagulant that solubilises fibrin clots in the 
blood.  The proteolytic system contains five different enzymes, namely: the 
inactive precursor zymogen plasminogen, the active protease plasmin, 
plasminogen activators (PA), plasmin inhibitors (PI) and plasminogen activator 
inhibitors (PAI) [20,22]. 
 
The fibrinolytic system is in a state of dynamic equilibrium in which fibrin clots in 
the blood are constantly being formed and dissolved [6,9,10,11]. 
 13 
2.3.1. Haemostasis and thrombosis 
 
Haemostasis and thrombosis are processes that encompass the coagulation or 
the clotting of blood.  Haemostasis is the cessation of bleeding from a cut or 
severed vessel.  Initially there is vasoconstriction of the injured vessel that 
reduces the flow of blood to the area of injury.  Thrombosis occurs when the 
endothelium lining in the blood vessels is injured or removed (Fig. 2.3). 
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Figure 2.3: Diagrammatic representation of haemostasis during acute 
inflammation [33]. 
 
Both haemostasis and thrombosis can be divided into three phases: (i) the 
formation of loose and temporary platelet aggregates at the site of the injury, (ii) 
the formation of a fibrin network that binds to the platelet aggregate forming 
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hemostatic plug or thrombus, and (iii) the partial or complete dissolution of the 
thrombus, due to the function of the anti-coagulant plasmin, takes place. 
 
As shown in Fig. 2.4, thrombus formation begins with the release of the pro-
inflammatory cytokine interleukin-5 (IL-5) and the tumour necrosis factor alpha 
(TNF-α).  The tissue factor (TF) stimulated by interleukin-6 (IL-6) and other 
cytokines, are expressed on the surface as activated mononuclear cells and 
endothelial cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Diagrammatic representation of fibrinolysis during acute inflammation 
with special mention to the activation systems is place [34]. 
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TF binds to factor VII to form the activated TF-factor VIIa complex. TF-factor VIIa 
directly or indirectly (via activated factor IX and factor VII) activates factor X.  
Activated factor X and activated factor V converts prothrombin (factor II) to 
thrombin (factor IIa). 
 
Impairment of the three coagulation systems involving anti-thrombin III, protein C 
and tissue factor pathway inhibitor (TFPI) is initiated primarily by the release of 
TNF-α.  The resulting intra-vascular formation of fibrin is not balanced by the 
adequate removal of fibrin, because fibrinolysis is inhibited by the high levels of 
PAI 1, mainly because of the influence of TNF-α.  Increased PAI 1 inhibits PA 
activity, therefore reducing the rate of plasmin formation.  The end result is the 
deposition of fibrin in the microvasculature and compromised perfusion [34]. 
 
2.3.2. The plasminogen activation system 
 
The removal of blood clots from circulation and the turnover of the extracellular 
matrix proteins are facilitated by specialised enzymes, one of the most important 
being plasmin [6,7]. 
 
Plasmin performs many functions, but its primary role is to degrade fibrin that can 
be seen as the “structural matrix” of a blood clot.  Plasminogen is activated to 
plasmin by serine plasminogen activator (u-PA and t-PA) enzymes [20].  The 
proteolytic activity of plasmin is regulated by PAI 1&2 (Figs. 2.5 and 2.6). 
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Figure 2.5: Inactive precursor zymogen plasminogen before activation to the two-
chained active plasmin molecule [6]. 
 
 
PROTEIN KINASE C
THROMBIN COMBINES THROMBOMODULIN 
(Glycoprotein present on surface of endothelial cells)
PA
PAI
NH3+ Arg Val COO-
S S
NH3+ Arg COO-
S S
Val
Serine residue = 
active site 
NH3+
COO- CH2
OH
CH
FIBRIN FIBRIN DEGRADATION 
PRODUCTS 
PLASMIN 
Serine protease 
2 chain 
molecule 
PLASMINOGEN 
Precursor 
zymogen 
Bind to fibrin 
Bind Blood 
clots 
 
PI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Activation of plasminogen activators during fibrinolysis (adapted from 
Ganong, W.F.) [34]. 
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 The plasminogen activating system actively participates in cell movement 
(cellular migration), wound healing (blood clot dissolution or fibrinolysis), 
metastatic spread of cancer and contributes to the turnover of the extracellular 
matrix in the central nervous system [35,36]. 
 
 
2.4. The fibrinolytic system in human milk 
 
Although there is almost a 75% homology between bovine and human PA, 
extrapolation of results from human to bovine milk is not justified due to the 
difference in the composition of the milk between the species.  Therefore results 
from research on human milk can be utilised as a guideline but should not be 
accepted for different models.  
 
2.4.1. Human plasminogen and plasmin 
 
During the first few days after birth high levels of PA and plasmin activity occur in 
human milk.  After a few weeks the PA activity gradually decreases [37].  
Comparison of the molecular weights of different PA's in human milk correlates 
well with the PA in blood, suggesting that the PA in milk originates from the 
blood, rather than being produced by the tissue of the mammary gland itself [38-
41]. 
 
Human plasminogen is a single peptide chain with the N-terminal glutamine and 
the C-terminal asparagine [42,43].  Native plasminogen can be divided into two 
subgroups, namely Glu-plasminogen 1 (Mr 91,500 Da) and Glu-plasminogen 2 
(Mr 89,300 Da) [40].  Glu-plasminogen 1 has four subforms with different pI 
values, namely 6.2, 6.3, 6.4 and 6.6.  Glu-plasminogen 2 has 2 different 
subforms with different pI values, namely 6.4 and 6.6 [44].  Activation of 
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plasminogen to plasmin by t-PA or u-PA is as a result of the proteolyitic cleavage 
of a single peptide bond at Arg561-Val562 in human plasminogen [46].  The N-
terminal peptide is released, forming Lys-plasminogen 1 and Lys-plasminogen 2.  
Lys-plasminogen 1 has three subforms with different isoelectric (pI) points, 
namely 6.7, 7.2 and 7.5.  Lys-plasminogen 2 has three different subforms with 
different pI values, namely 7.5, 7.8 and 8.1 [40,41].  A three dimensional model of 
plasminogen reveals triple disulfide loops or the so-called kringles, whereas 
plasmin contains five kringle domains on the N-terminal A chain [44]. 
 
Human plasmin (Mr approximately 90,000 Da) is capable of hydrolysing a 
broader spectrum of proteins than any other blood protease, but is highly specific 
for the peptide bonds containing lysine residues [38,39].  Plasmin catalyses the 
hydrolysis of the peptide bonds on the C-terminal side of the Lys and Arg 
residues [40].  The active site on the plasmin molecule is located at the serine 
residue on the C-terminal B chain and is connected to the N-terminal A chain two 
by a disulfide bridge [41,42]. 
 
Plasmin digests fibrin to form soluble degradation products, thus solubilising the 
fibrin-clot.  Both plasmin and PA is then released into the fluid phase of the blood; 
subsequent inactivation by their natural inhibitors, PAI and PI, renders these 
molecules inactive [38,43]. 
 
2.4.2. Human plasminogen activators 
 
Plasminogen activator activity is present in human milk and human mammary 
gland tissue [37].  The sources of PA are the mammary epithelial cells, 
endothelial cells or the leakage of PA from the mammary epithelial tissue via the 
blood into the milk.  PA is native to human milk and can be divided into two 
distinct groups, namely: u-PA and t-PA [38-46].  Plasmin and plasminogen is 
functionally the same in milk and blood.  PA activates plasminogen to plasmin; 
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PA is inhibited by PAI.  The activation of plasmin results in an increase in 
proteolysis in blood and milk, in the latter instance casein is converted into 
smaller peptides.  Plasmin inhibitors (PI) also inhibit the conversion of plasmin 
activity [21,23]. 
 
2.4.2.1. Urokinase plasminogen activators 
 
Urokinase-PA is a serine proteinase and is probably the best-characterised PA 
with a molecular weight of 54,000 Da that can be divided into two subunits, a C-
terminal B chain (containing the serine proteinase domain) and a N-terminal A 
chain, with molecular weights of 27,000 Da each.  These two subunits are linked 
with a disulfide bond.  The N-terminal A-chain contains a growth factor domain 
(amino acids 1-49), a kringle domain (amino acids 50-131), and an inter-domain 
linker region (amino acids 132-158) [40].   The one chain zymogen precursor of 
u-PA, pro-u-PA, has an activity of 250-fold less than that of the two chained u-
PA.  The activation of the pro-u-PA occurs by proteolytic cleavage of Lys158-Ile159 
in human u-PA [47].  U-PAs with molecular weight of 93, 57, 42, 35 and 27 kDa 
have been isolated from bovine and human milk and are associated with the 
somatic cells (leukocytes) in milk. The u-PA is synthesised by all cell types such 
as macrophages, fibroblasts and epithelial cells.  The main function of u-PA is the 
degradation of extracellular matrix.   
 
Glu-plasminogen 1 and 2 are converted to plasmin due to activation by 
urokinase.  There are two proteolytic cleavages that firstly release a pre-
activation peptide from the N-terminal with a molecular weight of 7,000.  The 
cleavage takes place between Lys76 and Lys77 to yield either Lys-plasminogen 1 
or 2 [40,41,43].  The second takes place between Arg560 and Val561 to yield Glu-
plasminogen [45].  If the pre-activation peptide has already been released Glu-
plasminogen will be converted to Lys-plasminogen.  The release of the pre-
activation peptide induces conformational changes in the Glu-plasminogen that 
enhance the activation of Lys-plasminogen.  The dissociation of non-covalent 
 20 
bonds at residues 45-51 and unidentified residues elsewhere on the molecule 
result in the Arg561-Val562 bond being more accessible for proteolytic cleavage 
[40,44,45].  
 
2.4.2.2. Tissue type plasminogen activator 
 
Tissue type PA is a serine-protease (Mr approximately 90,000 Da) which is 
released from the vascular endothelium tissue in a single-chain form.  The single 
chain t-PA can be proteolytically converted to a two-chained form, by a cleavage 
of a single polypeptide bond at Arg275-Ile276 [45]. The two chains are held 
together by a disulfide bond, The N-terminal A chain (starting from the N-
terminal) contains a fibronectin type II domain, a growth factor domain, and two 
kringle domains.  The C-terminal B chains contains the serine proteinase domain 
[48,49].  T-PA is released into the blood stream where it binds to fibrin, and is 
biologically inactive when it is not bound to fibrin.  Upon binding with fibrin, the t-
PA cleaves the inactive precursor zymogen, plasminogen, between the Arg561-
Val562 bond to render the two-chain active protease plasmin [45,48,49].  The 
plasminogen activity of the single-chain t-PA is 10 to 50-fold lower than that of 
the two-chained form [48,49]. 
 
 
2.5. The fibrinolytic system in bovine milk 
 
In fresh bovine milk plasmin is present in low concentration, but during storage 
the plasmin concentration increases significantly [9,10,20,22].  Any factor or 
combination of factors that activates the inactive plasminogen to the active 
protease plasmin will have a negative influence in the overall quality of the milk, 
due to the effect on protein functionality.  In dairy products, proteolysis due to an 
increase in plasmin negatively influences the body, texture, consistency and 
flavour of dairy products.  Plasmin is a heat stable enzyme that survives 
pasteurisation and UHT treatment.  The proteolytic cleavage of casein by 
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proteases also influences a number of dairy processing factors, such as the yield 
of cheese, gelation of UHT milk, milk protein functionality and overall dairy 
product quality [44,50-54]. 
 
In bovine milk plasmin, plasminogen and the plasminogen activators are 
associated with the casein micelles and plasminogen activator inhibitors and 
plasminogen inhibitors with the serum phase of the milk [55,56]. 
 
2.5.1. Bovine plasminogen and plasmin 
 
Inflammation is the host defence mechanism against bacterial infection.  During 
sub-clinical and clinical mastitis the invasion of antigens evokes an inflammatory 
response which includes the plasminogen activation system.  T-cells sensitized 
toward antigens, release lymphokines which activate monocytes.  The 
monocytes and macrophages migrate to the infected area and secrete mediators 
of the inflammatory response including proteinases [57]. 
 
In bovine milk the plasminogen acts as a proteolytic reservoir with concentrations 
between 0.8 and 1.6 mg.l-1 [50,51,56].  The molecular mass of plasminogen and 
plasmin is 88 kDa and 58 kDa respectively [56-58].  The optimum pH for plasmin 
hydrolysis is pH 8.  Plasmin can hydrolyse αs-casein and β-casein in bovine milk 
yielding a number of peptides referred to as the γ-caseins and the proteose 
peptones [56,59]. 
 
Plasmin is associated with the iso-electric casein in milk (at a pH value of 4.60) or 
the casein micelles [3,6,23,56].  Plasmin is also the main protease associated 
with the milk fat globule membrane, although not the only protease present.  
Plasmin is an alkaline serine protease with trypsin-like activity, also inhibited by 
trypsin inhibitors (soybean trypsin inhibitors), but is not inhibited by chymotrypsin 
inhibitors [60-62].  Plasmin cleaves Lys-X and Arg-X at the C-terminal and the 
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rate of hydrolysis is faster at the Lys residues [60,63,64].  Maximum enzyme 
activity is exhibited at a pH of 7.5 and a temperature of 35°C.  It is a two chain 
molecule with a heavy chain (Mr 60,000 Da) and a light chain (Mr 25,000 Da).  
These two chains are connected via a disulfide bond, the active site of the 
molecule is located in the light chain [20,23,25,28,56]. 
 
In bovine milk plasmin can be dissociated from casein and casein micelles in 
vitro by the addition of lysine or 6-aminohexanoic acid, in concentrations up to  
1 M in milk or blood.  In blood, plasmin is coupled to fibrin via lysine-binding sites 
on the plasmin.  These lysine-binding sites interact with the lysine or 6-
aminohexanoic acid, followed by the subsequent dissociation of fibrin from the 
fibrin–plasmin complex.  Thus the interaction of plasmin in bovine milk with 
casein and the casein micelles is likely to be as a result of the interaction of 
lysine residues [23,65,66].  Blood only contains plasminogen, thus the presence 
of plasmin in freshly secreted milk suggests that the activation of plasminogen 
occurs while the milk is stored in the lumen of the udder prior to milking or 
perhaps earlier in the process of milk synthesis [50,51].  Both blood and milk 
plasminogen are inactive precursor zymogens that function as anti-clotting 
enzymes.  The activated plasmin solubilises fibrin clots to form soluble products.  
Plasminogen concentration is higher in the colostrum than in late lactation milk 
[56,57,65]. 
 
In milk the major native proteolytic enzyme is plasmin, which functions optimally 
at a pH of 8.0.  The plasmin readily hydrolyses the αs2- and β-casein at the same 
rate to form shorter peptides referred to as γ-casein and the proteose peptones 
[52,67,68].  In β-casein there are 15 plasmin susceptible bonds, depending on 
the genetic variant.  The first cleavage in β-casein of the peptide bonds by 
plasmin occurs at Lys28-Lys29, Lys105-Hys106 and Lys107-Glu108.  The three large C 
fragments released by the hydrolysis of β-casein is the γ1-3-casein [69].  The γ1-3-
casein is considered to consist of fragmentation products rather than minor 
casein components.  The position of the hydrolysis of the other caseins via 
 23 
plasmin is not yet established, although the αs2-casein yields three γ-caseins or 
fractions with molecular masses of 20.5, 12.3 and 10.3 kDa respectively. κ-
Casein is resistant to proteolytic hydrolysis by plasmin [64, 70]. 
 
Plasmin has no effect on αs2-lactalbumin and β-lactoglobulin, although these 
whey proteins inhibit plasmin activity to a certain extent [60]. 
 
2.5.2. Proteolysis of milk proteins by plasminogen 
 
In the fibrinolytic system of bovine milk the proenzyme plasminogen is activated 
by PA to form the proteolytic enzyme plasmin as diagrammatically indicated in 
Fig. 2.7. 
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Figure 2.7: Native enzyme activator-inhibitor system in bovine milk with the 
activation of plasminogen to plasmin. 
 
Alphas2- and β-casein are the preferred substrates for hydrolyses by plasmin.  In 
trials with stored UHT milk the rates of hydrolysis of both αs2- and β-casein were 
similar [6,14].  However, the whey proteins are resistant to the action of plasmin.  
Denatured β-lactoglobulin inhibits plasmin activity as the free sulfhydryl group of 
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the denatured β-lactoglobulin forms a thiol-disulphide interchange with the 
disulphide groups of the plasminogen.  The allosteric hindrance renders the 
plasminogen molecule inactive for activation by PA [71,72,73]. 
 
2.5.3. Bovine plasminogen activators 
 
Deharveng and Nielsen [22] reported the presence of at least two native PA in 
bovine milk.  Plasminogen activator activity is associated with the casein micelles 
and the SCC in milk, whereas PAI and plasmin activity is localised in the milk 
serum.  The serine proteases, t-PA and u-PA, activate plasminogen by the 
cleavage of its Arg561 – Val562 peptide bond.  The newly formed amino group 
Val562 forms a salt bridge to Asp740, resulting in conformational changes 
(specificity pockets) in the active domain of plasminogen to form the active form 
plasmin [22,45]. 
 
The cellular source of t-PA is still unknown, although the endothelial cells are rich 
in t-PA and is therefore probably the main source of t-PA extracts [20,56].   The t-
PA activity in bovine milk is predominantly localised in the milk casein fraction.  
The molecular mass of the molecule is 75 kDa, and the activity of the t-PA is 
increase four-fold in the presence of fibrin, but remains unaffected by the 
presence of amiloride and urokinase [56]. 
 
The u-PA activity is localised in the somatic cell fraction of milk and has a 
molecular mass of 30 kDa and 50 kDa. Activity of the u-PA is enhanced by 
amiloride and urokinase, but remains unaffected in the presence of fibrin [57]. 
 
In bovine milk all the individual caseins (αs1-, αs2-, β- and κ-casein) enhance the 
activity of the PA.  Optimal casein concentrations (α-casein 5 μg.ml-1, β-casein 25 
μg.ml-1 and κ-casein 0 - 200 μg.ml-1) that are needed to enhance PA activity were 
determined by Politus et al. [75].  It was also determined that when the 
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concentration of these caseins exceeded the optimum concentration the activity 
of the PA decreased.  On a percentage weight for weight basis α-casein is the 
most effective enhancer of PA activity [65,74,75].  Bastian et al. [73] 
demonstrated that casein also acts as a competitive inhibitor of plasmin because 
casein is the natural substrate for plasmin in milk.  When determining the activity 
under assay conditions casein will also compete with the chromaphore (D-Val-
Leu-Lys-ρ-nitroanalide V0882) for the active site of the plasmin molecule.  Once 
plasminogen is converted to plasmin, the plasmin promotes further activation of 
the plasminogen molecule, and can therefore be described as being autocatalytic 
(positive feedback mechanism) [72-73]. 
 
In bovine milk the u-PA and t-PA proteins contain 413 and 566 amino acids, 
respectively [57].  The t-PA and u-PA are believed to have different functions due 
to their different localization in milk fractions [9,45]. 
 
In addition to the native physiological PA in bovine milk, several pathogenic 
microorganisms also have developed PA (streptokinase produced by a variety of 
streptococci and staphylokinase produced by Staphylococcus aureus) [23,51,52].  
Streptokinase, an extracelIular protein of Streptococcus uberis, binds to 
plasminogen to form a plasminogen-complex in a 1:1 ratio [76]. The 
conformational changes to the plasminogen-complex render the plasminogen 
active and in cheese production will increase soluble nitrogen and increase the 
breakdown of β-casein [67].  In mastitis the function of these PAs produced by 
pathogenic microorganisms is to assist the proteolytic breakdown of fibrin and 
other extracellular matrix proteins, which facilitates bacterial penetration of 
normal tissue barriers and enables bacterial colonisation in deep tissue sites.  
The mechanism of function in cancer cells can be described as analogous to the 
invasion process of bacteria as they both immobilise plasmin on their surfaces in 
order to enhance proteolytic activity. 
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2.5.4. Serine Proteinase Inhibitors 
 
Various plasmin inhibitors (PI) and plasmin activator inhibitors (PAI) inhibit the 
conversion of plasminogen to the active form plasmin [77].  Precetti et al. [78] 
isolated two major serine proteinase inhibitors in bovine milk, namely 
plasminogen activator inhibitor 1 (55,000 Da) and α2-antiplasmin (60,000 Da).  
The principle plasmin inhibitor in bovine milk is α2-antiplasmin that directly inhibits 
plasmin activity in vivo [79].  In humans the α2-antiplasmin is a single chain 
glycoprotein with a molecular weight of 70,000 Da [80].  There is homology 
between human and bovine α2-antiplasmin, particularly at the reactive site and at 
the N-terminal [81].  Bovine PAI–1 is also a 55,000 Da single chain glycoprotein.  
The low molecular mass of both α2-antiplasmin and PAI–1 allows these inhibitors 
to migrate from the blood into the milk in order to participate in the control of 
plasmin activity. 
 
In Chapter 3 the composition, functionality and protein structure of bovine milk is 
discussed in detail to better understand the effect of fibrinolytic milk proteases on 
milk proteins. 
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Chapter 3 
 
 
COMPOSITION AND FUNCTIONALITY OF MILK PROTEIN 
 
3.1. Introduction 
 
In 1890 Stephen Babcock suggested the occurrence of an indigenous protease 
in milk and since the 1900’s there have been numerous publications confirming 
the presence of proteases in milk [27]. There are also well documented examples 
of the effect that such protease activity induces on milk proteins, the character of 
milk and milk products [44,50-54].  At first it was believed that all protease activity 
occurs as a result of bacterial contamination.  The presence of native milk 
proteases in milk has since been confirmed and as a result the native milk 
proteases have been studied intensely for the past three decades.  In Table 3.1 a 
general classification of proteases in bovine milk, according to Hartley, is given 
[82].   
 
Table 3.1:  General classification of proteases [82] 
 
General classification of proteases 
Class Examples Inhibitorsi
Serine proteases trypsin, chymotrypsin, elstase, 
thrombin, plasmin 
DFP, PMSF, natural trypsin 
inhibitor (soybean, pancreas)  
Sulphydryl proteases papain, bromelain, ficin SH reagents (e.g. NEM, 
PCMB) 
Metallo proteases aminopeptidase, 
carboxypeptidases A and B, 
thermolysin 
metallo complexing agents 
(e.g. EDTA) 
Acid (carboxyl) proteases pepsin, chymosin, gastricsin DAN, EPNP, pepstatin 
i DFP, di-isopropylfluorophosphate; PMSF, phenylmethylsulfonyl fluoride; NEM, N-
ethylmaleimide; EDTA, ethylenediaminetetraacetic acid; DAN, diazoacetylnorleucine methyl 
ester; EPNP, 1,2 epoxy-3(p-nitrophenoxy) propane; PCMB, para-chloromercuribenzoate 
28 
The main indigenous protease identified in milk is plasmin, which occurs in its 
inactive precursor form plasminogen in milk [3-6,12,23,27,28].  Plasmin has been 
isolated and characterised, but the exact mechanism of its activation still remains 
the main focus of studies conducted on the fibrinolytic system in milk.  The 
cascade of reactions resulting in the activation of plasminogen consists of various 
activator and inhibitor enzymes [8-10,19,20].  The fibrinolytic system acts as an 
anti-coagulant that solubilises fibrin clots in the blood [56,57,65]. 
 
3.2. Protein composition of bovine milk 
 
In order to elucidate the functionality of proteases, especially with regard to the 
fibrinolytic system in bovine milk, it is important to understand the composition of 
milk in terms of the protein structure and functionality of its proteins. 
 
There are two distinct types of proteins present in milk, namely caseins and whey 
proteins.  The ratios of these two types of proteins can differ significantly 
throughout the season and stage of lactation.  Typical values (mid-season) are 
indicated in Table 3.2 [59]: 
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Table 3.2:  Typical composition of mid-lactation bulk milk [59] 
 
The average composition of raw bulk milk 
Constituent Concentration (g.l-1) Percentage (m/m) 
Fat 37.00 3.58 
Protein 34.00 3.29 
Casein 27.60 2.67 
 αs1-casein 10.54 1.02 
 αs2-casein 2.86 0.27 
 β-casein1 10.62 1.03 
 κ -casein 3.58 0.35 
Whey protein 6.40 0.62 
 β-lactoglobulin 0.61 0.06 
 α-lactoglobulin 0.24 0.02 
 Bovine serum albumin 0.09 0.01 
 Minor components2 0.20 0.02 
Non-protein Nitrogen 1.90 0.18 
Lactose 48.00 4.64 
Ash (minerals) 7.00 0.68 
Total Solids 127.90 12.37 
1Including γ -casein 
2Including immunoglobulins 
 
Due to the unique properties of the protein components in milk, the casein and 
the whey protein fractions can be separated for further classification using at 
least one of the following four techniques [83-86]: 
 
Iso-electric precipitation: The caseins are insoluble at their iso-electric point (pI 
4.6) at temperatures greater than 8 °C.  Whey proteins are also insoluble at their 
iso-electric point (pI 5.0), but at a low ionic strength.  However, in the ionic 
environment of milk they are solubilised at a pH of 5.0. 
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Rennet coagulation: The induction of coagulation of casein is caused by limited 
proteolysis, which is induced by crude protease preparations, known as rennets.  
Commercially this is the basic principle of the manufacturing of cheese. 
 
Centrifugation/filtration: In milk, casein occurs in its natural form as large 
aggregates or micelles.  Thus these casein micelles can be separated from 
molecularly dispersed whey proteins by ultracentrifugation techniques.  Although 
not of significance in the dairy industry, it is commonly used in laboratory 
environments when casein micelle preparations are prepared (100,000 X g for  
60 minutes).  Micelles can also be separated from whey proteins by using 
ultrafiltration techniques.  Ultrafiltration has been used with success in the dairy 
industry for the manufacture of cheese and fermented products. 
 
Salting out:  Casein can be precipitated from solution by a variety of salts.  
Casein together with some whey proteins can be salted out by the addition of 
ammonium sulphate ((NH4)2SO4) at a concentration of 260 g.l-1 of milk. 
 
3.2.1. Casein 
 
Iso-electric casein, which constitutes over 80 percent of the total protein in milk, 
can be divided into four primary caseins, namely: alphas1- (αs1-), alphas2- (αs2-), 
beta- (β-) and kappa (κ-) casein.  The approximate ratio of these four caseins in 
bulk milk are 40 (αs1):10 (αs2): 35 (β): 12 (κ).  The minor protein fraction in milk 
originates as a result of post-secretion proteolysis of the primary casein fractions 
due to the action of plasmin.  These polypeptides include gamma-caseins (γ1, γ2, 
γ3) and proteose peptones [84,85]. The four primary caseins exhibit “micro-
heterogeneity” due to the variations in the degree of glycosylation, disulphide-
linked polymerization and genetic polymorphism (genetically controlled amino-
acid distribution) [84-88].   
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Of the 80 % of casein in milk, 94 % of the dry weight is the physical protein and 
the remaining 6 % consists of citrate and calcium, phosphate and magnesium 
ions [89-92].  The calcium and phosphate are referred to collectively as the 
colloidal calcium phosphate fraction in the milk. 
 
The casein micelle has a porous structure and is composed of submicelles,  
10-15 nm in diameter [93-95].  The micelles are highly hydrated, approximately  
2 g H2O.g-1 protein [96].  Caseins are relatively small molecules as indicated by 
their respective molecular weights in Table 3.3. The casein micelles are 
composed of spherical submicelles, 10-15 nm in diameter.  The hydrophobic core 
of the submicelles is considered to consist of the Ca-sensitive αs1-, αs2- and β-
caseins, with variable amounts of κ-casein located principally on the surface.  
The hydrophobic N-terminal of the κ-caseins interact hydrophobically with the αs1-
, αs2- and β-caseins, while the hydrophilic C-terminal protruding from the surface 
of the casein submicelles forms the “hairy” region [55]. 
 
Table 3.3: Molecular mass and physio-chemical characteristics of bovine casein 
[59] 
 
 
Casein Moles P 
per mole 
Molecular 
mass (Mr) 
Charge at 
pH 6.6 
Isoionic pH Hφaverage KJ 
per residue 
Absorptivity 
(cm2/g) at 
280 nm 
alphas1- (αs1-) 8 23,600 - 20.9 4.96 4.87 1.05 
alphas2- (αs2-) 13 25,388 -18.0 5.19 - 1.10 
alphas2- (αs2-) 12 25,308 - 16.4 5.25 - 1.10 
alphas2- (αs2-) 11 25,228 - 14.8 5.32 - 1.10 
alphas2- (αs2-) 10 25,148 - 13.2 5.39 4.64 1.11 
beta- (β-) 5 23,980 - 12.3 5.19 5.58 0.46 
gamma- (γ-) - 19,550 - - - - 
kappa (κ -) 1 19,037 - 3.9 5.43 5.12 0.95 
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The casein micelle structural network consists of αs-casein molecules interacting 
with calcium phosphate by virtue of the serine phosphate esters in the αs casein 
[86-88].  Kappa- and β-casein are also accommodated within this structural 
framework of the αs-casein and the casein phosphate.  Migration of the κ- and β- 
casein can occur in milk from the casein micelle itself into the serum phase of the 
milk.  This normally occurs during prolonged storage of the milk at low 
temperatures [89-93,97].  During the heating of milk the β-and κ-casein re-
associates with the casein micelle, but at this stage it is unclear whether the 
same native structure of the β- and κ-casein is attained.  The κ-casein is mainly 
localised near the surface of the casein micelle, where it provides stability to the 
entire structure by virtue of its charge [94-96]. 
 
 
Casein micelle Casein sub-micelle 
Ca9(PO4)6 cluster 
 
CMP “hairy” layer 
hydrophobic core 
κ -casein enriched surface 
 
Figure 3.1: Diagrammatic representation of casein micelles and sub-micelles 
[98]. 
 
Natural casein is remarkably stable, and this can be attributed to a zeta potential 
of approximately -20 mV at 20°C and the steric stabilisation provided by the 
“hairy” layer [98]. All casein molecules are insoluble around their iso-electric 
points (pI 4.5 – 4.9).  Caseins are strongly hydrophobic in the order β > κ > αs1 > 
αs2 and are small, random, unstructured, open molecules [95].  These features 
markedly influence their functional properties. 
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 The αs1-casein is a highly charged molecule (net charge at pH 6.6 = 20.6) 
whereas αs2-casein is the most hydrophilic of all the casein species (net charge 
at pH 6.6 = 9.5).  The αs2-casein molecule can be divided into definite 
hydrophobic and hydrophilic domains.  Beta-casein is also a highly charged 
molecule (net charge at pH 6.6 = 12) while κ-casein is an amphipathic molecule 
(net charge at pH 6.6 = 10). The α- and β-caseins are phosphoproteins with 
between 5 and 13 phosphoserine groups [91-94].  As a result of the high content 
of the phosphoserine residues, αs1-, αs2- and β-casein binds the polyvalent 
calcium (Ca++) and zinc cations (Zn++) strongly.   
 
Kappa-casein has one serine phosphate ester and contains a charged 
carbohydrate moiety.  Therefore, in contrast to the other casein species is 
insensitive to the addition of calcium [89,92]. 
 
Gamma casein is formed by hydrolyses of the β-casein molecules after secretion 
of the β-casein in the mammary glands into the milk.  Gamma-casein constitutes 
only a small portion of the casein in good quality milk from cows in mid-lactation 
(less than 5% of the total casein fraction), but can be as high as 10% of the total 
casein fraction in cows in late lactation [90].  When the γ-casein exceeds this 
level, it is due to protease activity within the milk [99].  The source of the milk 
protease can either be of bacteriological origin, or could be as a result of native 
proteases present in the milk.  Due to proteolysis it can be difficult to process the 
milk into certain types of products.  To limit the bacteriological protease activity, 
better hygienic practices can be instigated in order to improve the bacteriological 
quality of the milk.  However, in the case of native protease being present in the 
milk, no prompt remedial action can be taken [90]. 
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 Table 3.4: Average Characteristics of Casein Micelles [55] 
 
Characteristic  Value 
Diameter 120 nm (range: 50 – 500 nm) 
Surface Area 8 X 10-10 cm2
Volume 2.1 X 10-15 cm3
Density (hydrated) 1.0632 g.cm-3
Mass 2.2 X 10-15 g 
Water content 63% 
Hydration 3.7 g H2O. g-1 protein 
Voluminosity 4.4 cm3. g-1
Molecular weight (hydrated) 1.3 X 109 Da 
Molecular weight (dehydrated) 5 X 108 Da 
Number of peptide chains 104
Number of particles / ml milk 1014 - 1016
Surface area of micelles / ml milk 5 X 104 cm2
Mean free distance 240 nm 
 
The calcium concentration in bovine milk is of technological importance to the 
dairy industry as it influences a number of properties in the milk, such as heat 
stability, alcohol stability, rennet coagulability and the strength and syneresis 
properties of rennet gels [84].  Temperature, pH and ionic strength of the solution 
influences calcium binding to casein micelles.  Calcium binding to the casein 
molecules takes place exclusively at the phosphoseryl residues, but at higher 
concentrations it can also bind to the Asp or Glu residues [67].  Binding of the 
casein to the calcium at the phosphoseryl groups reduces the net charge of the 
casein molecules, resulting in the association of the protein molecules [67,86-90].  
Calcium and αs1-casein form octamers, which aggregate and precipitate at higher 
calcium concentrations.  Calcium mediated association with the hydrophobic β-
casein is temperature dependant and β-casein is soluble in the presence of 
calcium at temperatures less than 20°C.  Kappa-casein contains only one 
phosphoserine residue and, therefore, does not bind calcium strongly and 
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remains soluble at high calcium concentrations.  Kappa-casein also binds with 
αs1- and β-casein at high calcium concentrations to form colloidal particles.  
These colloidal particles, however, are less stable than the native casein micelles 
[83,84]. 
 
The phosphoserine resides are responsible for the unique properties of casein, 
such as the calcium sensitivity of milk protein [82-86].  With the addition of 
calcium in casein solutions such as milk, the casein coagulates due to inter-
molecular calcium bridges that are formed.  Eighty-five percent of the iso-electric 
αs1-, αs2- and β-casein are insoluble at calcium concentrations of above 6 mM 
[67,89].  Destabilisation of the casein micelles will result in coagulation, 
precipitation or gelation.  The destabilisation of the casein micelle structure can 
be introduced by: (i) acid treatment (usage of lactic acid bacteria), (ii) organic 
solvents (such as hydrochloric and phosphoric acid), (iii) heat treatment, (iv) 
limited proteolysis (αs2- and β-casein being the preferred substrates for native 
proteases and κ-casein being the substrate for rennet coagulation), (v) addition of 
ethanol, (vi) addition of calcium or a combination of the treatments mentioned 
above [82-96].  The knowledge of such behaviour and the application thereof in 
the food industry, directly relates to the manufacturing of cheese and the 
formation of acidic gels in yoghurt manufacture.   
 
The clusters of the phosphoserine residues in the casein molecule are 
responsible for the highly charged hydrophilic areas in the molecule.  When the 
separation of the hydrophobic and hydrophilic regions within the casein molecule 
takes place, it acts as an effective surface-active agent.  As a result casein 
molecules are excellent stabilisers of foams and emulsions and therefore have 
widespread applications in the food industry. 
 
In Fig. 3.2 a conceptual model by Carl Holt and co-workers at Hannah Research 
Institute, Scotland, is presented for the casein molecule, indicating the 
equilibrium between the micelle and the milk serum with acidification and with 
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heating [100].  The casein particle is demonstrated as a highly hydrated, 
spherical, open sized micelle with the polypeptide chains in the core partly cross-
linked by nanometer sized clusters of calcium phosphate.  The internal structure 
gives rise to an external region of lower segment density known as the hairy 
layer, which confers steric and/or charge stability to native casein particles. 
 
 
 
Figure 3.2: Casein model as suggested by Carl Holt and co-workers at Hannah 
Research Institute, Scotland [100]. 
 
Table 3.5 lists the amino acid composition of the principle proteins of bovine milk.  
In Figs. 3.3 to 3.5 the amino acid composition of αs1-casein, αs2-casein, β-casein 
and κ-casein are indicated [55].  The plasmin cleavage on β-casein yields    γ 1-,  
γ 2-, γ 3-caseins, which are indicated in Fig. 3.5. 
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Table 3.5: Amino Acid Composition of the Principle Proteins in Bovine Milk 
 
Amino Acid αs1-casein 
B 
αs2-casein 
A 
β-casein 
A2
κ-casein B γ1-casein 
A2
γ2-casein 
A2
γ3-casein 
A 
β-LG A α-LA B 
Asp 7 4 4 4 4 2 2 11 9 
Asn 8 14 5 7 3 1 1 5 12 
Thr 5 15 9 14 8 4 4 8 7 
Ser 8 6 11 12 10 7 7 7 7 
SerP 8 11 5 1 1 0 0 0 0 
Glu 24 25 18 12 11 4 4 16 8 
Gln 15 15 21 14 21 11 11 9 5 
Pro 17 10 35 30 34 21 21 8 2 
Gly 9 2 5 2 4 2 2 3 6 
Ala 9 8 5 15 5 2 2 14 3 
½ Cys 0 2 0 2 0 0 0 5 8 
Val 11 14 19 11 17 10 10 10 6 
Met 5 5 6 2 6 4 4 4 1 
Ile 11 11 10 13 7 3 3 10 8 
Leu 17 13 22 8 19 14 14 22 13 
Tyr 10 12 4 9 4 3 3 4 4 
Phe 8 6 9 4 9 5 5 4 4 
Trp 2 2 1 1 1 1 1 2 4 
Lys 14 24 11 9 10 $4 3 15 12 
His 5 3 5 3 5 4 3 2 3 
Arg 6 6 4 5 2 2 2 3 1 
PyroGlu 0 0 0 1 0 0 0 0 0 
          
Total residues 199 207 169 209 181 104 102 162 123 
Mr 23612 25228 19005 23980 20520 11822 11557 18362 14174 
HΦave 
(kJ/residue) 
4.89 4.64 5.12 5.58 5.85 6.23 6.29 5.03 4.68 
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1                              Glu-Val-Leu-Asn-Glu-Asn-Leu- 
H. Arg-Pro-Lys-His-Pro-Ile-Lys-His-Gln-Gly-Leu-Pro-Gln-…………………………………. 
21 
Leu-Arg-Phe-Phe-Val-Ala-(Variants B, C, D, E) 
               -Pro-Phe-Pro-Glu-Val-Phe-Gly-Lys-Glu-Lys-Val-Asn-Gln-Leu             
…………………………………………………… …(Variant A)  
41         Ala (Variants A, B, C, E)             Gln (Variants A, B, C, D) 
Ser-Lys-Asp-Ile-Gly-SerP-Glu-SerP-Thr-Glu-Asp-Gln-  -Met-Glu-Asp-Ile-  -Met 
          ThrP (Variant D)               Glu (Variant E) 
61 
Glu-Ala-Glu-SerP-Ile-SerP-SerP-SerP-Glu-Glu-Ile-Val-Pro-Asn-SerP-Val-Glu-Gln-Lys-His- 
81 
Ile-Gln-Lys-Glu-Asp-Val-Pro-Ser-Glu-Arg-Tyr-Leu-Gly-Tyr-Leu-Glu-Gln-Leu-Leu-Arg 
101 
Leu-Lys-Lys-Tyr-Lys-Val-Pro-Gln-Leu-Glu-Ile-Val-Pro-Asn-SerP-Ala-Glu-Glu-Arg-Leu 
121 
His-Ser-Met-Lys-Glu-Gly-Ile-His-Ala-Gln-Gln-Lys-Glu-Pro-Met-Ile-Gly-Val-Asn-Gln- 
141 
Glu-Leu-Ala-Tyr-Phe-Tyr-Pro-Glu-Leu-Phe-Arg-Gln-Phe-Tyr-Gln-Leu-Asp-Ala-Tyr-Pro- 
161 
Ser-Gly-Ala-Trp-Tyr-Tyr-Val-Pro-Leu-Gly-Thr-Gln-Tyr-Thr-Asp-Ala-Pro-Ser-Phe-Ser- 
181            Glu (Variants A, B, D)          199 
Asp-Ile-Pro-Asn-Pro-Ile-Gly-Ser-Glu-Asn-Ser- -Lys-Thr-Thr-Met-Pro-Leu-Trp. OH 
            Gly (Variants C, E) 
 
 
Figure 3.3: Amino acid sequence information for αs1-casein; amino acid 
substitutions or deletions in principle genetic variants. 
 
 
1 
H. Lys-Asn-Thr-Met-Glu-His-Val-SerP-SerP-SerP-Glu-Glu-Ser-Ile-Ile-SerP-Gln-Glu-Thr-Tyr- 
21 
Lys-Gln-Glu-Lys-Asn-Met-Ala-Ile-Asn-Pro-Ser-Lys-Glu-Asn-Leu-Cys-Ser-Thr-Phe-Cys- 
41 
Lys-Glu-Val-Val-Arg-Asn-Ala-Asn-Glu-Glu-Glu-Tyr-Se-Ile-Gly-SerP-SerP-SerP-Glu-Glu- 
61 
SerP-Ala-Glu-Val-Ala-Thr-Glu-Glu-Val-Lys-Ile-Thr-Val-Asp-Asp-Lys-His-Tyr-Gln-Lys- 
81 
Ala-Leu-Asn-Glu-Ile-Asn-Gln-Phe-Tyr-Gln-Lys-Phe-Pro-Gln-Tyr-Leu-Gln-Tyr-Leu-Tyr- 
101 
Gln-Gly-Pro-Ile-Val-Leu-Asp-Pro-Trp-Asp-Gln-Val-Lys-Arg-Asn-Ala-Val-Pro-Ile-Thr- 
121 
Pre-Thr-Leu-Asn-Arg-Glu-Gln-Leu-SerP-Thr-SerP-Glu-Glu-Asn-Ser-Lys-Lys-Thr-Val-Asp- 
141 
Met-Glu-SerP-Thr-Glu-Val-Phe-Thr-Lys-Lys-Thr-Lys-Leu-Thr-Glu-Glu-Glu-Lys-Asn-Arg- 
161 
Leu-Asn-Phe-Leu-Lys-Lys-Ile-Ser-Gln-Arg-Tyr-Gln-Lys-Phe-Ala-Leu-Pro-Gln-Tyr-Leu- 
181 
Lys-Thr-Val-Tyr-Gln-His-Gln-Lys-Ala-Met-Lys-Pro-Trp-Ile-Gln-Pro-Lys-Thr-Lys-Val- 
201        207 
Ile-Pro-Tyr-Val-Arg-Tyr-Leu.  OH 
 
 
Figure 3.4: Amino acid sequence information for αs2-casein, indicating 11 of the 
possible 13 phosphorylation sites. 
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1 
H. Arg-Glu-Leu-Glu-Glu-Leu-Asn-Val-Pro-Gly-Glu-Ile-Val-Glu-SerP-Leu-SerP-SerP-Serp-Glu- 
 
21      γ1-caseins           Ser          Lys  (Variant C) 
Glu-Ser-Ile-Thr-Arg-Ile-Asn-Lys-Lys-Ile-Glu-Lys-Phe-Gln- -Glu- -Gln-Gln-Gln- 
              SerP         Glu (Variants A, B) 
41 
Thr-Glu-Asp-Glu-Leu-Gln-Asp-Lys-Ile-His-Pro-Phe-Ala-Gln-Thr-Gln-Ser-Leu-Val-Tyr-     
61           Pro (Variants A2, A3) 
Pro-Phe-Pro-Gly-Pro-Ile- -Asn-Ser-Leu-Pro-Gln-Asn-Ile-Pro-Pro-Leu-Thr-Gln-Thr-  
           His (Variants A1, B, C) 
81 
Pro-Val-Val-Val-Pro-Pro-Phe-Leu-Gln-Pro-Glu-Val-Met-Gly-Val-Ser-Lys-Val-Lys-Glu-    
 
      γ2-caseins 
101       His (Variants A1, A2, B, C) 
Ala-Met-Ala-Pro-Lys- -Lys-Glu-Met-Pro-Phe-Pro-Lys-Tyr-Pro-Val-Glu-Pro-Phe-Thr- 
 (Variant A3)  Gln  
              γ3-caseins 
121  Ser (Variants A, C) 
Glu- -Gln-Ser-Leu-Thr-Leu-Thr-Asp-Val-Glu-Asn-Leu-His-Leu-Pro-Leu-Pro-Leu-Leu 
       Arg (Variant B) 
141 
Gln-Ser-Trp-Met-His-Gln-Pro-His-Gln-Pro-Leu-Pro-Pro-Thr-Val-Met-Phe-Pro-Pro-Gln- 
161 
Ser-Val-Leu-Ser-Leu-Ser-Gln-Ser-Lys-Val-Leu-Pro-Val-Pro-Gln-Lys-Ala-Val-Pro-Tyr 
181 
Pro-Gln-Arg-Asp-Met-Pro-Ile-Gln-Ala-Phe-Leu-Leu-Tyr-Gln-Glu-Pro-Val-Leu-Gly-Pro 
201      209 
Val-Arg-Gly-Pro-Phe-Pro-Ile-Ile-Val.  OH 
 
Figure 3.5: Amino acid sequence information for β-casein; amino acid 
substitutions in principle genetic variants and plasmin cleavage sites are 
indicated. 
 
 
1 
Pyro-Glu-Glu-Gln-Asn-Gln-Glu-Gln-Pro-Ile-Arg-Cys-Glu-Lys-Asp-Glu-Arg-Phe-Phe-Ser-Asp- 
21 
Lys-Ile-Ala-Lys-Tyr-Ile-Pro-Ile-Gln-Tyr-Val-Leu-Ser-Arg-Trp-Pro-Ser-Tyr-Gly-Leu- 
41 
Asn-Tyr-Tyr-Gln-Gln-Lys-Pro-Val-Ala-Leu-Ile-Asn-Asn-Gln-Phe-Leu-Pro-Tyr-Pro-Tyr- 
61 
Tyr-Ala-Lys-Pro-Ala-Ala-Val-Arg-Ser-Pro-Ala-Gln-Ile-Leu-Gln-Trp-Gln-Val-Leu-Ser- 
81 
Asn-Thr-Val-Pro-Ala-Lys-Ser-Cys-Gln-Ala-Gln-Pro-Thr-Thr-Met-Ala-Arg-His-Pro-His- 
101          105  106 
Pro-His-Leu-Ser-Phe-Met-Ala-Ile-Pro-Pro-Lys-Lys-Asn-Gln-Asp-Lys-Thr-Glu-Ile-Pro- 
121         Ile (Variant B) 
Thr-Ile-Asn-Thr-Ile-Ala-Ser-Gly-Glu-Pro-Thr-Ser-Thr-Pro-Thr-         -Glu-Ala-Val-Glu- 
          Thr (Variant A) 
141    Ala (Variant B) 
Ser-Thr-Val-Ala-Thr-Leu-Gln-  -SerP-Pro-Glu-Val-Ile-Glu-Ser-Pro-Pro-Glu-Ile-Asn- 
    Asp (Variant A) 
161           169 
Thr-Val-Gln-Val-Thr-Ser-Thr-Ala-Val.  OH 
 
 
Figure 3.6: Amino acid sequence information for κ-casein; amino acid 
substitutions in principle genetic variants and chymosin cleavage sites are 
indicated. 
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3.2.2. Whey proteins 
 
Whey proteins are typical globular proteins with high levels of secondary, tertiary 
and quarternary structures that can be denatured when heating takes place at 
temperatures above 65°C [67].  The four major constituents of the whey protein 
fractions in milk, from healthy mid-lactation cows, are: beta-lactoglobulin  
(β-lactoglobulin, 50%), alpha-lactalbumin (α-lactalbumin, 20%), bovine serum 
albumin (BSA, 10%) and immunoglobulins (Ig, 10%) - mainly IgG1 with lesser 
amounts of IgG2, IgM and IgA present [67]. During late lactation milk or milk with 
mastitis (with high somatic cell counts) increased levels of the blood-derived 
proteins such as bovine serum albumin and immunoglobulin may be present.  
Human milk contains no β-lactoglobulin and the principle Ig is IgA.  The whey 
proteins in bovine milk are not phosphorylated and are insensitive to calcium; 
they contain intra-molecular disulfide bonds that stabilise their structure [67,86].  
 
Beta-lactoglobulin is the most abundant protein in whey (about 6 g.l-1) and is 
responsible for functional properties such as the ability of whey proteins to form a 
gel upon heating. Beta-lactoglobulin, contains the sulphur amino acid, cysteine, 
which upon heating may participate in sulfhydryl exchange reactions leading to 
inter-and intra-molecular cross-linking with other proteins [55,67].  One such 
reaction is the interaction of κ-casein and β-lactoglobulin which upon heating at 
75°C for 15 seconds forms a complex [67].  The κ-casein and β-lactoglobulin 
complex can impair rennet coagulation properties of milk and alter the gel 
structure and rheological properties of acid-based gel products, such as yoghurt 
and fresh cheeses. 
 
Beta-lactoglobulin is a dimer of identical units, each unit contains a number of β-
sheet structures as well as some α-helix [101]. A special feature is that the β-
sheets are arranged in such a way as to give rise to a central cavity (a β-barrel) 
where small hydrophobic molecules may be bound.  
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3.2.3. Proteose peptones 
 
Proteose peptones are short peptides that are formed as a result of the 
breakdown of casein by proteases.  The proteose peptone fraction in milk consist 
of approximately 38 components of which at least 65% can be attributed to 
hydrolysis of casein by the native enzyme plasmin [5,56,57,65].  Quantification of 
these results on gel electrophoresis indicated that 52% was as a result of the 
hydrolysis of β-casein, 29% from αs1-casein, 9% from αs2-casein and 4% from κ-
casein [102].  The remaining 6% of the proteose peptone fractions can be 
attributed to the function of other proteases [56,102].  It has been shown that 
there is an almost linear relationship between plasmin activity and the proteose 
peptone fraction.  Seventy seven percent of the fraction can be attributed to 
proteose peptones being produced within the secretory cell cytoplasm and the 
remaining 23% can be attributed to the function of post secretory plasmin activity 
[44,51,52]. 
 
3.2.4. Milk proteases 
 
Milk proteases present in bovine milk originate from endogenous proteases or 
from proteases produced by microorganisms.  Endogenous proteases are 
transferred from the blood to the milk through the blood-milk barrier, and 
proteases produced from microorganisms are secreted in the milk after 
contamination [4,55]. 
 
Endogenous enzyme originates from three different sources; namely the blood or 
other organs via the blood, the secretory cell cytoplasm and the fat globule itself 
(the outer layer of the fat globule membrane is made up of the apical membrane 
of the secretory cells, which is formed by the membranes of the Golgi-apparatus) 
[6]. 
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Bacterial proteases can originate from multiple sources and do not necessarily 
occur after the secretion of milk.  The remaining 45% of the proteose peptone 
fraction is attributed to the proteolytic activity of other proteases present in the 
milk.  Infection can take place within the udder of the cow. Bacteria such as 
Staphylococcus aureus, Streptococcus uberis, Escherichia coli, Streptococcus 
agalactia and Streptococcus dysagalactiae can infect the cow’s udder via the teat 
channel.  The infection can take place due to a number of reasons, such as: 
over-milking, contaminated feed, contamination of the milk with soil and dust, 
contaminated silage, unhygienic milking utensils, contaminated water and 
unhygienic milking parlours [55].  Bacterial contamination of the milk can also 
take place after milk production, which normally relates to unhygienic practices 
such as incorrect cooling of the milk. The presence of psychrotrophic bacteria is 
the main contributing factor to extra cellular bacterial proteases in milk.  
Psychrotrophic bacteria are not part of the secreted udder-flora, and therefore 
their presence can normally be attributed to: (i) poor cleaning practices and 
hygiene on farms and in factories, (ii) extended storage of raw milk (more than 24 
hours) at temperatures less than 4°C and (iii) post-pasteurization contamination 
[103,104].  Gram-negative Pseudomonas psychrotrophic bacteria, such as 
Pseudomonas putida, Pseudomonas fragi and Pseudomonas fluorescens, 
produce thermo-stable proteases, which are killed at normal pasteurisation 
temperature (72.5°C for 15 seconds). However, normal pasteurisation 
temperature do not inactivate psychrotrophic spore forming bacteria, such as 
Bacillus, which are more heat resistant [7,84,105,106].  Studies have indicated 
that contamination with psychrotrophic bacteria at levels of between 1.8 million 
and 9.5 million bacteria.ml-1 can hydrolyse between 61-91% of the κ-casein and 
19-76% of the α-casein in 9 days [7,103,104]. 
 
Acid milk protease has a pH optimum of 4.0 and a Mr of 36,000 Da.  The 
properties of acid milk protease are similar to that of cathepsin D, with αs1-casein 
being the preferred substrate for hydrolysis over β-casein.  The enzyme is 
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associated with the casein micelles in the milk and due to its activity and plays a 
significant role during the ripening of cheese [61]. 
 
Thrombin is a serine protease that hydrolyses the peptide bonds containing 
arginine.  Thrombin exhibits high substrate specificity and, therefore, the 
proteolysis effect in milk is strongly reduced in contrast to other proteases, such 
as plasmin and acid milk protease [6]. 
 
Aminopeptidases originate in the blood and have similar hydrolysis properties to 
plasmin.  They are concentrated in the milk serum and can hydrolyse peptide 
bonds containing lysine, alanine and leucine [6]. 
 
In Chapter 4 the influence of the activity of plasmin and plasminogen activators 
on milk and some secondary dairy products is discussed. Plasmin activity in 
bovine milk influences the final overall quality of the product including such 
parameters as, organoleptic acceptability, favourable product composition and 
shelf-life. 
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Chapter 4 
 
 
THE INFLUENCE OF THE FIBRINOLYTIC SYSTEM IN BOVINE 
MILK ON THE DAIRY INDUSTRY 
 
4.1. Introduction 
 
The fibrinolytic system in bovine milk affects both the primary and secondary 
dairy industries.  Two features of the plasmin protease system in milk makes it of 
particular interest to the manufacturers of dairy products. Firstly, the enzyme 
remains active indefinitely during storage of dairy products and secondly, plasmin 
activity survives high heat temperature treatments [107-111]. Therefore the 
reduction or control of plasmin activity in bovine milk will be of benefit to overall 
product quality; including parameters such as organoleptic acceptability, 
favourable product composition and shelf-life.   
 
4.2. Raw, Pasteurised, UHT and Sterilised Milk 
 
Milk proteases can induce thickening, gelation and coagulation upon storage of 
raw bulk milk, pasteurised milk, extended shelf-life milk, UHT milk and sterilised 
milk [7,13,14,28,55,106].  These proteases can be native to the milk (plasmin) or 
can be of bacteriological origin (contamination of milk with spoilage bacteria) 
such as the psychrotrophic bacteria Pseudomonas fluorescens and 
Pseudomonas fragi K122 [5,55].  Plasmin is a heat stable enzyme that survives 
normal pasteurisation and UHT processes. Proteolytic activity in the milk can 
also result in the breakdown of casein to form short peptides and free amino 
acids causing a bitter flavour.   
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Blood only contains plasminogen, thus the activation of plasminogen to plasmin 
occurs during milk synthesis, storage of the milk in the lumen of the udder (prior 
to milking), storage of milk post secretion and during the processing of milk [112-
115].  
 
In fresh milk the plasminogen is activated resulting in an increase in plasmin 
concentration and activity that will lead to the proteolysis of casein substrates.  
The ratio of plasminogen to plasmin can vary from 5:1 to 40:1 in milk of individual 
cows.  The average ratio in good quality bulk milk with a low SCC and low 
bacterial count is approximately 8:1 [19,58].   
 
Due to the increase of PA released from the leukocytes, plasminogen is activated 
to form plasmin.  Plasmin catalyses the breakdown of casein with subsequent 
disruption of the casein micellular structure and liberation of the associated PA.  
The resulting effect is more activation of the pro-enzyme and more plasmin being 
formed as well as an increase in protease activity [6].  It is reported that there is 
an increase of the plasmin and plasminogen concentrations in milk of 82% and 
21%, respectively, during sub-clinical mastitis [8]. 
 
In bovine milk the concentration and activity of the native protease plasmin may 
vary due to numerous factors. 
 
4.2.1. The stage of lactation 
 
As the stage of lactation progresses, the activity of the plasmin and PA increases 
[99,106].  Separate studies showed an increase in γ-casein concentrations and a 
subsequent reduction in the concentration of β-casein fraction in bovine milk 
[100].  The concentration of plasminogen also increased from mid-lactation milk 
to end-lactation milk (almost 2 fold) also indicating more substrate and a bigger 
proteolytic reservoir [107].  The concentration of the plasminogen activators is at 
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the highest level during the dry period of the cow.  This will result in greater 
permeability of the blood-milk barrier and as a result there will be more leakage 
of plasminogen from the blood into the milk where it is converted to plasmin.  Not 
only does the plasmin and proteolytic activity increase with the stage of lactation, 
but also with the number of lactations and the age of the cow [52,66,107]. 
 
4.2.2. Breed of the cow 
 
Plasmin activity can also be correlated to the breed of the cow.  The rate of 
proteolysis by plasmin activity is greater in Friesian milk than in Jersey and 
Ayrshire milk [116].  Once again the results were correlated with the amount of γ-
casein formed after hydrolysis of β-casein, and it was found that Friesian milk 
has twice the concentration of that of Ayrshire and Jersey milk [114].  Jersey milk 
exhibits the lowest concentration of γ-casein produced as a result of proteolytic 
cleavage, due to the activity of plasmin and PA [115].  The results are interesting 
if one also takes into account the relative differences in protein content between 
the cows, that of Ayrshire milk and Jersey milk being approximately 0.4-0.5% 
higher than the protein content in Friesian milk. 
 
4.2.3. Age of the cow 
 
The plasmin content is affected by the age of the cow.  The increase in 
proteolytic activity is mainly as a result of the higher permeability of the blood-
milk barrier in the secretory cells in the udder of the cow.  Subsequently there is 
a bigger transfer of plasmin, plasminogen and PA from the blood to the milk.  The 
plasmin activity also increases with the number of lactations of the cow [115]. 
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 4.2.4. Mastitis 
 
Colonisation of the bovine mammary gland by pathogenic bacteria results in a 
series of events that lead to major alterations in the milk secreted by the bovine 
mammary glands [67,117-119]. 
 
Mastitic infection due to an increase of the pathogenic bacteria in the milk will 
also result in an increase in the somatic cell count (SCC) of the milk.  The effect 
on lactation and milk composition is a reduction in milk yield and impaired 
synthetic stability of the secretory tissue.  This results in changes in the major 
and minor constituents in the milk as indicated in Table 4.1 [67,117-121]. 
 
Table 4.1: Changes in level of various proteins in milk with mastitic infection [67]  
 
Protein (mg/ml) Normal milk Mastitic milk 
Total casein 27.90 22.50 
Total whey protein 8.20 – 8.70 13.10 –19.80 
Caseins   
αs1-casein 9.50 – 13.30 3.00 – 8.50 
β-casein 5.00 – 11.00 0.80 – 6.50 
κ-casein 1.60 1.90 
Para κ-casein 0 0.50 
Whey proteins   
β-lactoglobulin 4.00 – 4.25 2.67 – 4.15 
α-lactalbumin 1.03 – 3.20 0.58 – 2.50 
Bovine serum albumin 0.10 – 0.30 0.65 – 21.50 
Total immunoglobulin 0.25 – 1.33 2.45 – 18.30 
Others   
Proteose peptone 1.82 9.24 
Lactoferrin 0.10 – 0.20 6.20 
Milk fat globule membrane (MFGM) protein 
(mg.100 g-1 fat) 513.70 408.80 
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Zachos et al. [8] also concluded that the PA activity present in the milk somatic 
cells increases approximately eight fold during mastitis (increase in SCC from 
50,000 – 1,000,000 cells.ml-1).  Furthermore, the PA was tissue type rather than 
urokinase type PA, due to an increase in the activity of the PA in the presence of 
fibrin.  Heegaard et al. [20] confirmed an increase in t-PA of 10 to 20 fold 
subsequent to mastitic inflammation induced by Staphylococcus aureus.  The 
increased level of t-PA remained for a period of up to 42 days after infection.  In 
addition to the increase in t-PA, u-PA associated with the bovine cells in the milk 
also increased. 
 
Somatic cell counts are frequently used in the dairy industry as an indicator of 
mastitis and the general udder health of the herd.  In the milk the SCC can be 
divided into two distinct groups, namely the macrophages and the poly-
morphonuclear leukocytes (PMN) [19-21,27,50,57].  These cells are the principle 
phagocytes and constitute the first line of defence against bacterial infection.  
These cells induce inflammation due to the secretion of a number of proteins that 
help the defence against bacterial cells [66,107,117-121]. 
 
Macrophages are more prevalent than PMN in the healthy quarters of cows.  
Upon bacterial infection of the mammary gland, there is a rapid influx of PMN into 
the milk.  Several days after the infection the macrophages again become the 
predominant cell type in the quarter.  The activity detected in the PA from 
macrophages is not fibrin dependent, and is therefore urokinase type PA 
[8,50,57,66].  In Table 4.2 the changes of the ratios of SCC of milk with mastitic 
infection are indicated, the major change with high SCC is the increase in the 
neutrophil concentration in the milk. 
49 
 Table 4.2: Changes in ratios of somatic cells in milk with mastitic infection [8] 
 
 Healthy cows Mastitis 
Somatic cell count (SCC) 50,000 – 200,000 200,000 – 5,000,000 
Lymphocytes 1 1 
Neutrophyls (PMN) 1.5 10 
Epithelial cells 14 10 
 
4.2.5. Post-harvesting and Storage 
 
In order to prevent the growth of spoilage organisms and to protect milk from any 
enzymatic activity (bacteriological or native), post harvesting conditions must be 
optimal.  The conversion of plasminogen to plasmin will increase with an 
increase in temperature.  The plasmin activity will be non-significant at a 
temperature of less than 4°C, but optimal at 37°C.  It is also interesting that the 
activity of plasmin decreases to only between 10-17% with normal pasteurisation 
treatment (72.5°C for 15 seconds).  The longer the storage of pasteurised milk, 
the higher the plasmin activity due to the inactivation of the PAI.  Complete 
inhibition of plasmin will only occur at sterilisation temperatures of 120°C for 15 
minutes, or 142°C for 18 seconds [22,114]. 
 
4.2.6. Solubility 
 
At a pH of 4.6, which is the iso-electric point of casein, there is an approximate 
increase of 4% (from 6% to 10%) in the soluble nitrogen fraction of the milk due 
to proteolysis [29,66,107].  Ninety four percent of the proteose peptone fraction 
can be attributed to the plasmin proteolysis of casein [50,57,107,117]. 
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4.2.7. Ethanol stability 
 
The presence of plasmin induces little if any effect on the alcohol stability in milk 
[44]. 
 
4.3. Cheese 
 
The effects of plasmin on cheese ripening characteristics have also been under 
investigation and there are numerous articles published on this topic 
[54,55,67,72,108,111]. With regard to the final quality of the cheese produced 
with enhanced plasmin activity, the results are, however, contradictory.  
However, these contradictions should be seen in context as different cheeses will 
have different organoleptic, chemical and physical properties, and therefore 
plasmin activity will either enhance or detract from the final product quality, 
depending on the cheese variant produced.  Furthermore the manufacturing 
parameters are different in different types of cheeses.  These parameters include 
starter culture used, ripening time, rennet addition and quantity, type of rennet, 
rennet vs. acid coagulation, heating and scalding, pressing, ripening and curing 
of the cheese.   
 
Fig. 4.1 illustrates the process flow for the basic production of hard and semi-
hard cheeses, while Fig. 4.2 illustrates the process flow for the basic production 
of semi-hard, semi-soft and soft cheese.  These process flows explains the 
difference in production techniques, and will also vary between different varieties 
produced within the same class designation. 
 
In cheese the effect of plasmin in the different variants can be summarised as 
follow: Emmental > Blarney and Romano-types > Gouda > Cheddar > Cheshire.  
The differences in the effect of the plasmin activity can mainly be attributed to the 
cooking temperatures of the cheese, the pH and the percentage moisture in the 
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final product.  Overall the increase in the plasmin concentration and activity 
decreases the viscosity of a caseinate solution.  In cheese plasmin, plasminogen 
and PA are incorporated into the curd, while PAI and PI are located mainly in the 
whey fraction [55,122].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Raw Milk 
Pasteurisation 
Standardisation 
Ultra-filtration 
Cream
Separation 
Thermisation 
Bactofugation
Microfiltration 
Curd 
Manufacture 
Pre-pressing 
Moulding Cheddaring 
Final Pressing Milling 
Brining 
Hooping 
Final Pressing 
Ripening 
Starter Culture, 
Rennet, CaCl2 
Cheese milk
1. Fat standardisation 
2. Fat relative to Solids Non Fat 
 
Pasteurisation:  
3. 70-72°C/15-20 s (not always 
employed) 
4. Cooling to about 30°C (renneting 
temperature) 
Optional - Mechanical reduction of 
bacteria: 
Bactofugation or Microfiltration 
 
Curd manufacture: 
5. Ripening in the cheese vat 
6. Additives: 
– Calcium chloride 
– Saltpeter (Optional) 
– Starter bacteria 
Coagulum 
7. Additives: 
– Rennet as coagulant 
 
Cutting  
8. Into grains (curd) / Cheese knives 
 
Heating / Scalding 
9. Directly or indirectly, depending on 
type of cheese 
 
Pre-pressing and Salting 
10. Collection of curd for pre-pressing 
and/or 
final moulding/pressing, and if required 
11. Brine salting 
 
or for Cheddar cheese 
 
Cheddaring 
12. Cheddaring followed by milling, salting, 
hooping, and final pressing 
 
Ripening and Maturation  
13. Formed, pressed, and salted cheese to 
ripening room storage for required time 
 
Salting 
 
Figure 4.1:  Production of hard and semi-hard cheeses. 
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Cutting  
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24°C at 90% + humidity.  Turning while 
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Brining 
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13. Camembert / Brie: 23% NaCl solution, 
1 - 2 hours at 15°C 
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Blue Veined: 
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17. Storage and distribution at < 5°C. 
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18. Maturation at 18°C for 2 days at 80% 
relative humidity.  
19.  Maturation at 12°C for 10 - 12 days at 
90% relative humidity with frequent 
turning of moulds.  
20. Wash and wrap in aluminum foil. 
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Skimmilk Cream 
Surface Mould 
growth medium 
addition 
Camembert / 
Brie (Spray) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2:  Typical process flow for the production of semi-hard / semi-soft 
cheese.  The process flow is basically the same for the production of semi-soft / 
soft cheese. 
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Proteolysis in cheese ripening can be attributed to two sources, namely the 
action of the residual rennet in the cheese, of which approximately 6–10% is 
retained in the final product, and plasmin activity [123-128].  The hydrolysis of 
αs1- and para-κ-caseins during ripening is mainly associated with the function of 
the rennet enzyme.  Plasmin in cheese is more specific for firstly, β-casein, 
secondly, αs2-casein and thirdly, αs1-casein.  Alpha-lactalbumin and β-
lactoglobulin are quite resistant against the hydrolytic action of plasmin [129].   
 
Plasmin is not rate limiting for the development of flavour during cheese ripening, 
as it is responsible for the formation of rather large to medium-sized peptides 
(primary proteolysis), which does not contribute to flavour.  However, during 
secondary proteolysis these large to medium-sized peptides may be broken 
down by proteinases and peptidases from lactic acid starter bacteria, which will 
result in the formation of the flavour components, consisting of shorter peptides 
and free amino-acids [129,130,131]. 
 
4.3.1. Hard and Semi-hard Cheese 
 
Farkye and Landkrammer [125] reported that proteolysis in the production of 
Cheddar cheese increased with plasmin activity and resulted in an overall 
improvement of flavour and quality of the cheese after three and six months of 
ripening. They also concluded that a 6-fold increase in plasmin activity in the milk 
did not significantly affect the composition of the cheese produced in terms of 
moisture, protein and NaCl, although there was a slight increase in moisture and 
decrease in protein percentages in the final product.  They concluded that milk 
with an approximate 3-fold enhanced level of plasmin resulted in the best overall 
quality cheddar cheese produced.  The increased plasmin activity was obtained 
by adding plasmin to the milk before ripening and renneting, although it will not 
be viable in commercial applications due to the cost associated with the 
purification of bovine plasmin.  They suggested that alternative methods should 
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be investigated such as increasing PA activity to convert native plasminogen to 
plasmin. 
 
Lau et al. [132] produced Cheddar cheese from raw and heated milk (63°C for 30 
minutes), and concluded that the cheese produced from the heated milk 
exhibited a lower proteolysis rate for αs- and β-caseins than from raw milk used.  
This was attributed to the lower plasmin activity in the heated milk.  In contrast 
Banks et al. [133], Alichanidis et al. [109] and Calvo et al. [134] applied different 
heat treatments in milk to produce Cheddar cheese and concluded that the 
cheese manufactured at higher temperatures (110 °C for 60 seconds) resulted in 
an increased proteolytic digestion of β-casein as supposed to milk heated at 63 
°C for 30 minutes. The cheese of the milk treated with higher temperature will 
incorporate more denatured whey proteins in the cheese curd and increase 
cheese yield due to the formation of heat induced complexes between casein 
and denatured β-lactoglobulin, this will negatively impact on the maturation of the 
cheddar cheese.  The findings of Banks et al. [133] and Calvo et al. [134] 
correlate favourably with published articles by Fox et al. [70], Farkye et al. [108] 
and Grandison et al. [135]. 
 
Farkye and Fox [127] produced cheddar cheese with added 6-amino-hexanoic 
acid which is a PI stimulator.  The result was a slower breakdown of β-casein due 
to an increase in PI activity and a reduction in plasmin activity.  Bastian et al. 
[128] produced Cheddar cheese with added urokinase to the milk.  The result 
was an increase in proteolysis in the cheese due to an increase in plasmin 
activity.  The breakdown of β- and αs2-caseins during extended ripening periods 
resulted in the formation of short peptides which produced a bitter off-flavour.  Le 
Bars et al. [136] reported that plasmin proteolysis in the manufacture of Cheddar 
cheese released astringent and bitter tasting hydrophobic peptides that detracts 
from the overall quality of the cheese. 
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In summary the effects of lactation and higher plasmin activity on the 
manufacture of Cheddar cheese are summarised in Table 4.3.  The different 
stages of lactation will also exhibit different values for plasmin activity as 
mentioned in paragraph 4.4.1. The main effect of increased plasmin activity is the 
prolonged rennet coagulating time (RCT) during the manufacturing process of 
Cheddar cheese.   
 
Table 4.3: Effect of lactation on cheddar cheese manufacturing [59] 
 
Effect1 Mid lactation Late lactation 
Plasmin concentration Lower Higher 
Rennet coagulation time Shorter Longer 
Curd strength Higher Lower 
Syneresis rate Faster Slower 
Moisture Lower Higher 
1 It is also noted that the concentration of plasmin is not the only factor influencing the 
manufacturing of Cheddar cheese using milk produced in different stages of lactation.  Other 
factors include the mineral balance of the milk, the breed of the cow and the pH of the milk 
 
4.3.2. Swiss Style Cheese  
 
Benfeldt et al. [137] studied the effect of heat treatment on cheese milk, which 
was used for the production of semi-hard Swiss-style cheese, on plasmin activity 
and proteolysis during cheese ripening.  They found reduced plasmin activity in 
the cheese manufactured from milk treated at higher temperatures (95°C for 15 
to 90 seconds) than milk treated at lower temperatures (72°C for 15 to 90 
seconds).  However, they could not conclude that the thermal treatments had any 
effect on the endogenous proteolytic enzymes in the milk (such as cathepsin D) 
the proteolytic enzymes of the starter culture and non-starter bacteria, as well as 
the proteolytic action of the rennet enzyme used for coagulation.  The reduced 
digestion of β-casein and αs2-casein during ripening can be attributed to the 
inactivation of plasminogen and plasmin rather than the inactivation of PA due to 
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the lower decimal reduction values (D-values) of plasminogen and plasmin 
[109,137-140]. 
 
However, plasmin plays a beneficial role in the flavour development of Swiss-
type cheeses such as Emmentaler.  In Swiss-type cheeses the higher cooking 
temperatures of the curd destroy the PAI and PI.  As a result there is a higher 
concentration of plasmin present and this result in an increased breakdown of 
casein during the cheese ripening process. 
 
4.3.3. Pasta filata type cheese – Mozzarella 
 
Late lactation milk with added native bovine plasmin was used for the 
manufacture of Mozzarella cheese.  The Mozzarella cheese had inferior 
stretchability and meltability profiles, due to the increased breakdown of β-casein 
[138]. 
 
4.3.4. Semi-soft Cheese Mould Ripened – Camembert and Brie 
 
In Camembert, Brie (mould ripened) and Tilset (smear ripened) cheese plasmin 
activity plays an important role in proteolysis.  The catabolism of casein and the 
deamination of the amino acids produce ammonia (NH3).  Due to the production 
of ammonia there is an increase in the surface layer pH of these cheeses to a pH 
of approximately 7.0.  The pH in the interior of the cheese also gradually 
increases due to outward migration of the ammonia and the higher pH facilitates 
the action of plasmin [67]. 
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4.4. Fermented Products 
 
In contrast to the effect of the fibrinolytic system on cheese manufacture and final 
product quality, there is limited literature available on the effect of plasmin and 
plasminogen activators on fermented milk products such as yoghurt.  It is 
hypothesised that the proteolytic effect of the plasmin will be reduced due to the 
inactivation thereof by the high pasteurisation temperature during yoghurt 
manufacture (95°C for 5 minutes).  Yoghurt is also a short shelf-life product, and 
therefore the effect of plasmin would not be as severe as in other long-life dairy 
products.  However, it would be interesting to investigate and evaluate the effect 
of increased PA activity on the quality of the final product, as these fermented 
milks are acidified milk gels as opposed to rennet induced gels or coagulum. 
 
In Chapter 5 bovine t-PA and u-PA were purified and characterised from bovine 
milk.  In Chapter 6 the practical implication of addition of the purified t- PA to UHT 
milk, Gouda cheese and yoghurt is quantified in order to evaluate the effect of 
enhanced plasmin activity on final product quality.  The investigation could 
benefit the primary and secondary dairy industry, as critical control parameters in 
the production of milk and dairy products could possibly be identified to limit the 
detrimental affect of endogenous milk proteases to raw milk and ultimately final 
product quality. 
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Chapter 5 
 
 
ISOLATION AND CHARACTERISATION OF BOVINE 
PLASMINOGEN ACTIVATOR 
 
5.1. Introduction 
 
Due to the different species of plasminogen activators present in bovine milk, this 
study concentrated mainly on the isolation and purification of tissue plasminogen 
activator (t-PA) associated with the casein micelles, rather than urokinase 
plasminogen activator (u-PA) associated with the somatic cell fraction in the milk.  
According to Zachos et al. [8] t-PA is the major enzyme contributing to the 
activation of plasmin which leads to the subsequent proteolysis of the β-casein 
fraction in the milk.  t-PA is associated with casein, the major functional 
component in rennet and acid casein-gels.  The influence of t-PA on the stability 
and functionality of the casein-gels, in products such as cheese and yoghurt, will 
therefore be an important factor contributing to the characteristics, shelf-stability 
and quality of the final product. 
 
Apparent molecular masses of between 75,000 Da to 84,500 Da for t-PA, and 
30,500 Da and 47,500 Da for u-Pa have been reported [9,20,56,66].  As 
indicated in Fig. 5.1, in this study, the PAs in bovine milk have been isolated and 
partially purified using a combination of centrifugation, fractionation and 
solubilisation steps, followed by ion-exchange and size exclusion 
chromatography. 
 
The main goal of the study was to isolate and characterise t-PA associated with 
the casein fraction in milk.  The isolated bovine t-PA was further characterised by 
SDS-PAGE, high performance liquid chromatography (HPLC) and iso-electric 
focussing (IEF).   
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 PHASE 1 PHASE 2 
The isolation and the purification 
of bovine plasminogen activators 
Fractionation, solubilisation 
Chromatographic techniques 
SDS PAGE  
The characterisation of PA  
SDS PAGE  
Plasmin activity assay 
Protein determination - Pierce 
Iso-electric focussing (IEF) 
HPGPC-analyses 
Amino Acid analyses
 
Figure 5.1: Different techniques used to isolate and purify (phase 1) and 
characterise t-PA (phase 2) from bovine milk. 
 
 
5.2. Origin and characteristics of milk samples used for the isolation of t-
PA  
 
Raw bulk milk samples from morning and evening milk, obtained from a mixed 
herd of Holstein and Jersey cows, was collected from the Elsenburg Dairy 
Research Centre of the Department of Agriculture Stellenbosch, South Africa.  
The average number of days that the cows were in lactation was between 150 
and 180 days (mid to late lactation).  All samples were kept refrigerated at a 
temperature below 4°C and were tested within 48 hours of collection.  
 
The milk was subjected to routine tests that would normally be conducted as part 
of the quality assurance program of milk producers and milk buyers.  The tests 
were done to confirm the values of the following parameters: 
 
1. Standard Plate Count (SPC): to test whether the milk is within acceptable 
microbiological specifications. 
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2. Coliform bacteria: to test standard hygiene practise of milk production and 
to test whether the milk is within acceptable microbiological specifications. 
3. Somatic cell count (SCC): to test herd health and possible infection and/or 
mastitis. 
4. Percentage fat, protein and lactose: to test whether the percentage of total 
solids (TS) in the milk is within the normal parameters and feeding status 
of the cows. 
5. Freezing point (Fp): to test for unadulterated milk (no added water). 
6. Ethanol test (70% (v/v)) : to test for protein stability of the milk. 
7. pH: to test if the milk is within acceptable limits and that no microbial 
growth has occurred (i.e. sour milk). 
8. Percentage titratable acidity (%TA): to test if the milk is within acceptable 
limits and no microbial growth has occurred (i.e. sour milk). 
9. Clot-boiling test: to test for protein stability of the milk. 
 
5.3. Determination of PA activity 
 
The PA-activity was determined spectrophotometrically according to the method 
of Zachos et al. [8] using the synthetic substrate, D-Val-Leu-Lys-ρ-nitroanalide 
(V0882, Sigma Aldrich; millimolar extinction coefficient of 5.57 mM-1.cm-1).  The 
progress of the PA catalysed reactions was measured by determining the change 
in absorbence at 405 nm due to the hydrolysis of the chromatogenic substrate, 
D-Val-Leu-Lys-ρ-nitroanalide, to yield the free chromophore, ρ-nitroanalide (see 
Fig. 5.2). 
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D-Val-Leu-Lys-ρ -nitroanalide ρ -nitroanalide
Plasmin 
hydrolysis
 
Figure 5.2: Schematic representation of the hydrolysis of the synthetic substrate, 
D-Val-Leu-Lys-ρ-nitroanalide, by plasmin to yield the chromatophore  
ρ-nitroanalide in the PA assay. 
 
All assays were performed in triplicate. A typical reaction mixture (final volume 
250 μl) contained 100 mM Tris-HCl buffer (pH 8.0), 50 μg.ml-1 plasminogen 
(P5661, Sigma Aldrich), 0.6 mM D-Val-Leu-Lys-ρ-nitroanalide and 5 μl of the PA 
fraction (see Table 5.1).  White et al. [56] reported that casein had no influence 
on PA activity and no corrections for turbidity were therefore made for casein 
present in the PA fractions investigated in this study. 
 
Table 5.1: Summary of the PA activity assay 
  
Sample preparation before measuring PA activity 
Ingredient Control 1 Control 2 Sample 1 Sample 2 
100 mM Tris-HCl buffer, pH 8.0 255 μl 250 μl 250 μl 250 μl 
0.6 mM D-Val-Leu-Lys-ρ-nitroanalide Yes Yes Yes Yes 
50 mg.ml-1 plasminogen Yes No Yes  Yes 
PA  fraction - 5 μl 5 μl 5 μl 
TOTAL VOLUME 255 μl 255 μl 255 μl 255 μl 
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The reaction mixtures were incubated at 37°C in a New Brunswick Scientific Co. 
G24 Environmental Shaker for 3, 4 and 5 hours respectively.  The reaction was 
stopped by adding 100 μl of 30% (v/v) acetic acid to the samples followed by 
centrifugation at 8,000 X g for 5 minutes, before reading the absorbance at 405 
nm.  A sample without added plasminogen served as the control.  The activity of 
the endogenous plasmin was subtracted from total the plasmin activity. 
 
t-PA activity can be distinguished from u-PA activity by adding fibrin (20 μg) and 
amiloride (20 mM) to the PA-containing fractions.  In the presence of fibrin there 
will be an increase in t-PA activity and in the presence of amiloride a decrease in 
u-PA activity. t- PA is not affected by amiloride and the activity of u-PA will not be 
enhanced by the addition of fibrin [140,141]. 
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 5.4. The isolation and purification of t-PA from bovine milk 
 
A schematic representation of the isolation and separation of PA from bovine 
casein is given in Fig. 5.3. 
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Figure 5.3: Schematic representation of the method for separation of u-PA and t-
PA from casein in bovine milk. 
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The isolation and purification steps were modified from methods used by Politus 
et al. [75], Deharveng and Nielsen [22] and Yamauchi et al. [139].  Fresh bovine 
milk (RM) was centrifuged at 4,000 X g for 20 minutes at 4°C to separate the 
cream (milk-fat) and somatic cell fraction (SCC pellet - SP) from the casein 
fraction (milk serum).  The skimmed milk, SUP1, was then ultracentrifuged at 
100,000 X g for 60 minutes at 4°C to separate the whey proteins (supernatant – 
SUP2) from the casein pellet (CP1).  Alternatively, the casein and whey fractions 
can also be separated by iso-electric precipitation of casein with acidification to a 
pH of 4.6 with HCl. 
 
In order to dissociate the PA from the casein micelle structure the casein pellet 
(CP1) was reconstituted to the original volume (5 ml) with 0.023 mM Phosphate 
buffer (pH 7.0) and stirred overnight at 4°C (RCP1).  NaCl (1 M) was added to 
the reconstituted casein pellet fraction (RCP1) and incubated for 3 hours at 22°C 
and subsequently ultracentrifuged at 100,000 X g for 60 min at 4°C.  The 
resulting casein pellet (CP2a) was reconstituted to the original volume (5 ml) with 
50 mM Tris-HCl (pH 8.0) and the supernatant fraction (SUP3a) was dialysed for 
24 hours against 1000 volumes of 0.023 M phosphate buffer, pH 7.0 containing 
0.2 M of boric acid pH 7.0 (the pH of boric acid solution was adjusted to 7.0 with 
5 M KOH) and 20% DMF with one change of the external medium.  The function 
of the DMF is to dissociate any κ-casein still present in SUP2. 
 
The SCC pellet (SP), containing PA, obtained after the initial centrifugation step 
of 4,000 X g for 20 minutes at 4°C, was washed three times with 0.01 M 
phosphate buffer containing 0.15 M NaCl at (pH 7.2) with centrifugation at 
4,000 X g for 20 minutes. The resulting RSP1 pellet was resuspended in 0.023 M 
phosphate buffer (pH 7.0) to yield at least 106 viable cells.ml-1.  Tryphan blue 
(5 µl of a 2.5 g.l-1 solution) was added to 20 µl of the SSP fraction.  The 
proportion of cells excluding the dye was counted and sonicated for 45 seconds.  
The sonicated cell extract was ultracentrifuged at 100,000 X g for 1 hour to 
remove the entrapped casein (pellet).  The SPP extracts (supernatant) were 
stored at –80°C for further investigation. 
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 5.4.1. Purification of PA using chromatography 
 
A schematic representation of the isolation and purification techniques, utilised 
for the purification of PA, is given in Fig. 5.4. 
 
PA FRACTIONS
SUP3 (t-PA) & SSP (u-PA) 
Metal Chelate Chromatography
Gelfiltration
SDS-PAGE Gel
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Schematic representation of the purification steps followed to purify 
PA from bovine milk. 
 
5.4.2. Gel filtration (size exclusion chromatography) 
 
Size exclusion chromatography was carried out to separate PA from other low 
molecular mass proteins and to determine the apparent molecular mass of the 
PA.  Separation was achieved with a Sephadex G-75 resin in glass column 
(18 mm ID X 950 mm).  The column was equilibrated at a flow-rate of 7.0 ml.h-1 
with 50 mM Tris-HCl buffer (pH 8.0) containing 0.50 M of NaCl.  The two PA 
containing fractions, RCP2 and SUP3a, were both subjected to gel filtration on 
the same column.  The column was calibrated, using molecular weight standards, 
and the void (V0) and total volumes (Ve) were determined by using a mixture of 
N-2,4-DNP-glycine (Sigma Aldrich) and dextran blue at concentrations of  
2 mg.l-1.  The resulting fractions were collected at 10 minute intervals and the 
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flow-rate was calibrated for the running of the samples at 5 ml.h-1. The eluting 
fractions were detected with a UV-flow detector set at 280 nm. 
 
5.4.3. Metal chelate (affinity) chromatography 
 
A Zn-chelating column (25 mm x 100 mm inner diameter) was prepared 
according to the manufacturers instructions using chelating-Sepharose 6B.  The 
resin was equilibrated with running buffer of 20 mM phosphate buffer containing 
1 M NaCl, 0.01% (v/v) Tween 80 (pH 7.50).  After equilibration the resin was 
mixed with the PA containing fractions on a shaker plate at 4°C for 3 hours 
before the mixture was poured into the column. 
 
The column was washed at a flow-rate of 40 ml.h-1 with 4 volumes of running 
buffer.  An imidazole gradient of 0-0.1 M was subsequently applied to the column 
and fractions of 3 ml each were collected.  After the gradient was completed an 
additional 75 ml of 0.1 M imidazole buffer was used to elute all the remaining 
proteins from the column, while fractions of 5 ml each were collected.  All the 
fractions containing PA activity were pooled, dialysed against deionised distilled 
water overnight at 4 °C and freeze dried.  The protein concentration of each 
sample was determined spectrophotometrically at 280 nm while the PA-activity 
was detected using a colorimetric PA assay at 405 nm in the presence of D-Val-
Leu-Lys-ρ-nitroanalide. 
 
5.4.4. SDS-PAGE  
 
Gel electrophoresis was carried out using the SDS-PAGE gel system of Life 
Technologies, South Africa.  Stock acrylamide solutions were prepared according 
to the prescribed method to yield a 10% polyacrylamide resolving gel and a 3.9% 
polyacrylamide stacking gel solution. 
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5.4.5. Iso-electric focusing (IEF) 
 
Iso-electric focusing was performed using a PhastGel IEF kit (Amersham 
Biosciences), pH 3-10. After the separation of the proteins by IEF, the proteins 
were visualised by silver staining.  
 
5.5. High Performance Gel Permeation Chromatography (HPGPC) 
analyses 
 
5.5.1. Sample preparation of t-PA for HPGPC analyses 
 
The t-PA fraction obtained after Zn-chelating chromatography still contained 
plasmin, β-casein and low molecular weight proteins.  As a result only Peak 2 of 
the SUP3b gel filtration step was used for HPLC analyses after SDS-PAGE 
analyses.  For localisation of t-PA activity the lanes of the PAGE-gel were cut into 
slices of approximately 5 mm2 and incubated overnight at 4°C in 0.1 M Tris-HCl 
buffer (pH 8.0) containing 5.5 g.l-1 Triton X100, to remove the polyacrylamide.  
After 2 hours the buffer was discarded and the slices soaked in 0.5 ml fresh 
0.1 M Tris-HCl buffer (pH 8.0) for 24 hours to elute the proteins.  The buffer 
containing 125 μg of protein was tested for t-PA activity in the presence of fibrin.  
The buffer containing t-PA protein was dialysed against deionised distilled water 
for 24 hours at 4 °C before lyophilisation. 
 
5.5.2. Molecular mass analyses of t-PA 
 
HPGPC of t-PA and protein standards was performed on a 0.75 × 60 cm 
prepacked TSK G 3000 SW column (Sigma Aldrich).  The TSK G 3000 SW 
column contained a silica-based, hydrophilic bonded phase packing that 
minimises interaction with proteins. Purified t-PA (200 μg) was analysed by 
HPGPC on the column equilibrated with 50 mM Tris-HCl, 100 mM NaCl (pH 7.2). 
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The same buffer was used to elute the protein at a flow rate of 0.4 ml.min-1. The 
column effluent was monitored at 280 nm.  
 
5.5.3. Amino acid analyses of t-PA 
 
A 100 μg sample of lyophilised t-PA was mixed with 1 ml of 6 M HCl in a 5 ml 
ampoule.  The acidified mixture was subsequently flushed with nitrogen under 
sonication, evacuated and flame-sealed before transfer to a pre-heated oven at 
110°C for 24 h.   Twenty μl of filtrated ampoule solution was transferred to a test 
tube and dried under a gentle stream of nitrogen gas. Each dried sample was 
hydrated with 250 μl of Beckman Na-S dilution buffer and the resulting solution 
was filtered through a 0.2 μm pore size syringe filter before it was loaded into the 
amino acid analyser autosampler cartridge.  Amino acids were derivatised with  
o-phthaldialdehyde and 2-mercaptoethanol (MCE).  The OPA reagent was 
prepared by combining 25 ml of 100 mM sodium borate, 2.5 ml 20% (w/w) SDS, 
40 mg OPA dissolved in 1 ml methanol, and 100 μl MCE, then adjusting the 
volume to 50 ml with water.  Derivatised amino acids were analysed by HPLC on 
a reverse phase C18 column.  A tetrahydrofuran/methanol solvent gradient 
[solvent A, tetrahydrofuran / methanol / 0.1 M sodium acetate, pH 7.2 (5:95:900, 
by vol.); solvent B, methanol] was used for the separation of amino acids with a 
flow rate of 2.2 ml.min-1.  Effluent was monitored by fluorescence at an excitation 
wavelength of 330 nm and an emission wavelength of 450 nm.   
 
5.6. Results 
 
5.6.1. Chemical and Microbiological analyses of raw milk 
 
Only unadulterated, mid-lactation, raw bulk milk samples with an SPC of less 
than 50,000 cfu.ml-1 and SCC of less than 500,000.ml-1 were used to isolate and 
purify the PAs. The SCC was higher than the average for raw bulk milk, an 
indication of late lactation milk. 
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All the results obtained from the chemical and physical analyses of the milk were 
within the normal range associated with raw bulk milk as indicated in Table 5.2, 
which includes negative results for the clot-boiling and ethanol tests (i.e. no 
flocculation or precipitation of proteins indicative of protein instability).  The pH 
and %TA values were also within the normal range specification.  The results of 
the chemical and microbiological tests of the raw milk used for PA isolation are 
summarised in Fig. 5.5 and Fig. 5.6.  
 
Table 5.2: Analyses of raw milk used for partial purification of PA 
Sample 
SPC 
(cfu.ml-1) 
Coliforms 
(cfu.ml-1) 
SCC.ml-1 % Fat % Protein % Lactose 
Fp 
(-m°C) 
pH %TA 
1 42,500 2,850 320,105 3.45 3.32 4.65 523 6.67 0.135 
2 23,000 1,400 280,900 3.39 3.28 4.70 526 6.63 0.130 
3 33,000 3,800 420,332 3.35 3.20 4.65 522 6.70 0.125 
4 49,000 8,250 385,300 3.55 3.40 4.68 530 6.68 0.140 
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Figure 5.5: Results of Microbiological and SCC analyses of raw milk used for 
partial purification of PA. 
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Figure 5.6: Results from the chemical analyses of raw milk used for partial 
purification of PA: Percentage Fat, Protein, Lactose and Total Solids (TS). 
 
 
5.6.2. PA activity 
 
The purification of t-PA and u-PA was monitored with the colorimetric PA activity 
assay described in 5.3.  The SCC and casein fractions were tested for PA activity 
in the absence (sample 1) and the presence of fibrin and amiloride (sample 2) to 
differentiate between the presence of u-PA and t-PA.  Control samples 1 and 2 
were also tested for PA activity, control sample 1 was used as blank-control, and 
control sample 2 was tested without plasminogen to detect endogenous plasmin 
activity that might occur within the samples as a result of native plasminogen 
present in the samples.  The native plasmin activity was, however, insignificant 
and therefore no correction for native detected plasmin activity was applied 
(results not shown). 
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In my hands the increase in absorbance between 0 to 3 hours was not linear 
during this pre-incubation period.  Linearity in the rate of ρ-nitroanalide formation 
was calculated from the linear portion of the absorbance versus time curve as 
indicated in Fig. 5.7, which occurred between 3 to 5 hours.  The PA activity 
detected was expressed in units (U); one unit of enzyme activity was defined as 
the amount of enzyme that produced a change in absorbance of 0.1 at 405 nm in 
60 minutes.  The units of PA were calculated from the change in absorbance 
between 3 hours and 4 hours at 450 nm.   
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Figure 5.7: Change in absorbance with the PA activity assay at 405 nm for the 
different fractions isolated. 
 
The PA activity of the casein fractions (RM, SUP1, RCP, SUP3b) showed a 
significant increase in activity in the presence of fibrin, indicating the presence of 
t-PA.  The average increase of t-PA activity for these samples was 34%; 
however, the RM fraction had a lower increase in activity (13%) than the other 
fractions. 
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 In Table 5.3 a summary of the absorbance values of the casein milk fractions 
obtained are given, as well as the deviation and % deviation between sample 1 
(no fibrin and amiloride) and sample 2 (8 μg.ml-1 fibrin and 20 mM amiloride 
added). 
 
Table 5.3: PA activity and PA concentration of casein fractions  
 
PA activity assay (CASEIN FRACTIONS) 
 Δ A405nm 3 h, 4 h @ 37°C  
 Casein fractions Sample 1 Sample 2 Dev (±) Dev (%) Units PA 
Specific 
Activity 
(U.g -1 prot) 
RM 0.204 0.230 0.026 13% 2.0350 0.0599 
SUP1 0.191 0.255 0.064 34% 1.9100 0.0562 
RCP1 0.170 0.236 0.066 39% 1.7000 0.0654 
SUP3b 0.162 0.234 0.071 44% 1.6200 72.3214 
ZNF 0.150 0.212 0.061 41% 1.4950 398.6667 
 
As indicated in Table 5.4 the PA activity measured in the SCC fractions (RSP1, 
RSP2) showed a decrease in the presence of amiloride, indicating the presence 
of u-PA.  The minor decrease (3%) of PA activity in sample RSP 1 could be 
contributed to some t-PA being present in the fraction, associated with the casein 
fragments as reported by White et al. [56]. The casein fragments were removed 
from RSP1 by sonication followed by ultracentrifugation at 100,000 X g for 60 
minutes at 4°C.  The net effect of the amiloride was enhanced on sample RSP2, 
indicating the presence of u-PA, therefore it could be concluded that some of the 
t-PA was removed from fraction RSP1 together with the casein fragments. 
 
In summary it could be concluded that the fractions isolated from casein 
contained predominantly t-PA activity while the final fractions isolated from the 
SCC contained predominantly u-PA activity. 
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 Table 5.4: PA activity and PA concentration of SCC fractions 
 
PA activity assay (SCC FRACTIONS) 
 Δ A405nm 3 h, 4 h @ 37°C  
 Casein fractions Sample 1 Sample 2 Dev (±) Dev (%) Units PA 
Specific 
Activity 
(U.g -1 prot) 
RM 0.204 0.230 0.026 13% 2.0350 0.0599 
RSP1 1.860 1.801 -0.056 3% 0.4650 7.7500 
RSP2 1.113 0.879 -0.234 21% 0.2783 30.9259 
 
 
5.6.3. Purification of t-PA and u-PA 
 
The purification tables for the respective PA’s isolated from the casein pellet and 
somatic cell fraction are indicated in tables 5.5 and 5.6 respectively. 
 
Only the SUP3b fraction was subjected to Zn chelating chromatography as the 
main aim was to isolate and purify t-PA.  However, both the SUP3b and RSP1 
fraction was further purified using size exclusion chromatography, in an effort to 
separate u-PA and t-PA from low molecular mass proteins. 
 
During the purification of t-PA (casein fraction) there was a significant increase in 
the t-PA activity in fractions SUP3a and SUP3b, after incubation of the 
reconstituted casein pellet fraction (RCP1) with 1 M NaCl followed by 
ultracentrifugation at 100,000 X g for 60 minutes at 4°C.  This indicates that the 
dissociation of t-PA from casein resulted in an increase in specific activity of the 
enzyme in the final SUP3b fraction.  The percentage yield obtained from the 
initial purification steps was satisfactory at more than 75% with high specific 
activity in the SUP3b fraction of 72.32 U.g-1 protein.  The SUP3b fraction was 
then further purified using Zn chelating chromatography. The t-PA was purified 
more than 6,000 times with a final Specific Activity of 398.66 U.g-1 protein and a 
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final yield of 73% in the ZNF fraction. In Fig. 5.8 the units of t-PA isolated is 
plotted against Specific Activity of t-PA and %Yield.  
 
Table 5.5: Plasminogen Activator activity from casein pellet in different fractions 
during isolation and purification steps 
 
Fraction 
Total vol. 
(ml)1  
[Prot] 
(mg.ml-1)2  
Tot. Prot. 
(mg)3
Units PA4
Specific 
Activity 
 (U.g-1 prot)5
% Yield6
Fold 
Purification7
RM 1000 34.00 34000.00 2.0350 0.0599 100.00 1.00 
SUP1 985 34.50 33982.50 1.9100 0.0562 93.86 0.94 
RCP1 30 866.00 25980.00 1.7000 0.0654 83.54 1.09 
SUP3b 28 0.80 22.40 1.6200 72.3214 79.61 1208.32 
ZNF 5 0.75 3.75 1.4950 398.6667 73.46 6660.77 
 
1 Total Volume (ml)  = Direct volumetric measurement  
2 [Prot] (mg/ml)  = Pierce protein measurement  
3 Total protein (mg)   = Total volume (ml) X [Prot] (mg.ml-1)  
4 Units PA  = Spectrophotometric measurement where PA activity detected was 
expressed in units (U); one unit of enzyme activity was defined as the 
amount of enzyme that produced a change in absorbance of 0.1 at 405 nm 
in 60 minutes.  The units of PA were calculated from the change in 
absorbance between 3 hours and 4 hours at 450 nm.  
5 Specific activity = Units PA / Tot. Prot (mg) = U.g –1 protein  
6 % Yield  = (Units PA in fraction / Units PA in RM fraction)X 100  
7  Purification  = Specific Activity PA fraction  / Specific Activity fraction RM 
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 Table 5.6: Plasminogen Activator activity from SCC pellet in different fractions 
during isolation and purification 
 
Fraction 
Total vol. 
(ml)1  
[Prot] 
(mg.ml-1)2  
Tot. Prot. 
(mg)3
Units PA4
Specific 
Activity 
 (U.g-1 prot)5
% Yield6
Fold 
Purification7
RM 1000 34.00 34000.00 2.0350 0.0599 100.00 1.00 
RSP1 30 2.00 60.00 0.4650 7.7500 22.85 129.48 
RSP2 30 0.30 9.00 0.2783 30.9259 13.68 516.69 
 
1 Total Volume (ml)  = Direct volumetric measurement  
2 [Prot] (mg/ml)  = Pierce protein measurement  
3 Total protein (mg)   = Total volume (ml) X [Prot] (mg.ml-1)  
4 Units PA  = Spectrophotometric measurement where PA activity detected was 
expressed in units (U); one unit of enzyme activity was defined as the 
amount of enzyme that produced a change in absorbance of 0.1 at 405 nm 
in 60 minutes.  The units of PA were calculated from the change in 
absorbance between 3 hours and 4 hours at 450 nm.  
5 Specific activity = Units PA / Tot. Prot (mg) = U.g –1 protein  
6 % Yield  = (Units PA in fraction / Units PA in RM fraction)X 100  
7  Purification  = Specific Activity PA fraction  / Specific Activity fraction RM 
 
 
Although a relatively low yield of u-PA of 13.68 % was obtained in the final RSP2 
fraction, the Specific Activity was relatively high at 30 U.g-1 protein.  The final 
purification was lower than that of the t-PA fraction in SUP3b, with u-PA in the 
RSP2 fraction purified 516 times.  The low yield could be attributed to the loss of 
u-PA during the final reconstitution step of the RSP1 fraction, as some of the  
u-PA could have been lost in the serum isolated during the separation from 
casein.  During the initial purification step of sample RM, some u-PA could also 
have remained in the defatted milk fraction (SUP1) and was subsequently 
removed during the ultracentrifugation step at 100,000 X g for 60 minutes at 4°C 
from the casein pellet (CP1) and remained in the milk serum supernatant (SUP2).  
SUP2 did yield some Specific Activity associated with u-PA, 0.014 U.g-1 protein, 
with a low yield of 4.91%. The activity was contributed to u-PA as there was a 
decrease in absorbance at 405 nm with the PA activity assay in the presence of 
fibrin and amiloride, indicating the presence of u-PA (results not shown).  This 
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corresponds well with studies from Saksela et al. [74] and Precetti et al. [78] 
which concluded that u-PA and PAI activity is associated with the SCC and milk 
serum fractions in bovine milk. 
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Figure 5.8: Purification of t-PA: Units of PA isolated against Specific Activity of 
PA and %Yield. 
 
 
5.6.4. Gel filtration of t-PA (SUP3b) and u-PA (RSP2) fractions 
 
The gel filtration results of the SUP3b and RSP1 fractions are indicated in Fig. 
5.9.  Absorbance of the column effluent was monitored at 280 nm, while the PA 
activity assay was used to determine PA activity.   
 
In the SUP3b fraction PA activity was detected in peaks 1 to 4 as indicated in Fig. 
5.9.  The activity assay of the pooled fractions for SUP 3b, peaks 1–4, are 
indicated in Table 5.7.  Peak 1 (Fig. 5.9) did display some plasmin activity that 
was enhanced by the addition of fibrin (sample 2).  The activity in peak 1 was 
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attributed to endogenous plasmin activity, as the protein isolated had a molecular 
mass of 88,500 Da.  The molecular mass of bovine plasmin was reported to be 
between 86,000 – 90,000 Da [70].  PA activity was enhanced by 21% with the 
addition of fibrin to the pooled fractions of peak 2, which clearly indicated the 
presence of t-PA.  The molecular mass of the t-PA was calculated as 75,000 Da.  
Peak 3 and 4 also exhibited PA activity that was inhibited by the addition of 
amiloride, therefore indicating the presence of u-PA.  The u-PA in peak 4 was 
associated with lower molecular mass proteins (estimated Mr between 10,500 – 
18,000 Da).  The Mr of u-PA in peak 3 and 4 was estimated to be between 
30,500 – 47,600 Da. 
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Figure 5.9: Gel filtration elution profiles of RCP and SUP3a PA fractions. 
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Table 5.7:  PA activity of pooled gel filtration fractions for SUP3b 
 
PA activity assay (GEL FILTRATION SUP3b ) 
  Δ A405nm 3 h, 4 h @ 37°C   
SUP3ba Sample 1 Sample 2 Dev (±) Dev (%) U PA 
Peak 1 (Fractions 25-28) 0.200 0.214 0.014 7% 2.00 
Peak 2 (Fractions 29-34) 0.357 0.431 0.074 21% 3.57 
Peak 3 (Fractions 36-38) 0.139 0.115 0.023 17% 1.39 
Peak 4 (Fractions 43-46) 0.030 0.025 0.005 17% 0.005 
 
 
In the RSP2 fractions PA activity was detected in peaks 5, 6, 7 and 8 as indicated 
on the Fig. 5.9.  The activity assay of the pooled fractions for RSP2 peaks 5-8 are 
given in Table 5.8.  Low activity was observed in the pooled fractions of peaks 5 
and 6; the Mr corresponds well with the Mr of plasmin and t-PA as detected in the 
pooled fractions of peaks 1 and 2 of the SUP3b fraction (Mr plasmin 88,500 Da 
and Mr t-PA 75,000 Da).  The activity was enhanced with the addition of fibrin by 
17% and 57% respectively for pooled fractions of peaks 5 and 6. Pooled fractions 
of peaks 7 and 8 indicated the presence of u-PA as the activity was inhibited by 
15% and 11% respectively with the addition of amiloride. The u-PA in peak 8 was 
associated with lower molecular weight proteins, estimated Mr between 10,500 – 
18,000 Da.  The Mr of u-PA in peak 7 and 8 was estimated to be between 30,500 
– 47,500 Da. 
 
Table 5.8:  PA activity of pooled gel filtration fractions for RSP2 
 
PA activity assay (GEL FILTRATION RSP2) 
  Δ A405nm 3 h, 4 h @ 37°C   
RSP2a Sample 1 Sample 2 Dev (±) Dev (%) U PA 
Peak 5 (Fractions 18-23) 0.030 0.035 0.005 17% 0.30 
Peak 6 (Fractions 29-34) 0.035 0.055 0.020 57% 0.35 
Peak 7 (Fractions 39-41) 0.098 0.083 0.015 15% 0.98 
Peak 8 (Fractions 43-46) 0.019 0.017 0.002 11% 0.19 
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5.6.5. Zinc chelating chromatography of t-PA (SUP3b) fraction 
 
Fig. 5.10 summarises the results obtained when the t-PA-containing fraction of 
SUP3b was chromatographed on a Zinc chelating resin.  Fractions 20 – 26 were 
pooled and evaluated for t-PA activity.  The result of the PA activity assay is 
given in Table 5.3. The t-PA was purified more than 6,000 times with a final 
Specific Activity of 398 U.g-1 protein.  The pooled fractions containing t-PA 
activity were dialysed for 24 hours against deionised distilled water at 4°C and 
lyophilised before use as discussed in Chapter 6. 
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Figure 5.10: Zn chelating chromatography results of the SUP3a fraction run 
against a 1 M imidazole gradient. 
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5.6.6. SDS-PAGE  
 
SDS-PAGE analyses were conducted on the following purified samples: (i) gel 
filtration sample of peak 2 (Fractions 29-34) in lanes 2 and 3, (ii) Zn-chelating 
fraction in lane 5 and (iii) RSP2 fraction in lane 6 as indicated in Fig. 5.11. 
 
The gel filtration sample loaded in lanes 2 and 3 of the SDS-PAGE gel showed 4 
distinct bands.  Band 1 corresponded to an Mr 85,000 Da and appeared to be 
plasmin, band 2 corresponded to an Mr of 73,000 Da and appeared to be t-PA, 
band 3 corresponded to an Mr of 25,500 Da and appeared to be β-casein. Band 
4 was an idistinct smear corresponding to an Mr 10,000 – 18,000 Da and 
appeared to be lower molecular mass proteins. The Zn-chromatography fraction 
loaded in lane 5 showed one distinct band which corresponded to an Mr of 
73,000 Da and appeared to be t-PA. 
 
1               2               3                 4             5              6              7
94 kDa
67 kDa
43 kDa
30 kDa
20.1 kDa
14.4 kDa
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: SDS-PAGE analyses of the pooled samples of peak 2 after gel 
filtration, Zn-chelating chromatography fraction and RSP2 fraction; Lane 1 – 
Molecular Marker (94 kDa, 67 kDa, 43 kDa, 30 kDa, 20.1 kDa and 14.4 kDa); 
Lane 2 – Gel filtration peak 2; Lane 3 – Gel filtration peak 2; Lane 4 – Molecular 
Marker; Lane 5 – Fraction from Zn-chelating chromatography (t-PA); Lane 6 – 
RSP2 fraction; Lane 7 – Molecular Marker.  
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 The results of the SDS-PAGE analyses compared favourably with the results 
obtained from the gel filtration and Zn-chelating chromatography steps.  Peak 2 
of the SUP3b gel filtration analyses was tested for t-PA activity (lanes 2 and 3).  
For localisation of t-PA activity the electrophoretic lanes were cut into slices of 
approximately 5 mm2 and incubated overnight at 4°C in 0.1 M Tris-HCl (pH 8.0) 
buffer containing 5.5 g.l-1 Triton X100 to extract the proteins from the gel.  After 2 
hours the buffer was discarded and the gel slices were soaked in 0.5 ml fresh 0.1 
M Tris-HCl (pH 8.0) buffer for 24 hours to elute the proteins.  125 μl of the buffer 
containing protein was tested for t-PA activity in the presence of fibrin.  The SDS-
PAGE isolated fraction had PA activity which was enhanced in the presence of 
fibrin indicating t-PA.  The molecular mass of the isolated t-PA, according to 
SDS-PAGE analyses, was calculated as 73,000 Da.  The u-PA active RSP2 
fraction in lane 7 appeared to have some t-PA protein associated with it (band 1, 
Mr 73,500 Da) while the u-PA protein was associated with bands 2 and 3 (Mr 
33,500 and 50,000 Da). 
 
5.6.7. Iso-electric focusing (IEF) 
 
The IEF analyses yielded 3 distinct pI values for the purified t-PA of 6.60, 6.85 
and 7.30 respectively as indicated in Fig. 5.12.  These results corresponded well 
with results obtained by Okamoto et al. [36] on the pI values for purified t-PA from 
human milk. 
 
 
PosNeg
7.3             6.85   6.60               
 
 
 
 
 
Figure 5.12:  IEF electropherogram of purified t-PA. 
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 5.6.8. HPGPC analyses of purified t-PA 
 
The determination of the molecular mass of purified bovine t-PA with HPGPC 
analyses confirmed a Mr of 74,500 Da, which compares well with the Mr obtained 
by SDS-PAGE and gel-filtration.  The recovery of the protein was high and less 
than 10% of the t-PA activity was lost after HPGPC analyses (results not shown).  
The chromatogram of t-PA and the standard proteins is shown in Fig. 5.13. 
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Figure 5.13: HPGPC of purified t-PA analysed together with molecular mass 
protein standards; 1. Phosphorylase B (94 kDa); 2. Purified t-PA indicated by a 
red arrow (75,5 kDa); 3. BSA (66 kDa); 4. ovalbumin (45 kDa); 5. carbonic 
anhydrase (29 kDa); 6. chymotrypsinogen (24 kDA) and 7. cytochrome C (12,5 
kDa). The column was equilibrated and subsequently eluted with 50 mM Tris-
HCl, 100 mM NaCl, pH 7·2. 
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 5.6.9. Amino acid analyses of purified t-PA 
 
Acid hydrolysis considerably influences amino acid recovery.  During acid 
hydrolysis Trp and Cys are destroyed, Ser and Thr are partially lost and Met can 
undergo oxidation.  Gly and Ser are common contaminants, therefore average 
responses were subtracted for blank runs.  Pre-column derivitisation of amino 
acids with OPA, in the presence of MCE, yield isoindolic derivatives in a quick 
and simple reaction.  However, secondary amino groups, such as proline and 
hydroxyproline do not react with OPA, and were also not detected.  Some OPA-
amino acid derivatives are unstable, therefore it is very important to control both 
the reaction and injection times [142]. The elution profile of the amino acid 
analyses of bovine t-PA is represented in Fig. 5.14.  Amino acid concentrations 
were calculated based on Beckman amino acid standards, which had been 
treated similarly to the samples.  An internal standard of 7.5 mM norvaline was 
added to the samples and amino acid standards prior to analyses as a reference 
and in order to compare linearity and range of analyses.  Linear regression 
analyses confirmed a squared correlation coefficient (R2) of greater than 0.989 
for detection of norvaline. Amino acid analyses of the bovine t-PA hydrolysate 
indicated that the bovine protein consisted of 478 amino acids. 
 
The amino acid composition of bovine t-PA is summarised and compared to that 
of humans and Vampire bats in Table 5.9 [143-146].   
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Figure 5.14: Amino acid analyses of bovine t-PA hydrolysate. Separation was 
achieved on a reverse phase C18 HPLC column. A tetrahydrofuran/methanol 
solvent gradient [solvent A, tetrahydrofuran / methanol / 0.1 M sodium acetate, 
pH 7.2 (5:95:900, by vol.); solvent B, methanol] was used for the separation of 
amino acids with a flow rate of 2.2 ml.min-1. 
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Table 5.9: Comparison of the amino acid composition of purified bovine t-PA with 
other species 
 
AMINO ACID COMPOSITION : t-PA 
Amino Acid Bovine (Bos taurus) 
Human 
(Homo sapiens) 
Vampire Bat 
(Desmodus 
rotundus) 
Asx 53 - - 
Asn - 22 23 
Asp  29 20 
Glx 46 - - 
Gln - 27 21 
Glu - 27 26 
Ser 43 50 36 
His 20 17 12 
Gly 47 46 38 
Thr 31 25 31 
Arg 40 40 31 
Ala 35 36 25 
Tyr 23 24 21 
Val 27 28 31 
Met 7 7 8 
Phe 19 18 15 
Ile 16 20 14 
Leu 44 43 37 
Lys 27 22 25 
Trp Not detected 13 10 
Cys Not detected 38 30 
Pro Not detected 30 23 
TOTAL 478 562 477 
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5.7. Discussion 
 
t-PA and u-PA were successfully isolated and purified from a mixed herd of 
Jersey and Friesland cows at Elsenburg Dairy Laboratory, Stellenbosch.  A 
combination of treatments were used to isolate the t-PA, including defatting of the 
milk, concentration of the casein by ultracentrifugation, salting out and finally 
dissociation of the t-PA from the casein micelles, yielding the t-PA containing 
fraction SUP3B.  u-PA was isolated from the somatic cell fraction in the milk, the 
final fraction obtained after isolation and purification being RSP2.   
 
The resulting t-PA obtained in the SUP3B fraction was purified 1200 times from 
the raw milk, with a specific activity of 72 U.g-1 protein and a yield of 79%.  
Further purification of t-PA was obtained by using a combination of gel filtration 
and metal chelate (affinity) chromatography.  The u-PA in the RSP2 fraction 
obtained was purified more than 516 times from the raw milk, with a specific 
activity of 30 U.g-1 protein and a yield of 13%.  No further purification of the u-PA 
fraction was conducted in this study. 
 
The t-PA obtained after zinc chelating chromatography was purified more than 
6,000 times with a final Specific Activity of 398 U.g-1 protein and a final yield of 
73%. The t-PA was then characterized by SDS-PAGE, iso-electric focusing (IEF) 
and HPGPC.  The Mr of t-PA after gel filtration was estimated at 75 kDa, and this 
result correlated well with the Mr obtained from the SDS-PAGE, which was 
estimated at 73 kDa, and the chromatogram of the HPGPC, which confirmed a 
Mr of 74,5 kDa. The IEF analyses yielded 3 distinct pI values for the purified t-PA 
of 6.60, 6.85 and 7.30 respectively. The t-PA was analysed for amino acid 
composition and sequence compared to the t-PA of humans and Vampire Bats.  
The significance of the comparison is found in the extensive review of the human 
fibrinolytic system and the role of t-PA in haemostasis and thrombosis, as 
described in Chapter 2.  Reuters reported in January of 2003 that t-PA 
(desmoteplase) in Vampire Bats has been studied by researchers in Australia, 
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who reported that the t-PA isolated from the Vampire Bats and administered to 
patients could decrease the mortality rate of patients that have suffered from 
strokes.  According to Dr. Robert Medcalf of Monash University, the t-PA isolated 
from Desmodus rotundus assists with the solubilisation of fibrin clots in the blood, 
and will have advantages over commercially available drugs currently used due 
to the increased specific activity of the t-PA isolated. 
 
Chapter 6 describes the study of the effect of the addition of the purified t-PA to 
milk.  The investigation focussed on the t-PA and plasmin activity achieved with 
addition of t-PA, as well as on the extent of proteolysis that occurred during the 
normal shelf-life of value added products such as UHT milk, Gouda cheese and 
fermented milks (yoghurt). 
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Chapter 6 
 
 
THE EFFECT OF t-PA ADDITION TO DIFFERENT DAIRY 
PRODUCTS 
 
6.1. Introduction 
 
Protease hydrolysis of micellular and casein dispersions in milk by the fibrinolytic 
system, of which t-PA is a key element, causes multiple changes in the functional 
properties of milk and dairy products.  These changes directly influence the 
quality of milk as basis for all dairy products [12-16].  In this chapter the 
experiments investigating the effect of the addition of t-PA on the final quality of 
various milk products are described.   
 
A number of factors determine the levels of (native) plasmin activity in fresh milk. 
These factors are: (i) the milk yield of cows, as they should be dried off at low 
milk yields; (ii) animal health, as high somatic cell counts (SCC) result in 
increased plasmin activation; (iii) nutritional status of the animals, as animals on 
poor nutritional rations are more susceptible to producing abnormal milk, (iv) 
seasonality of production and supply and (v) the degree of dilution of milk at the 
milk collection facility. 
 
The knowledge gained from the isolation and purification of t-PA described in 
Chapter 5 was, as illustrated in this chapter, put into practice by manufacturing 
milk products with increased levels of plasmin activity.  It is important to 
understand the effect of t-PA on the biochemical and physical properties of 
manufactured dairy products, as this will determine the overall quality, the 
organoleptic profile and shelf-life of the final products.  These factors play an 
important role in producing products, in both the primary and secondary dairy 
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industries, that are economically viable and conform to consumer expectations 
and demand. 
 
The milk products selected for this investigation included; (i) ultra-high 
temperature (UHT) milk, (ii) Gouda cheese and (iii) yoghurt.  The rationale behind 
this selection was that these dairy products are representative of different 
manufacturing protocols within the dairy industry.  The different manufacturing 
protocols contribute to the unique characteristics of each of the products, the 
main differences between the products selected for evaluation being: 
 
(i) pH of the final product; neutral pH vs. low pH, in this instance UHT 
(pH 6.70) milk vs. Gouda cheese and yoghurt (<pH 4.60) 
(ii) shelf-life of the final product; short shelf-life vs. extended shelf-life, 
in this instance yoghurt (20-36 days) vs. Gouda cheese (>3 
months) and UHT milk (>6 months) 
(iii) type of gel formation during fermentation, in this instance acid gel 
formation (yoghurt) vs. rennet gel formation (Gouda cheese) 
 
6.2. Ultra-High Temperature (UHT) milk 
 
6.2.1. Introduction 
 
The gelation of UHT milk is a result of proteolysis either by native proteases such 
as plasmin, or heat resistant bacterial proteases in the milk [13,14,53,147,148] 
and is a well-documented phenomenon in the dairy industry,.  It has been 
reported that there is no correlation between the degree of proteolysis of casein 
and the formation of non-casein nitrogen and non-protein nitrogen compounds, 
due to the difference in the activity of proteolytic enzymes as well as the 
metabolic activity of the bacteria present [149].  However, a decrease in the 
casein nitrogen content of the curd or the presence of short peptides or amino 
acids (proteose peptones) in milk serum is a good estimate of protease levels.  
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An increase in protease activity will result in breakdown of casein and 
subsequent protein destabilisation in UHT milk and other dairy products. 
 
Onset of gelation in UHT milk is affected by various factors, such as the heat 
treatment, homogenisation, sequence of processing steps, milk solids content, 
composition of milk, quality of milk and storage temperature [150,151].  Age 
gelation has been attributed to various changes in UHT milk during storage and 
to various conditions that alter the gelation time. In general, gelation occurs when 
casein micelles lose colloidal stability and form a three-dimensional gel network 
[149,150]. The stability of casein micelles has been attributed to the presence of 
κ-casein, colloidal calcium phosphate, a high zeta potential (-18 mV) and steric 
stabilisation (prohibition of aggregation of submicelles by steric repulsion) by the 
hydrophilic C-terminals of κ-casein or “hairy layers” [146]1. Gelation is preceded 
by changes at the surface of the casein micelles. These changes enhance 
interaction between micelles and can be categorised as changes that arise from 
protease activity [42,151]. 
 
The ambient storage temperature of the UHT milk influences the rate of 
proteolysis [148].  The proteolytic cleavage of β-casein is more rapid than that of 
αs1-casein with the subsequent production of the γ-casein.  The gelation pattern 
of UHT milks correlates well with the formation of γ-casein and therefore relates 
directly to the plasmin activity in the milk.  Several experimental data sets confirm 
these results [6,14,15,103].  In experiments where serine-protease inhibitors that 
inhibit PA activity and thereby reduce the formation of γ-casein had been added 
to UHT milk, the onset of gelation was reduced or completely inhibited as 
opposed to the control samples without added serine-protease inhibitors [53].  It 
is also interesting to note that the general plasmin activity was higher in UHT milk 
produced with the indirect method than with the direct infusion or injection 
methods [14,15,53].  In UHT, sterilised, unconcentrated milks the onset of 
gelation is preceded by proteolysis, which is not the case for concentrated 
                                            
1 Refer to Chapter 3, pp 32-33 
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sterilised UHT milks.  The gelation of the latter is a result of a nonenzymatic 
physico-chemical process (dissociation of proteins from the casein micelles and 
association of the proteins to the micelle surface; aggregation or gel formation 
occurs through association of micelle surface proteins). 
 
6.2.2. Experimental protocol 
 
The objective of this study was to evaluate the effect of added t-PA to UHT milk 
on the shelf-life of the product.  Commercial full cream UHT treated milk (indirect 
heating 141.5°C with 4 seconds holding time) was collected from Parmalat Cape 
Town, South Africa, 7 days post production.  Twenty units of the purified t-PA, 
obtained after Zinc chelating chromatography, as described in the previous 
chapter, was then added aseptically to 1000 ml milk in the presence of fibrin at a 
concentration of 8 μg.ml-1 of final product.  The milk was then evaluated over a 6-
month period for changes in appearance, pH, apparent viscosity, gel formation, 
enzymatic activity, and casein breakdown. 
 
The lyophilised t-PA enzyme, isolated after Zn-chelating chromatography, was 
resuspended in 100 mM Tris-HCl buffer (pH 8.0) and injected aseptically into the 
commercial containers, in a laminar flow cabinet. Twenty-four 1 litre containers of 
UHT milk were injected with t-PA and fibrin solution, and an equal number of 
samples were kept as controls.  The area of injection was swabbed with ethanol 
(95% v/v) prior to inoculation. The t-PA / fibrin solution was cold filter sterilised 
through an 0.2 μm pore size filter into a sterile test tube before injection with 
sterile disposable needles and syringes. After injection the cartons were 
immediately sealed with an adhesive. After the adhesive had set (approximately 
1 h), each container was gently rotated by hand for about 20 seconds. When the 
adhesive had hardened (after 24 hours), all containers (injected milk cartons and 
controls) were placed in enclosed cabinets for storage at an average temperature 
of 23°C. 
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The milk was evaluated for appearance and colour, pH, gel formation, sediment, 
viscosity, PA activity and proteolysis after 30, 60, 90, 120, 150 and 180 days. 
 
Appearance, colour and sediment were visually investigated.  Gel formation and 
apparent viscosity were measured with a Brookfield viscometer at 20°C (spindle 
1 at a speed of 60 rpm).  Triplicate readings were taken directly in centipoise 
when the spindle had been rotating for 30 s. Protein analyses of the samples 
were done according to standard IDF procedure (IDF, 1964) by Kjeldahl analysis 
of the total protein (TP), non-protein nitrogen (NPN) and non-casein nitrogen 
(NCN).   Casein nitrogen (CN) was calculated as the difference between NCN 
and NPN.  All nitrogen determination were done in triplicate and results were 
expressed as protein equivalent using a conversion factor of 6.38.  The UHT 
milks were analysed for the presence of short peptides and amino acids, which 
would indicate casein breakdown and protease activity. The UV absorption at 
280 nm of milk serum, isolated from the experimental milk samples, was 
determined in order to detect the aromatic amino acid side chains of short 
peptides originating from hydrolysed casein [106]. An increase in absorbance at 
280nm indicates the presence of the liberated breakdown products (proteose 
peptones) of casein in the serum.  The PA assay was performed 
spectrophotometrically according to the method of Zachos et al. [8] using a 
synthetic substrate, D-Val-Leu-Lys-ρ-nitroanalide (V0882, Sigma Aldrich; 
millimolar extinction coefficient of 5.57 mM-1.cm-1). 
 
6.2.3. Results 
 
Raw milk normally contains approximately 0.3 mg.l-1 plasmin and up to nine 
times more plasminogen [7]. Some of the plasmin and plasminogen is inactivated 
during heat treatment of milk. However, the potential for plasmin activation 
remains if t-PA is still active after heat treatment.  PAs are more resistant to heat 
treatment than plasmin and plasminogen [151-154].  Table 6.1 summarises the 
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reported decimal reduction time (D-values) for plasmin, plasminogen and PA 
reported by various researchers. 
 
Table 6.1: D-Values for plasmin, plasminogen and PA 
 
D1-VALUES OF PLASMINOGEN, PLASMIN AND PA 
D-Value Enzyme Reference  
35.7 min at 72.5°C PL Driessen and van der Waals (1978) [153] 
12.4 min at 72.5°C PL Driessen and van der Waals (1978) [153] 
10 sec at 142,5°C PL Driessen and van der Waals (1978) [153] 
2 min at 85°C PL and PG Alichanidis et al. [109] 
17 sec at 130°C PL and PG Alichanidis et al. [109] 
7 sec at 140°C PL and PG Alichanidis et al. [109] 
1.5 min at 85°C PL and PG Rollema and Poll [71] 
15 sec at 110°C PL and PG Rollema and Poll [71] 
6 sec at 140°C PL and PG Rollema and Poll [71] 
109 min at 72.5°C PA Dongjin, Lu and Nielsen [152] 
32 sec at 140°C PA Dongjin, Lu and Nielsen [152] 
1 D-value refers to decimal reduction time. This is the amount of time that it takes at a certain 
temperature to inactivate 90% of the enzyme being studied 
 
The milk containers with added t-PA began to form a gel after 60 days of storage, 
and this gelation was accompanied by an increase in apparent viscosity (Table 
6.2 and Fig. 6.1)2.  The PA activity was constant throughout shelf-life, and there 
was an approximate increase in absorbance at 280 nm of 0.12 in milk with added 
t-PA as compared to that of the control milk (Table 6.3). 
                                            
2 In the samples with added t-PA, activity was detected using the PA activity assay as described 
in Chapter 5. 
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Table 6.2: Apparent increase in viscosity of UHT milk with added t-PA during 180 
days shelf-life 
 
VISCOSITY OF UHT MILK (BROOKFIELD, cpi- 20°C)1
Day Control 1 Control 2 Control AVE t-PA 1 t-PA 2 t-PA AVE 
0 2.30 2.40 2.35 2.35 2.40 2.38
30 2.40 2.60 2.50 2.40 2.20 2.30
60 3.00 2.80 2.90 3.50 3.20 3.35
90 3.20 3.00 3.10 18.00 21.00 19.50
120 2.40 2.50 2.45 32.00 29.00 30.50
150 3.40 3.40 3.40 38.00 42.00 40.00
180 3.00 3.00 3.00 45.00 43.00 44.00
1 Measured at 21°C with spindle 1 at 60 rpm 
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Figure 6.1: Apparent increase in viscosity of UHT milk with added t-PA during 
180 days shelf-life. 
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Table 6.3: PA activity of UHT milk with added t-PA during 180 days shelf-life 
 
PA ACTIVITY ASSAY (UHT MILK) 
 Δ A405nm 3 h, 4 h @ 37°C  
 Day Controla t-PA samplea Difference:  Control – t-PA  
Day 0 0.153 0.289 0.136 
Day 30 0.156 0.279 0.123 
Day 60 0.165 0.270 0.105 
Day 90 0.183 0.312 0.129 
Day 120 0.180 0.302 0.122 
Day 150 0.173 0.276 0.103 
Day 180 0.155 0.273 0.118 
Average 0.166 0.286 0.119 
a Fractions were diluted 1:2 before activity assay, therefore a 3-fold dilution 
 
Casein breakdown occurred, as indicated by Kjeldahl analysis of the total protein 
(TP), non-protein nitrogen (NPN), casein nitrogen (CN) and non-casein  nitrogen 
(NCN) fractions (Table 6.4 and Figs. 6.2, 6.3 and 6.4).  Between day 0 and day 
180 casein decreased by 0.14%, and this correlated with an increase in the 
proteose peptone (PP) fraction of 0.12% over the same period of time, indicating 
the breakdown of casein into smaller peptides and amino acids.  This was also 
confirmed by the increase in absorbance at 280 nm of milk serum as detected by 
the method of Richardson et al. [106].  The casein breakdown metabolites of the 
t-PA inoculated UHT milk, as measured by the absorbance at 280 nm, was 
approximately 9 fold higher than that of the control samples (Table 6.5 and Fig. 
6.5).  Literature reveals that absorption values in UHT milk serum exceeding 0.9 
lead to gel formation of UHT milk upon storage [154]. 
96   
97   
 
Table 6.4: Kjeldahl analysis of total nitrogen (TN), total protein nitrogen (TPN) 
and casein nitrogen (CN) of UHT milk with added t-PA during 180 days shelf-life 
 
KJELDAHL PROTEIN ANALYSIS (UHT MILK) 
Day TN1 TPN2 CN3 NCN4 WPN5 NPN6 PP7
CONTROL   
0 3.440 3.260 2.620 0.820 0.630 0.180 0.010
30 3.435 3.255 2.600 0.835 0.640 0.180 0.015
60 3.416 3.226 2.580 0.836 0.630 0.190 0.015
90 3.410 3.230 2.590 0.820 0.630 0.180 0.010
120 3.427 3.232 2.590 0.837 0.630 0.195 0.012
150 3.438 3.258 2.620 0.818 0.620 0.180 0.018
180 3.386 3.206 2.570 0.816 0.625 0.180 0.011
t-PA   
0 3.440 3.260 2.620 0.820 0.630 0.180 0.010
30 3.475 3.265 2.600 0.875 0.640 0.210 0.025
60 3.435 3.235 2.540 0.895 0.640 0.200 0.055
90 3.403 3.233 2.510 0.893 0.620 0.170 0.103
120 3.472 3.252 2.490 0.982 0.610 0.220 0.152
150 3.462 3.268 2.450 1.012 0.640 0.194 0.178
180 3.430 3.207 2.389 1.041 0.625 0.223 0.193
1TN  Total Nitrogen = TPN + NPN 
2TPN  Total Protein Nitrogen = CN + NCN 
3CN  Casein Nitrogen = TPN - NCN 
4NCN  Non-casein Nitrogen = TPN - CN 
5WPN Whey Protein Nitrogen = NCN – (NPN + PP) 
6NPN Non-Protein Nitrogen = TN - TPN 
7PP Proteose Peptones = NCN – (WPN + NPN) 
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Figure 6.2: Kjeldahl analysis of total nitrogen (TN), total protein nitrogen (TPN) and casein nitrogen (CN) of UHT milk with 
added t-PA during 180 days shelf-life.
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Figure 6.3: Kjeldahl analysis of non-casein nitrogen (NCN), whey protein nitrogen (WPN), non-protein nitrogen (NPN) and 
proteose peptones (PP) of UHT milk with added t-PA during 180 days shelf-life 
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Figure 6.4: Kjeldahl analysis of proteose peptones (PP) vs. casein nitrogen (CN) 
of UHT milk with added t-PA during 180 days shelf-life. 
 
Table 6.5: Spectrophotometric analysis of UHT milk serum at 280 nm with added 
t-PA during 180 days shelf-life 
 
ABSORBANCE 280 NM (UHT MILK SERUM) 
Day Control 1 Control 2 Control AVE t-PA 1 t-PA 2 t-PA AVE 
0 0.132 0.143 0.138 0.135 0.138 0.137
30 0.137 0.139 0.138 0.240 0.240 0.240
60 0.102 0.130 0.116 0.475 0.532 0.504
90 0.133 0.122 0.128 0.847 0.878 0.863
120 0.145 0.139 0.142 1.000 0.923 0.962
150 0.212 0.260 0.236 1.128 1.133 1.131
180 0.233 0.200 0.217 1.283 1.199 1.241
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Figure 6.5: Spectrophotometric analysis of UHT milk serum at 280 nm with added 
t-PA during 180 days shelf-life. 
 
There was no relationship between the decrease in pH and the onset of gelation 
in UHT milk as indicated in Table 6.6 and Fig.6.6. This finding correlates well with 
previous results obtained by Andrews et al. [155], which proposed that the 
decrease in pH during storage is due to loss of positive charges on the protein 
molecule, caused by the reaction of free amino groups in Maillard-type reactions 
[156].  
 
Visual and sensory analyses of the samples revealed a severe bitter off-flavour in 
the coagulated milks.  A typical visual distinction between bacterial protease in 
milk is the formation of sediment, while endogenous proteases cause a clear 
serum layer at the bottom of the container [60].  Prior to gelation at day 90, there 
was also a visible increase in severity of small white specs on the surface of the 
UHT milks.   
101   
Table 6.6: pH measurement of UHT milk serum at 280 nm with added t-PA 
during 180 days shelf-life 
 
pH (UHT MILK) 
Day Control 1 Control 2 Control AVE t-PA 1 t-PA 2 t-PA AVE 
0 6.66 6.66 6.66 6.66 6.65 6.66
30 6.63 6.64 6.64 6.60 6.62 6.61
60 6.62 6.61 6.62 6.59 6.58 6.59
90 6.60 6.61 6.61 6.57 6.55 6.56
120 6.60 6.61 6.61 6.50 6.52 6.51
150 6.58 6.57 6.58 6.50 6.51 6.51
180 6.56 6.55 6.56 6.48 6.49 6.49
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Figure 6.6: pH measurement of UHT milk serum at 280 nm with added t-PA 
during 180 days shelf-life. 
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 6.2.4. Discussion 
 
The results obtained from this study confirmed previous reports of an apparent 
link between proteolysis, an increase in apparent viscosity, and the formation of a 
gel and confirmed that there is a relationship between a low level of plasmin 
activity induced by the addition of t-PA and the gelation of UHT milk. In the study 
of Rollerma et al. [58], it was suggested that the added plasmin preferentially 
attacked β and α-caseins over κ-casein.  Venkatachalam et al. [157] concluded 
that age gelation involves dissociation of proteins from the casein micelles and 
their formation on the micelle surface as protuberances and tendrils. Aggregation 
of the protein particles occurs through these appendages, not through the original 
micelle surface as in rennet or acid coagulation of milk. 
 
6.3. Gouda Cheese 
 
6.3.1. Introduction 
 
Gouda cheese first appeared in the Netherlands in the sixteenth century.  Gouda 
cheese was produced on farms near the village Gouda, approximately 33 km 
from Rotterdam.   
 
South Africa produces about 65,000 metric ton of cheese per year from 650 
millions litres of milk. About 60% of this quantity is in the form of Cheddar and 
Gouda cheese and the balance consists of other types, headed by Feta and 
Mozzarella.  Of the 65,000 metric ton of cheese produced, it is estimated that 
15,600 metric ton produced is Gouda. The per capita consumption of cheese in 
South Africa has increased from 1 to 1.5 kilograms per year since 1995, but is 
still far less than France who top the list at 25 kilograms per year, followed by 
Greece and Germany with 20 kg and the Netherlands with 18 kg per year. 
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South Africa produces fine quality cheeses, but consumer demand is forcing 
manufacturers to constantly improve the quality their products.  Cheesemakers 
are well aware of the fact that inferior quality milk with high somatic cell count, 
reduces cheese yield and affects the characteristics of the final product.  This has 
been confirmed in research and numerous publications over the years [158-160].  
Internationally cheesemakers and milk buyers encourage farmers to produce milk 
with a low SCC in order to ultimately improve the quality of the final products.  
Milk buyers enforce penalties on farmers with high SCC milk and pay premiums 
for low SSC milk.  In South Africa premiums can be as much a 2-4 cents per litre 
for milk with low SCC (<500,000.ml-1), and penalties can be as much as 6 cents 
per litre for milk with high SCC (>500,000.ml-1).  
 
Summer et. al. at the University of Wisconsin have reported that milk production 
decreases linearly with an increase in SCC [159].  It is reported that in Wisconsin 
mastitis alone costs the dairy farmers more than $100 million per year as a result 
of reduced milk production. High levels of SCC cause a decrease in cheese yield; 
the relationship is, however, not linear.  The decrease in cheese yield can be as 
high as 1% for SCC that increases to 100,000.ml-1.  If the increase of SCC 
exceeds 1,000,000 SCC.ml-1 the rate of decrease in cheese yield is less; 
however, it can be as much as an additional 2% loss [159]. 
 
Verdi and Barbano [19] reported that the major enzyme responsible for the 
proteolytic activity in milk is the native serine protease plasmin.  Plasmin levels 
are elevated during mastitis, resulting in the hydrolysis of casein in the milk.  This 
disproves previous theories that the loss in cheese yield with high SCC is as a 
result of the cow producing milk with an increased whey protein to casein ratio.  
 
In addition to reduced cheese yield, hydrolysis of casein negatively affects the 
rheological properties of rennet-induced milk gels resulting in an increase in 
rennet coagulation time, an increase in moisture content in the final cheese, and 
an increase in fat losses in the whey [158-162].  Plasmin readily hydrolyses β- 
and αs-caseins to form peptides and amino acids [68].  This negatively impacts 
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on the formation of the casein matrix during renneting, forming a weaker gel that 
deteriorates during cooking and stirring of the curd.  The lower calcium in milk 
with a high SCC also contributes to a more fragile curd during renneting.  
 
6.3.2. Gouda Characteristics 
 
To evaluate the effect of t-PA addition to milk, prior to the manufacture of Gouda 
cheese it is important to understand typical product characteristics. 
 
6.3.2.1. Composition of Gouda Cheese 
 
The typical chemical composition of Gouda is indicated in Table 6.7. 
 
 
Table 6.7: Gouda Cheese Standards (Chemical and Microbiological) [163-168] 
 
GOUDA CHEESE STANDARDS 
CHEMICAL STANDARDS GOUDA ROUND GOUDA BLOCK 
pH 5.0 – 5.20 5.0 – 5.45 
% Moisture 38 – 43 38 – 43 
% Fat 29 – 34 29 – 34 
% Fat in Dry Matter (FDM) 48 – 60 48 – 60  
% Salt 0.9 – 1.6 1.0 – 2.0 
Maturing period ≥ 4 weeks ≥ 4 weeks 
MICROBIOLOGICAL STANDARDS GOUDA ROUND GOUDA BLOCK 
Coliforms (cfu.g-1) ≤ 500 ≤ 500/g 
E.coli (cfu.g-1) Negative Negative 
Yeast and Moulds (cfu.g-1) ≤ 300 ≤ 300 
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 6.3.2.2. Colour 
 
Gouda cheese may be uncoloured or coloured.  The colour is white to yellow, not 
waxy but dull, clear and uniform throughout.  Discoloured spots or patches are 
not tolerated [163-168]. 
 
6.3.2.3. Appearance 
 
The cheese must be well moulded and the surface without cloth creases or 
cracks.  In the case of round cheeses the top and bottom surfaces should be 
smooth, closed, flat and parallel.  The side surface of the cheese is evenly 
rounded without sharp corners.  If coated for example with wax, the coating 
should be clean, uniform, close-adhering and be free of blisters, scales, cracks, 
mould, and rot spots or soiled areas.  Vacuum packed block cheeses should 
have flat parallel sides, square even edges, and evenly folded, neat, close-fitting 
wrapper which is free from wrinkles [163-168]. 
 
6.3.2.4. Body and Texture 
 
The body must be waxy, reasonably solid, reasonably spreadable, elastic, easy 
to slice at ±15 °C, not too soft and pasty, not too hard and not too crumbly or 
"short". 
 
The texture must be close-knit with the exception for a few typical round Gouda 
"eyes".  Undesired gas-openings are not permissible [163-168]. 
 
6.3.2.5. Flavour 
 
Clean typical Gouda cheese flavours are; pleasant, nutty, mild becoming piquant, 
but not sour or too salty.  No off-flavours should be detectable [163-168]. 
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Controlled proteolysis is important for the flavour development in cheese, on the 
contrary uncontrolled proteolysis can cause detrimental effects in dairy products, 
such as the gelation of ultra high temperature (UHT) milk, the manufacturing of 
poor quality cheeses, poor ripening of cheese, decline cheese yield, degradation 
in stored casein products (decrease in viscosity) and decreased heat and ethanol 
stability of raw and processed milks, to name but a few. 
 
6.3.3. Experimental Protocol 
 
The object of the study was to evaluate the effect of added t-PA on Gouda 
cheese over shelf-life.  Purified t-PA, obtained after Zinc chelating 
chromatography as described in Chapter 5, was added to milk (20 U.l-1 milk) and 
incubated at 4°C for 24 hours prior to the manufacturing of the Gouda cheese in 
the presence of fibrin (concentration of 8 μg.ml-1 milk).  The cheese was then 
evaluated over a 6-month period for changes in flavour, appearance, enzymatic 
activity, and casein breakdown. 
 
The freeze-dried t-PA enzyme was resuspended in 100 mM Tris-HCl buffer (pH 
8.0) and added to the raw milk; this was done at Elsenburg Agricultural College, 
Stellenbosch, using morning and evening milk obtained of the mixed Jersey and 
Friesland herd.  After addition of t-PA, the milk was incubated at 4°C for 24 hours 
prior to cheese manufacture.  Gouda cheese was then manufactured on small 
scale (20 litres of milk was used) at Elsenburg Dairy Laboratory according to the 
flow-diagram in Fig. 6.7.  The production sheet of the Gouda manufactured (with 
added t-PA) is indicated in Fig. 6.8.  A control batch was also produced using the 
same milk and process on the same day as indicated in the production sheet in 
Fig. 6.9.   
 
After 60, 90, 120, 150 and 150 days the cheese was evaluated for flavour, 
appearance and colour, PA activity and proteolysis. Absorption at 280 nm of 
whey after the first drain was measured in order to detect the aromatic amino 
acid side chains of short peptides of hydrolysed casein molecules [106]. An 
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increase in absorbance would indicate the presence of the liberated breakdown 
products (proteose peptones) of casein in the serum.  The whey was analysed 
for whey protein nitrogen (WPN), non-protein nitrogen (NPN) and total protein 
(TP) using the standard International Dairy Federation procedure (IDF, 1964) by 
Kjeldahl analysis.  All nitrogen results were expressed as protein equivalent using 
a conversion factor of 6.38 and were analysed in triplicate.  Mojonnier analyses 
(ether extraction method) were done in order to determine the % fat in the whey.  
 
Sensory evaluations were performed by trained panellists in accordance with the 
guidelines of the American Dairy Science Association (ADSA) as described by 
Bodyfelt et al. [165].  Protein analyses of the samples were done according to 
standard IDF procedure (IDF, 1964) by Kjeldahl analysis of the total protein (TP), 
non protein nitrogen (NPN) and noncasein nitrogen (NCN).  Casein nitrogen (CN) 
was calculated as the difference between NCN and NPN.  All nitrogen results 
were expressed as protein equivalent using a conversion factor of 6.38 and were 
the result of triplicate analyses.  Cheese for PA activity were grated and 10 g 
samples were mixed with 90 ml of 0.1 M trisodium citrate, containing 13 mmol.l-1 
ε-amino caproic acid, and dissolved by stirring for 1 hour 30 minutes at ambient 
temperature. The samples were then centrifuged at 25,000 X g for 20 minutes 
after which the fat was removed and the remaining supernatant (milk serum) 
used for PA analysis. The PA activity was determined spectrophotometrically as 
previously described [8]. 
 
The water soluble N (WSN) extracts of the cheeses, after pressing (day 1) and at 
30, 60, 90, 120, 150 and 180 days of ripening, were prepared by the method of 
Kuchroo and Fox [169]. The N content of the extracts was determined by the 
Kjeldahl method and WSN was expressed as a percentage of TN.  Total free 
amino acid levels were determined by a modified Cd-ninhydrin reactive (CdN) 
method.  The CdN method is a photometric method, specific for free amino acids 
and spectrophotometrically measured at an absorbance of 507 nm.  Cd-ninhyrdin 
reacts with alpha-amino acids, and changes from a yellow to a deep purple 
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colour in solution.   Results are expressed as free amino acids in millimoles of 
Leucine [170].  
 
 
 
Raw Milk 
Pasteurisation 
Curd 
Manufacture 
Moulding 
Final Pressing 
Brining 
Ripening 
Starter Culture, 
Rennet, CaCl2 
Cheese milk
1. Fat standardisation 
2. Standardize Fat: Casein 
 
Pasteurisation:  
3. 63°C/30 minutes (batch pasteurisation) 
4. Cooling to 31°C (renneting 
temperature) 
 
Curd manufacture: 
5. Ripening in the cheese vat for 45 
minutes 
6. Additives: 
– Calcium chloride 
– Saltpeter (Optional) 
– Starter bacteria 
 
Coagulum 
7. Additives: 
– Rennet as coagulant (45 minutes) 
 
Cutting  
8. Into grains (curd 0.5 – 1.5 cm blocks) / 
Cheese knives 
 
Heating / Scalding 
9. Stir 20 – 30 minutes 
10. Drain 30 % whey 
11. Increase temp. to approximately 38°C 
after 45-50 minutes 
12. Add 10 – 15 % water and stir 30 – 60 
minutes 
13. Final drain whey 
 
Pre-pressing and Salting 
14. Pre-press curd in vat 
15. Collection of curd for final pressing 
16. Press for 1-3 hours at 0.5 kg/cm2 
17. Brine salting (20% NaCl solution) to 
final % NaCl in cheese of 
approximately 1.80% 
 
Ripening and Maturation  
18. Formed, pressed, and salted cheese to 
ripening room.  Storage at 80% 
humidity for minimum of 4 weeks at 12 
– 15°C  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7: Process-flow diagram of Gouda manufacture. 
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GOUDA CHEESE MANUFACTURING RECORD
DATE:  15/12/2003
BATCH: PA1
MILK ANALYSIS DATE TIME TEMP. (°C) % TA pH
 15/12/2003 12H00 4°C 0.15% 6.71
% FAT % PROT % CASEIN % LACTOSE CASEIN:FAT
3.70 3.51 2.79 4.55 0.75 : 1
DATE TIME TEMP. (°C) % TA pH
16/12/2003 12H00 4°C 0.17% 6.67
% FAT % PROT % CASEIN % LACTOSE CASEIN:FAT
3.72 3.49 2.68 4.53 0.72 : 1
MANUFACTURE DATE TIME TEMP. (°C) % TA pH
HOMOGENISE No
PASTEURISE 16/12/2003 12H30 63°C / 30 min 0.17 6.66
STARTER ADDED 16/12/2003 13H10 31°C 0.17 6.66
TYPE MAO (homofermentative)
QUANTITY 2 units per 20 l milk
CaCl2 ADDED 16/12/2003 13H10 31°C 0.17 6.66
TYPE
QUANTITY (ml) 4 ml
ANNATO ADDED 16/12/2003 13H10 31°C 0.17 6.66
TYPE
QUANTITY (ml) 1 ml
RENNETING 16/12/2003 13H55 31°C 0.12 6.68
TYPE Chymax (microbial) Liquid
QUANTITY (ml) 1.2 ml
CUTTING OF CURD 16/12/2003 14H50 31°C 0.13 6.68
FIRST DRAINING 16/12/2003 15H35 31°C 0.13 6.65
WATER ADDED 16/12/2003 15H55 31°C 0.10 6.57
FINAL DRAIN 16/12/2003 17H30 37.5°C 0.13 6.42
CALCULATIONS AND ANALYSIS COMMENTS
L MILK 20.00
KG MILK 20.60 SCC/ml of milk = 183,000
KG CHEESE 2.05
% ACTUAL YIELD 9.95%
% THEORETICAL YIELD 12.06%
KG CHEESE (4 WEEKS) 1.99
% FAT 31.20%
% FAT IN DRY MATTER 57.25%
% MOISTURE 45.50%
% TOTAL SOLIDS 54.50%
% SALT 1.63%
% SALT IN MOISTURE 3.58%
 
Figure 6.8: Production sheet of Gouda with added t-PA and fibrin. 
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GOUDA CHEESE MANUFACTURING RECORD
DATE:  15/12/2003
BATCH: CONTROL
MILK ANALYSIS DATE TIME TEMP. (°C) % TA pH
 15/12/2003 12H00 4°C 0.15% 6.71
% FAT % PROT % CASEIN % LACTOSE CASEIN:FAT
3.70 3.51 2.79 4.55 0.75 : 1
DATE TIME TEMP. (°C) % TA pH
16/12/2003 12H00 4°C 0.16% 6.67
% FAT % PROT % CASEIN % LACTOSE CASEIN:FAT
3.72 3.5 2.80 4.53 0.75 : 1
MANUFACTURE DATE TIME TEMP. (°C) % TA pH
HOMOGENISE No
PASTEURISE 16/12/2003 12H35 63°C / 30 min 0.16 6.67
STARTER ADDED 16/12/2003 13H15 31°C 0.16 6.66
TYPE MAO
QUANTITY 2 units per 20 l milk
CaCl2 ADDED 16/12/2003 13H15 31°C 0.16 6.67
TYPE
QUANTITY (ml) 4 ml
ANNATO ADDED 16/12/2003 13H15 31°C 0.16 6.67
TYPE
QUANTITY (ml) 1 ml
RENNETING 16/12/2003 14H00 31°C 0.125 6.68
TYPE Chymax (microbial) Liquid
QUANTITY (ml) 1.2 ml
CUTTING OF CURD 16/12/2003 14H30 31°C 0.13 6.68
FIRST DRAINING 16/12/2003 15H05 31°C 0.13 6.65
WATER ADDED 16/12/2003 15H20 31°C 0.09 6.55
FINAL DRAIN 16/12/2003 16H00 37°C 0.135 6.4
CALCULATIONS AND ANALYSIS COMMENTS
L MILK 19.98
KG MILK 20.58 SCC/ml of milk = 183,000
KG CHEESE 2.23
% ACTUAL YIELD 10.84%
% THEORETICAL YIELD 11.41%
KG CHEESE (4 WEEKS) 2.17
% FAT 32.50%
% FAT IN DRY MATTER 54.83%
% MOISTURE 40.73%
% TOTAL SOLIDS 59.27%
% SALT 1.50%
% SALT IN MOISTURE 3.68%
 
Figure 6.9: Production sheet of control Gouda. 
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6.3.4. Results 
 
The results obtained indicated a definite difference between the processing 
parameters and final product quality of the Gouda cheese processed with the 
control milk (control Gouda) and that of the Gouda cheese processed with the t-
PA inoculated milk (t-PA Gouda).   
 
The milk was analysed prior to cheese manufacture after 24 hours of incubation 
for TPC, Coliforms, Psychrotrophs, Spores and SCC.  The milk was of good 
bacterial quality and average SCC (APC 13,500 cfu.ml-1, Coliforms 4 cfu.ml-1, 
Psychrotrophs 1,250 cfu.ml-1, Spores 2 cfu.ml-1 and SCC 183,000 SCC.ml-1) 
 
After 24 hours of incubation, plasmin activity was already detected in the milk 
with added t-PA; plasmin activity was defined as the difference between the 
native plasmin activity in the control milk vs. the plasmin activity in the t-PA 
added milk.  Activation of plasmin, achieved by the addition of t-PA and fibrin, 
resulted in the breakdown of casein (0.11%) and an increase in the proteose 
peptone fraction (0.10%) of the milk.  No effect on the TN, TPN and NPN 
components were noted as indicated in Table 6.8 and Figs. 6.10 to 6.12.  Native 
plasmin and plasminogen were present in the milk, and as reported earlier in 
normal milk the plasminogen concentration can be up to 9 times that of plasmin.  
Therefore the addition of t-PA did activate the conversion of plasminogen (as the 
“proteolytic reservoir”) to plasmin, increasing the potential for proteolysis not only 
after 24 hours of incubation, but also during further ripening. 
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 Table 6.8: Protein analysis of Gouda milk after milking and after 24 hour 
incubation at 4°C 
 
KJELDAHL PROTEIN ANALYSIS MILK (GOUDA CHEESE) 
HOURS TN TPN CN CN/TPN NCN WPN NPN PP 
 CONTROL                
0 3.670 3.510 2.790 79.49% 0.880 0.700 0.160 0.020
24 3.667 3.502 2.810 80.24% 0.857 0.670 0.165 0.022
 t-PA GOUDA                
0 3.686 3.511 2.790 79.46% 0.896 0.700 0.175 0.021
24 3.653 3.490 2.680 76.79% 0.973 0.690 0.163 0.120
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Figure 6.10: Total nitrogen (TN), total protein nitrogen (TPN) and casein nitrogen 
(CN) of Gouda milk, after milking and 24 hour incubation. 
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 Kjeldahl analysis of Gouda milk samples
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Figure 6.11: Non-casein nitrogen (NCN), whey protein nitrogen (WPN), non-
protein nitrogen (NPN) and proteose peptones (PP) of Gouda milk, after milking 
and 24 hour incubation. 
 
The PA activity in the t-PA Gouda remained constant throughout shelf-life and 
was significantly higher than that of the control Gouda.  No retardation in activity 
was noted after 180 days which emphasises that the enzymatic activity of 
plasmin remains, and PA will therefore affect extended shelf-life products, such 
as UHT milk and matured cheese.  Accelerated plasmin activity was noted, as 
there was an increase in the absorbance of 0.043 for the control Gouda 
compared to the 0.120 increase in absorbance of the t-PA Gouda (as indicated in 
Table 6.9 and Fig. 6.13 and measured by the PA assay).  It is expected that there 
should be a decrease in plasmin activity after a certain period of time, however, 
this was not indicated in this study and has not been reported either.  Future 
analysis should investigate the “saturation” point for plasmin and PA activity in 
ripened cheese. 
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 Kjeldahl analysis of Gouda milk after 24 hours
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Figure 6.12: Casein nitrogen (CN) vs. proteose peptones (PP) of Gouda milk, 
after milking and 24 hour incubation with t-PA. 
 
 
Table 6.9: PA activity assay of serum isolated from Gouda cheese 0 to 180 days 
post production 
 
ABSORBANCE GOUDA SERUM Δ A405nm 3 h, 4 h @ 37°C1
Day Control 1 Control 2 Control AVE t-PA 1 t-PA 2 t-PA AVE 
0 0.123 0.120 0.122 0.610 0.630 0.620
30 0.132 0.111 0.122 0.623 0.634 0.629
60 0.144 0.139 0.142 0.611 0.607 0.609
90 0.154 0.180 0.167 0.701 0.698 0.700
120 0.150 0.170 0.160 0.713 0.722 0.718
150 0.190 0.123 0.157 0.732 0.742 0.737
180 0.165 0.165 0.165 0.730 0.749 0.740
1 Fractions were diluted 1:2 before activity assay, therefore a 3-fold dilution 
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Figure 6.13:  PA activity assay of serum isolated from Gouda cheese (t-PA 
Gouda vs. control Gouda) 0 to 180 days post production. 
 
The chemical analyses results of the Gouda cheeses, after 4 weeks storage, are 
summarised in Table 6.10.  The final product yield of the t-PA Gouda was less 
than the control Gouda and the theoretical yield, calculated according to the 
formula of Van Slyke and Price [171-172] (Table 6.11).   
 
During the manufacturing of the Gouda cheese (with and without added t-PA), 
the t-PA Gouda had a weaker gel formation and a much softer curd (higher 
moisture content) at final drain.  The renneting time of the t-PA milk was almost 
55 minutes as opposed to that of the control batch of 30 minutes, indicating an 
increase of 83% in rennet coagulation time.  The curd took longer to work dry in 
the vat, as normal production time after cutting for Gouda cheese is typically 1 to 
1 ½ hours.  From cutting the curd to final drain of the control cheese it took 
approximately 1½ hours in comparison to the t-PA added milk which took 2½ 
hours, as indicated in the production sheets.  The results correlate well with the 
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whey analysis during production and the final moisture analysis of the cheese 
after week 4.  The moisture of the t-PA Gouda was 10.48% higher than the 
control Gouda at 45.50% after week 4, as opposed to that of the control cheese 
with 40.73% moisture.   
 
Table 6.10: Chemical analysis of Gouda manufactured after 4 weeks 
 
CHEMICAL ANALYSIS GOUDA AFTER 4 WEEKS OF RIPENING 
 t-PA CONTROL 
KG CHEESE (4 WEEKS) 1.99 2.17 
    % FAT  31.20% 32.50% 
% FAT IN DRY MATTER 57.25% 54.83% 
% MOISTURE 45.50% 40.73% 
% TOTAL SOLIDS 54.50% 59.27% 
% SALT 1.63% 1.50% 
% SALT IN MOISTURE 3.58% 3.68% 
 
Table 6.11:  Theoretical vs. Actual Gouda cheese yields 
 
  GOUDA CHEESE YIELDS 
  CALCULATED WEEK 1 % Calc - Actual WEEK 4 % Calc - Actual 
Control 11.41% 10.84% 0.57% 10.54% 0.87% 
TPA 12.06% 9.95% 2.11% 9.68% 2.39% 
 
The results of the whey analysed after first drain also correlates well with the 
observations during the Gouda manufacturing as indicated in Table 6.12.  
Kjeldahl analysis indicated that the TN in the whey of the t-PA Gouda (TN 
0.973%) was approximately 13.50% higher than the control whey (TN 0.857%).  
The calculated PP fraction after Kjeldahl analysis was almost 3-fold higher than 
that of the control, and this correlated with the results of the spectrophotometric 
analysis at 280 nm.  The samples of the whey analysed also showed a significant 
increase in PA activity of the t-PA whey compared to that of the control whey.  
The fat loss in the t-PA Gouda whey was 85% higher than the fat loss in the 
control whey, which positively correlates with the reduction in cheese yield.  
Normally fat losses in whey can be attributed to poor handling of the curd during 
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manufacture, such as too much stirring, excessive pumping of the milk, 
excessive heating of the milk during pasteurisation, too high an initial fat 
percentage in the milk, or commencing stirring too quickly after cutting (therefore 
not allowing the curd to cure). 
 
Table 6.12: Whey analysis during Gouda cheese manufacture 
WHEY ANALYSIS FIRST DRAIN 
  % FAT1 % TN2 % WP2 % NPN2 PP3 Δ A280nm4 PA ACTIVITY5
Control 0.34% 0.86% 0.62% 0.17% 0.07% 0.099 0.232
TPA 0.63% 0.97% 0.60% 0.17% 0.21% 0.253 0.748
1 Mojonnier analysis 
2 Kjeldahl analysis 
3 Calculated value 
4 Absorbance at 280 nm 
5 Absorbance at 405 nm 
 
The protein analysis of the Gouda during maturation as indicated in Table 6.13 
gave interesting results.  Both cheeses had constant TN values throughout shelf-
life, as expected; however, there was a definite increase in WSN fractions as 
measured by the Kjeldahl method.  The increase in WSN and total free amino 
acids formed in the control cheese can be attributed to a combination of factors 
such as proteolysis by plasmin, residual rennet activity and normal proteases 
produced by the homo-fermentative MAO starter culture used.  This is necessary 
for normal flavour development in cheese, especially matured cheese where 
controlled proteolysis gives a certain character to the cheese.  The WSN, 
expressed as a percentage of TN, was significantly higher in the t-PA Gouda as 
opposed to that of the control Gouda.  There was a positive correlation in both 
batches of cheese produced between WSN, expressed as a percentage of TN, 
and the total free amino acids formed (mM Leucine.l-1).  The t-PA Gouda 
exhibited a 3-fold increase in % WSN: TN and free amino acids formed as 
supposed to in the control Gouda, which proves accelerated proteolysis due to 
enhanced plasmin activity, as residual rennet activity and starter culture 
proteolysis should be seen as a constant in both sets of Gouda.  The results 
obtained contradict previous reports by Farkye and Fox [108], who noted that a 
6-fold increase in plasmin activity in Cheddar cheese did not significantly 
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increase the % WSN:TN compared to the control cheese without accelerated 
plasmin activity.  However, the results of this study do agree with their findings 
that an increase in % WSN:TN occurs during normal maturation, with higher 
values obtained after 3 and 6 months.  According to Farkye and Fox [108] the 
plasmin alters the peptide profile of the WSN fraction in the cheese, which 
contributes to further breakdown of peptides in the WSN as a result of plasmin 
activity.  The results, summarised in Fig. 6.14, indicate a linear relationship 
between maturation time, % WSN:TN (R2 = 0.985 t-PA and R2 = 0.955 Control) 
and total free amino acids formed (R2 0.989 = t-PA and R2 = 0.957 Control). 
 
Table 6.13: Protein analysis of standard and t-PA augmented Gouda during 
shelf-life with specific mention of the water soluble nitrogen (WSN) as a 
percentage of total nitrogen (TN), and the total free amino acids as determined 
by the modified Cd-ninhydrin (CdN) reactive method 
KJELDAHL PROTEIN ANALYSIS (GOUDA CHEESE) 
DAY TN WSN1 WSN:TN CdN AMINO GROUP (mM) 
 CONTROL       
0 26.330 0.798 3.03% 0.20 
30 26.300 1.022 3.89% 0.20 
60 26.320 1.987 7.55% 0.24 
90 26.400 2.489 9.43% 0.25 
120 26.360 3.833 14.54% 0.27 
150 26.330 4.232 16.07% 0.30 
180 26.330 4.289 16.29% 0.30 
 t-PA GOUDA        
0 26.730 0.810 3.03% 0.20 
30 26.700 2.030 7.60% 0.30 
60 26.720 3.855 14.43% 0.40 
90 26.720 4.234 15.85% 0.45 
120 26.710 5.550 20.78% 0.60 
150 26.730 7.470 27.95% 0.69 
180 26.740 8.790 32.87% 0.83 
1 As percentage of TN 
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Figure 6.14:  Analyses of water soluble nitrogen (WSN), total nitrogen (TN) and 
mM Leucine in Gouda cheese from day of production to 180 days. 
 
 
The results of the sensory analysis correlated well with the chemical analysis and 
estimation of the degree of proteolysis that occurred during maturation.  
However, the cheese was only evaluated after day 30 and day 150 by 5 
individual trained panelists.  The control cheese was superior in terms of 
appearance, body and texture and final flavour delivery.  Overall, t-PA Gouda 
scored lower for these attributes, and this could be attributed to the higher final 
moisture in the cheese and the enhanced “uncontrolled” proteolysis induced by 
the addition of t-PA to the cheese milk.  The t-PA cheese appeared slightly more 
bleached, with a shorter body and brittle texture.  The control batch had a 
homogenous even colour, with no specs or discolouration and exhibited good 
elasticity.  The t-PA cheese had a bitter flavour that increased in severity during 
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shelf-life.  The most common descriptors used by the panelists could be 
summarised as follows: 
 
 Control Gouda (day 30): Neutral colour, creamy, nutty taste, good mild 
flavour 
 t-PA Gouda (day 30): White spots, bleached appearance, pasty, slight 
bitterness, high acid, astringent 
 Control Gouda (day 150): Neutral colour, creamy, nutty taste, good mild 
flavour 
 t-PA Gouda (day 150): White spots, bleached appearance, pasty, severe 
bitterness, high acid, astringent 
 
The results of the tasting panel are summarised in Table 6.14.  Scores were 
allocated as follow: Maximum 2 points for appearance, maximum 7 points for 
body and texture, maximum 11 points for flavour to give a final total out of 20 
points. 
 
Table 6.14: Sensory scores of Gouda cheese after 1 month and 5 months 
 
GOUDA SENSORY ANALYSIS - Average Scores (n=5) 
DAY 
Appearance (2) 
Body and 
texture (7) 
Flavour (11)     Score (20) 
t-PA     
30 1.330 4 7.8 13.130 
150 1.130 4 7 12.130 
CONTROL     
30 1.500 6 9.66 17.160 
150 1.500 6.2 10 17.700 
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 6.3.5. Discussion 
 
The results obtained from this study indicated that the extent of the breakdown of 
αs- and β-caseins increased with incubation time.  Snoeren and van Riel reported 
that κ-casein was not degraded by plasmin [12].  In this study the Gouda cheese 
manufactured with added t-PA exhibited a reduced cheese yield of almost 1.0% 
in comparison with the control Gouda cheese.  Hydrolysis of casein negatively 
affected the rheological properties of rennet-induced milk gel in this experiment, 
increasing rennet coagulation time (83%), increasing moisture in the final cheese 
(10.48%) and increasing fat losses in the whey (83%). 
 
From the results of this study it can therefore be deduced that the elevated 
plasmin activity in milk from cows that are in late lactation or experiencing 
mastitis, can alter the rennet coagulation properties of milk and ultimately lead to 
inferior final cheese quality. 
 
6.4. Fermented Dairy Products - Low fat yoghurt 
 
6.4.1. Introduction 
 
Acidified or fermented milk products are one of the oldest and most popular 
foodstuffs known to man.  The use of fermented milk dates back centuries, 
although no precise record of the date when it was first made is available.  It is 
likely that the origin of yoghurt was in Asia in the 8th century, where it was first 
produced by the Turks who lived as nomads.  It is estimated that today the world-
wide production of fermented milk products exceeds 20 million tons, of which 
approximately 145,000 tonnes (less than 1%) is produced in South Africa. 
 
The popularity of fermented milks, including yoghurt, is due to the association of 
these products with numerous proven health benefits, the main benefit being to 
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gastro-intestinal health.  In addition to providing good nutritional benefits, it is also 
widely used as a suitable vehicle (“carrier’) for fortification and added nutritional, 
functional ingredients.  The basic ingredients of yoghurt are milk and microflora.  
Milk is converted into yoghurt by cultivating in it specific lactic acid bacteria and 
souring it under defined conditions.   
 
6.4.2. Yoghurt characteristics 
 
According to the FAO/WHO (1977) the definition of yoghurt is as follow: 
 
 “Yoghurt is a coagulated milk product obtained by lactic acid fermentation, 
through the action of Lactobacillus bulgaricus and Streptococcus thermophilus, 
from milk and milk products (pasteurized and/or concentrated milk), with or 
without optional additions (milk powder, skim milk powder, whey powder etc.).  
The micro-organisms in the final product must be viable and abundant.”  
 
Yoghurt is distinguished by a typical and pleasant aroma attributable to the 
presence of sufficient quantities of acetaldehydes as the principle aroma 
compounds.  Yoghurt flavour relies on a good balance between the volatile fatty 
acids and is to some degree enhanced by the presence of diacetyl.  The milk 
acid and refreshing taste of yoghurt is attributable to the presence of lactic acid.  
The aroma and taste combines to produce a flavour that can be described as 
walnut-like. 
 
The method of gel formation and acidification is different to the coagulum 
formation in cheese, which is dependant on enzymatic action (rennet).  The 
production of lactic acid by lactic acid bacteria induces the process of 
coagulation, initiated at a pH of 5.2 - 5.3 and is completed at a pH of 4.6 - 4.7.  
The casein micelle is freed from bound salts, of which calcium is the main 
element, at its iso-electric point.  Removed calcium combines with lactic acid to 
form calcium lactate.  The solubilisation of the colloidal calcium phosphate (CCP) 
alters the charge on individual caseins, and results in an increase in ionic 
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strength of the solution.  The proteins coagulate and represent a coprecipitate of 
casein and denatured whey proteins.  The visible manifestation is the formation 
of semisolid gel entrapping fat globules and serum with dissolved constituents.  
The gel is of a white opaque appearance, gentle and smooth with a smooth 
custard like consistency and viscosity. 
 
6.4.3. Experimental protocol 
 
The objective of the study was to evaluate the effect of added t-PA to milk used 
for the production of yoghurt (t-PA yoghurt), and to evaluate the effect of the 
addition on shelf-life over a period of 30 days.  Yoghurt manufactured from the 
same milk with no t-PA addition prior to fermentation served as a control (control 
yoghurt).  Twenty Units of the purified t-PA, obtained after Zinc chelating 
chromatography as described in Chapter 5, was added per 1000 ml of milk in the 
presence of fibrin at a concentration of 8 μg.ml-1 of final product.  The yoghurt 
was evaluated over 30 days for changes in appearance, pH, apparent viscosity, 
gel formation, enzymatic activity, and casein breakdown. 
 
The freeze-dried t-PA enzyme was resuspended in 100 mM Tris-HCl buffer (pH 
8.0) and added to the raw milk (morning and evenings milk of the mixed Jersey 
and Friesland herd at Elsenburg Agricultural College, Stellenbosch).  The milk 
with the added t-PA was then incubated in a cold room (4°C) for 24 hours prior to 
yoghurt manufacture.   
 
Yoghurt was manufactured on small scale (20 litres of milk) at Elsenburg Dairy 
Laboratory according to the flow-diagram in Fig. 6.15. The yoghurt was 
manufactured using the basic yoghurt manufacturing process followed in most 
commercial factories in South Africa.  The main difference to the pilot plant 
samples produced was the time-temperature combination of pasteurisation (85°C 
with a holding time of 30 minutes as supposed to 95°C with a holding time of 5 
minutes).  No commercial available stabiliser was added to properly evaluate the 
effect of the added t-PA to the acid gel.  However, the percentage milk solids non 
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fat was increased by the addition of 2% skim milk powder (low-heat treated) to 
yield a final calculated protein value of 4.60%.  The reason for the addition of 
skim milk powder as supposed to milk solids such as whey protein concentrate, 
was to keep the casein: whey protein ration as close as possible as to that found 
in fresh milk.  The milk was analysed prior to manufacturing after 24 hours of 
incubation for TPC, Coliforms, Psychrotrophs and Spores by direct plating 
methods and SCC by laser spectroscopy.  The culture for fermentation was a 
typical heterofermentative yoghurt culture from Danisco Cultor which consisted of 
Lactobacillus delbreuckii subsp. bulgaricus and Streptococcus thermophilus. The 
production sheet of the yoghurt manufactured (with added t-PA) is indicated in 
Fig. 6.16.  A control batch was also produced using the same milk and process 
on the same day as indicated in the production sheet in Fig. 6.17.  The yoghurt 
was hygienically filled and sealed with aluminium foil in 175 ml cups and stored at 
4°C for the duration of shelf-life and evaluation.  Preservative, 50% lactose: 40% 
natamycin was added at a dosage level of 10 ppm to the final product in order to 
prevent yeast and mould growth. 
 
After 1, 5, 10, 15, 20 and 30 days the yoghurt was evaluated for appearance and 
colour, pH, gel formation, sediment, viscosity, PA activity and proteolysis. 
 
Appearance, colour and sediment were visually investigated.  Gel formation and 
apparent viscosity were measured with a Brookfield viscometer at 20°C at 4°C.  
Triplicate readings were taken directly in centipoises (cpi) when the spindle had 
been rotating for 30 seconds.  Protein analyses of the samples were done 
according to standard IDF procedure (IDF, 1964) by Kjeldahl analysis of TP, NPN 
and NCN.   CN was calculated as the difference between NCN and NPN.  All 
nitrogen results were expressed as protein equivalent, using a conversion factor 
of 6.38, and were analysed in triplicate.   
 
The yoghurt samples were analysed for the presence of short peptides and 
amino acids, indicating casein breakdown and protease activity. Milk serum 
(whey), isolated from the experimental and control milk, was tested to estimate 
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casein hydrolysis as previously described [106]. The PA activity was determined 
by the method of Zachos et al. [8], as previously described. If no whey formation 
was present in a given yoghurt sample, 10 grams of the sample was centrifuged 
at 25,000 X g for 20 minutes after which the remaining supernatant (milk serum 
or free whey) used for casein hydrolysis and PA analysis. 
 
Sensory evaluations were performed by trained panellists in accordance with the 
guidelines of the American Dairy Science Association (ADSA) as described by 
Bodyfelt et al. [165].   
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Figure 6.15: Yoghurt production process-flow 
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DATE
MILK VOLUME: 19.42 L BATCH NUMBER
PRODUCT RECIPE UNITS
L KG %
STANDARDISED LOW FAT MILK 19.42 20.000 97.790%
SKIMMILK POWDER 0.450 2.200%
Culture Yo-Mix 495 (100DCU per 1000 liter) 0.002 0.010% 5 UNITS
Total 20.45 100.000%
SPECIFIC GRAVITY (SG) 1.039
LITERS FROM 1000 KG 962.567
INGREDIENTS QTY BATCH CODE CHECKED BY SIGN
MILK
SKIM MILK 20.000
FULL CREAM MILK 0 L
CREAM 0 L
%BUTTERFAT 2.10
%TOTAL SOLIDS 11.00
°BRIX -
RESAZURIN PASSED
pH 6.67
ALCOHOL TEST 68% PASSED     YES
STABILISER
SUGAR
OTHER INGREDIENTS: SKIMMILK POWDER 2.00 KG
%BUTTERFAT 2.08
%TOTAL SOLIDS 13.00
°BRIX 13.00
TASTE GOOD
ODOUR GOOD
CULTURE
Yomix 495 5 UNITS
PROCESSING TEMPERATURE pH TIME STARTED TIME FINISHED
BATCHING 5 °C
HYDRATION TIME / SWELLING 1 H 00
HOMOGENISE  63.5 °C
PRESSURE  200 BAR
PASTEURIZE 85°C / 30 MIN
COOLING YOGHURT MILK TO INCUBATION TEMP 42.5 °C
INOCULATION
%BUTTERFAT 2.08%
%TOTAL SOLIDS 12.98%
°BRIX 13 °B
BREAK COAGULUM 4.55  6 H 00 FERMENTATION
COOLING 
FILLING QTY BATCH CODE TIME STARTED TIME FINISHED
FRUIT TYPE 0
YOGHURT BASE 0
VALUE SPEC SIGN COMMENTS
pH 4.55 4.2- 4.5
VISCOSITY
%TOTAL SOLIDS (PLAIN BASE) 13.04 12 - 14%
LOW FAT YOGHURT PA1
FINAL FACTORY QUALITY CONTROL RESULTS (RELEASING RESULTS)
YOGHURT PRODUCTION SHEET
 
 
Figure 6.16:  Production control sheet of yoghurt with t-PA addition. 
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DATE
MILK VOLUME: 19.42 L BATCH NUMBER
PRODUCT RECIPE UNITS
L KG %
STANDARDISED LOW FAT MILK 19.42 20.000 97.790%
SKIMMILK POWDER 0.450 2.200%
Culture Yo-Mix 495 (100DCU per 1000 liter) 0.002 0.010% 5 UNITS
Total 20.45 100.000%
SPECIFIC GRAVITY (SG) 1.039
LITERS FROM 1000 KG 962.567
INGREDIENTS QTY BATCH CODE CHECKED BY SIGN
MILK
SKIM MILK 20.000
FULL CREAM MILK 0 L
CREAM 0 L
%BUTTERFAT 2.10
%TOTAL SOLIDS 11.00
°BRIX -
RESAZURIN PASSED
pH 6.67
ALCOHOL TEST 68% PASSED     YES
STABILISER
SUGAR
OTHER INGREDIENTS: SKIMMILK POWDER 2.00 KG
%BUTTERFAT 2.08
%TOTAL SOLIDS 13.00
°BRIX 13.00
TASTE GOOD
ODOUR GOOD
CULTURE
Yomix 495 5 UNITS
PROCESSING TEMPERATURE pH TIME STARTED TIME FINISHED
BATCHING 5 °C
HYDRATION TIME / SWELLING 1 H 00
HOMOGENISE  63 °C
PRESSURE  200 BAR
PASTEURIZE 85°C / 30 MIN
COOLING YOGHURT MILK TO INCUBATION TEMP 42.5 °C
INOCULATION
%BUTTERFAT 2.08%
%TOTAL SOLIDS 12.98%
°BRIX 13 °B
BREAK COAGULUM 4.55  5 H 30 FERMENTATION
COOLING 
FILLING QTY BATCH CODE TIME STARTED TIME FINISHED
FRUIT TYPE 0
YOGHURT BASE 0
VALUE SPEC SIGN COMMENTS
pH 4.56 4.2- 4.5
VISCOSITY
%TOTAL SOLIDS (PLAIN BASE) 13 12 - 14%
LOW FAT YOGHURT CONTROL
FINAL FACTORY QUALITY CONTROL RESULTS (RELEASING RESULTS)
YOGHURT PRODUCTION SHEET
 
 
Figure 6.17:  Production control sheet of control yoghurt. 
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 6.4.4. Results 
 
The raw milk used for yoghurt manufacture was of good bacterial quality and 
average SCC (APC 18,900 cfu.ml-1, Coliforms 2 cfu.ml-1, Psychrotrophs 1,877 
cfu.ml-1, Spores 1 cfu.ml-1and SCC 142,000 SCC.ml-1). 
 
The viscosity measured followed the same trend for both the control and t-PA 
yoghurt samples.  There was a definite loss in viscosity after approximately 20 
days of shelf-life, although the initial viscosity of the t-PA yoghurt was also lower.  
The results are shown in Table 6.15 and Fig. 6.18. 
 
Table 6.15:  Viscosity measurement of yoghurt over a 30 day storage period 
. 
YOGHURT VISCOSITY (BROOKFIELD, cpi at 4 °C)1
Day Control 1 Control 2 Control AVE t-PA 1 t-PA 2 t-PA AVE 
1 1823 1825 1824 1798 1791 1795
5 1833 1835 1834 1807 1806 1806
10 1842 1841 1842 1811 1813 1812
15 1843 1839 1841 1808 1810 1809
20 1839 1838 1839 1811 1815 1813
25 1827 1825 1826 1801 1798 1800
30 1820 1828 1824 1790 1793 1792
1 Measured at 4°C with spindle 3 at 60 rpm 
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Figure 6.18:  Viscosity measurement of yoghurt during a 30 day storage period. 
 
The PA activity of the t-PA yoghurt was 3-fold higher than the PA activity in the 
control sample, but no significant increase in plasmin activity was measured over 
the 30 day storage period (Table 6.16 and Fig. 6.19). 
 
Table 6.16:  PA activity of serum from day of production to 30 days 
 
PA ACTIVITY ASSAY (YOGHURT) 
Day Δ A405nm 3h, 4h @ 37°C1
  Control t-PA sample Dev (±) 
0 0.059 0.198 0.139 
5 0.048 0.178 0.130 
10 0.063 0.175 0.112 
15 0.033 0.161 0.128 
20 0.047 0.184 0.137 
25 0.075 0.189 0.114 
30 0.066 0.200 0.134 
Average 0.056 0.184 0.128 
1 Fractions was diluted 1:2 before activity assay, therefore a 3-fold dilution 
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Figure 6.19:  PA activity of serum isolated from t-PA and control yoghurt from day 
of production to 30 days. 
 
Kjeldahl analyses of the yoghurt samples showed no significant change in TN, 
TPN, NPN and WPN as indicated in Table 6.17 and Figs. 6.20 and 6.21. There 
was a slight increase in the NCN of the t-PA yoghurt and a decrease in the CN in 
comparison to the control yoghurt, as a result of the increase of the PP (3-fold) as 
indicated in Table 6.17 and Figs. 6.22 and 6.23.  However, the reduction in CN 
was within the standard error range for analytical method used (0.03%) and 
therefore not significant. The main observation was a positive correlation between 
the increase in the PP fraction and the increase in absorbance at 280 nm as 
indicated in Table 6.18 and Fig. 6.24.  The A280 nm of the t-PA yoghurt on day 15 
was significantly lower than that on day 10 and did not follow the trend of the rest 
of the analyses throughout the storage period.  This can possibly be attributed to 
an experimental error or incorrect dilution prior to analysis.    
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The pH measurements (Table 6.19 and Fig. 6.25), of both the control and t-PA 
yoghurt samples, proved to be within the acceptable limits for yoghurts and no 
discrepancies were noted in this regard.  There was a slight acidification noted 
throughout shelf-life, but this can be attributed to the normal lactic acid production 
by the viable cultures added. 
 
Table 6.17:  PA activity assay of serum isolated from yoghurt at 405 nm from day 
of production to 30 days 
 
KJELDAHL PROTEIN ANALYSIS  (YOGHURT) 
Day TN TPN CN CN/TPN NCN WPN NPN PP 
CONTROL    
1 4.763 4.563 3.640 79.77% 1.123 0.910 0.200 0.013
5 4.754 4.534 3.630 80.06% 1.124 0.890 0.220 0.014
10 4.777 4.567 3.625 79.37% 1.152 0.930 0.210 0.012
15 4.803 4.573 3.640 79.59% 1.163 0.920 0.230 0.013
20 4.765 4.545 3.650 80.32% 1.115 0.880 0.220 0.015
25 4.756 4.556 3.633 79.74% 1.123 0.910 0.200 0.013
30 4.751 4.541 3.599 79.26% 1.152 0.930 0.210 0.012
t-PA    
1 4.763 4.563 3.640 79.77% 1.123 0.910 0.200 0.013
5 4.751 4.531 3.625 80.00% 1.126 0.890 0.220 0.016
10 4.760 4.550 3.604 79.20% 1.156 0.930 0.210 0.016
15 4.766 4.526 3.590 79.32% 1.176 0.920 0.240 0.016
20 4.745 4.525 3.620 80.00% 1.125 0.880 0.220 0.025
25 4.761 4.511 3.570 79.14% 1.191 0.910 0.250 0.031
30 4.772 4.542 3.580 78.82% 1.192 0.930 0.230 0.032
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Figure 6.20:  Kjeldahl analysis of TN, TPN and CN in yoghurt samples throughout 30 days shelf-life. 
 
134   
Kjeldahl analysis of Yoghurt
NCN and WPN
0.000
0.200
0.400
0.600
0.800
1.000
1.200
1 5 10 15 20 25 30
DAYS
%
 
N
i
t
r
o
g
e
n
 
NCN CONTROL NCN t-PA WPN CONTROL WPN t-PA
  
Figure 6.21:  Kjeldahl analysis of NCN and WPN in yoghurt samples throughout 30 days shelf-life. 
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Figure 6.22: Proteose peptone (PP) analysis of the yoghurt samples throughout 
shelf-life. 
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Figure 6.23: Kjeldahl results of casein nitrogen (CN) vs. proteose peptones (PP) 
of yoghurt samples throughout shelf-life. 
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 Table 6.18: Absorbance values of whey isolated from yoghurt samples throughout 
shelf-life at A280 nm
 
ABSORBANCE YOGHURT WHEY 280nm 
Day Control 1 Control 2 Control AVE t-PA 1 t-PA 2 t-PA AVE 
1 0.070 0.073 0.072 0.153 0.160 0.157
5 0.068 0.067 0.067 0.214 0.203 0.208
10 0.055 0.060 0.058 0.390 0.303 0.346
15 0.068 0.069 0.068 0.201 0.200 0.201
20 0.088 0.084 0.086 0.300 0.394 0.347
25 0.115 0.114 0.115 0.323 0.330 0.327
30 0.117 0.117 0.117 0.336 0.330 0.333
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Figure 6.24: Measurements of yoghurt whey at A280 nm throughout shelf-life to 
detect and quantify casein hydrolysates. 
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 Table 6.19: pH measurement of yoghurts samples throughout 30 days shelf-life 
 
pH (YOGHURT) 
Day Control 1 Control 2 Control AVE t-PA 1 t-PA 2 t-PA AVE 
1 4.55 4.54 4.55 4.55 4.55 4.55
5 4.50 4.50 4.50 4.50 4.50 4.50
10 4.45 4.45 4.45 4.45 4.45 4.45
15 4.48 4.48 4.48 4.44 4.44 4.44
20 4.43 4.43 4.43 4.42 4.42 4.42
25 4.44 4.44 4.44 4.43 4.43 4.43
30 4.38 4.38 4.38 4.40 4.40 4.40
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Figure 6.25:  pH measurement of yoghurts samples throughout 30 days shelf-life. 
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 The results of the sensory analysis indicated that the t-PA yoghurt lacked 
freshness and also had a flat flavour in comparison to the control sample.  The 
panelists did note the white spec formation in the t-PA sample as a defect, which 
resulted in a slight grainy or sandy texture.  As a result the control sample scored 
better marks overall for the final product.  The decrease in viscosity was also 
noted, however, it was still within acceptable limits for yoghurt produced without 
any stabilizing agent.  Free whey was noted after day 15 on the t-PA sample and 
only after day 25 in the control sample.  The most common descriptors used by 
the panelists could be summarized as follows: 
 
 Control Yoghurt: Neutral colour, good body and texture, glossy, creamy, 
clean flavour, mild acidity, slight diacetyl flavour. Preferred to t-PA sample. 
 t-PA Yoghurt: Neutral colour, white specs, slight dry mouthfeel, slightly 
weaker body than control, grainy / sandy texture, wheying-off, mild acidity, 
lacks freshness, flat.  
 
The results of the tasting panel is summarised in Table 6.20.  Scores were 
allocated as follow: Maximum 2 points for appearance, maximum 7 points for body 
and texture, maximum 11 points for flavour to give a final total out of 20 points. 
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 Table 6.20: Sensory scores of yoghurt during shelf-life 
 
YOGHURT SENSORY ANALYSIS - Average Scores (n=5) 
DAY 
Appearance (2) 
Body and 
texture (7) 
Flavour (11)     Score (20) 
CONTROL     
1 1.00 4.50 9.50 15.00 
5 0.80 4.30 9.60 14.70 
10 1.20 4.45 9.56 15.21 
15 1.23 4.78 9.21 15.22 
20 0.80 4.92 8.97 14.69 
25 0.80 4.28 8.88 13.96 
30 0.80 4.00 8.60 13.40 
Average 0.95 4.46 9.19 14.60 
t-PA     
1 1.50 6.00 10.00 17.50 
5 1.43 6.20 10.00 17.63 
10 1.55 6.20 10.50 18.25 
15 1.60 6.33 10.10 18.03 
20 1.60 6.35 9.90 17.85 
25 1.66 6.20 9.85 17.71 
30 1.62 6.20 9.85 17.67 
Average 1.57 6.21 10.03 17.81 
 
 
6.4.5. Discussion 
 
Published information on the effect of plasmin and PAs on fermented milk 
products is limited.  The results of this study confirmed that although plasmin 
activation had some effects on final product quality, the effect on chemical 
composition of the final product was limited and statistically not significant.  This 
can be attributed to the fact that yoghurt is a shorter shelf-life product, and also 
due to the loss in plasminogen and plasmin activity as a result of the extensive 
holding time during heat treatment, normally associated with yoghurt manufacture.  
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Therefore the potential for plasmin activation is less, due to less plasminogen 
being available for activation by PAs.  This correlates well with the D-values as 
measured by Alichanidis et al. [109] of 2 min at 85°C for plasmin and plasminogen 
as indicated in Table 6.1.  The most noticeable difference between the control and 
t-PA yoghurt samples was that the t-PA sample was a less viscous product that 
also had visible white spec formation.  Although the severity of the specs was 
mild, it is characterised as a negative product attribute and is as a result of protein 
destabilisation. During acid gel formation, denatured proteins associate with 
casein to form a co-precipitate, should casein breakdown occur this would 
negatively influence the potential for association of the denatured α-lactalbumin 
and β-lactoglobulin with casein. 
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Chapter 7 
 
 
DISCUSSION 
 
 
Plasminogen, plasmin, plasminogen activators, plasminogen activator inhibitors 
and plasmin inhibitors are key elements in the regulation of the fibrinolytic system 
in bovine blood.  When inflammation (haemostasis and thrombosis) in the udder 
of the cow occurs, the natural defense mechanisms of the cow are activated to 
combat the infection, which leads to an increased blood supply to and 
concentration of white blood cells in the infected areas. Due to an increase in 
vascular permeability, plasmin and plasminogen activators can enter the milk 
supply through the blood, resulting in increased proteolytic activity in the milk. 
 
Uncontrolled proteolysis in raw milk will affect the quality of the final products, as 
casein constitutes over 80% of the total protein content in milk.  Furthermore, the 
unique properties of casein make it the main functional component in most of the 
secondary value added products produced by the dairy industry, such as rennet 
casein and acid casein gels.  Increased proteolysis, induced by the increased 
activity of plasmin, will not only effect organoleptic properties, but also have a 
negative effect on the shelf-life and the yield of the final products.  To validate 
this hypothesis, tissue type plasminogen activator (t-PA) was isolated and 
purified from mid to late lactation bovine milk.  The purified t-PA was then added 
to 3 different dairy products to activate the zymogen, plasminogen, to the active 
form plasmin, subsequently promoting proteolysis.  The products were then 
analysed throughout shelf-life to investigate and quantify the influence of added t-
PA. 
 
The study focused mainly on the isolation of t-PA from bovine milk, which is 
associated with casein fraction in the milk, rather than urokinase plasminogen 
activator (u-PA), which is associated with the somatic cell fraction of the milk.  
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t-PA losses in secondary (processed) dairy products will theoretically be limited, 
unlike u-PA, where losses could occur as a part of the normal processing at dairy 
factories.  Processing that will increase u-PA losses include clarification, 
centrifugation, micro-filtration, ultra-filtration and standardization of milk.  These 
losses will subsequently diminish the effect of u-PA on dairy products. 
 
The characteristics of t-PA isolated and purified from a mixed herd of Jersey and 
Friesland cows at Elsenburg Dairy Laboratory, Stellenbosch, correlated well with 
the characteristics of the bovine t-PA previously isolated and partially 
characterized [9,10,20,22,56].  A modified combination of treatments and 
methods were used to isolate the t-PA, including de-fatting of the milk, 
concentration of the casein by ultracentrifugation, salting out, and dissociation of 
the t-PA from the casein micelles. The t-PA in the resulting fraction, SUP3B, was 
purified by a factor of 1200 from the raw milk fraction, with a specific activity of  
72 U.g-1 protein and a yield of 79.61 %.  Further purification of t-PA from SUP3B 
was obtained by a combination of gel filtration and metal chelate (affinity) 
chromatography.  The t-PA obtained after zinc chelating chromatography (ZNF 
fraction) was purified by a factor of 6,000 from the raw milk fraction with a final 
specific activity of 398 U.g-1 protein with a final yield of 73.46 %. The t-PA was 
subsequently characterized by SDS-PAGE, IEF, HPGPC and analyzed for amino 
acid composition.  The Mr of t-PA, estimated by gel filtration, was approximately 
75 kDa. This result correlated well with the Mr obtained from the SDS-PAGE 
anlyses, which was approximately 73 kDa, and HPGPC which yielded an Mr of 
74,5 kDa. The IEF analyses yielded 3 distinct pI values for the purified t-PA of 
6.60, 6.85 and 7.30 respectively, indicating the presence of three isoforms.  The 
presence of three isoforms for bovine t-PA has not been unequivocally 
established and is an area for future investigation.  
  
To determine the effect of increased proteolysis on dairy products, purified t-PA, 
obtained after Zinc chelating chromatography, was added aseptically to UHT milk 
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post packaging (20 U.l-1), Gouda cheese milk (20 U.l-1) prior to manufacture and 
yoghurt milk (20 U.l-1) prior to the manufacture. 
 
Gelation of the UHT milk occurred after 60 days of incubation with t-PA.  In 
addition to the gelation, visual and sensory analyses of the samples revealed a 
severe bitter off-flavour in the coagulated milks.   The PA activity in the t-PA 
added UHT milk was higher than that of the control milk, and remained constant 
throughout the 180 days of evaluation.  It is also noteworthy that the casein 
breakdown metabolites of the t-PA inoculated UHT milk were approximately 9 
fold higher than that of the control samples. These results are significant, as the 
normal shelf-life of UHT milk is from 9 – 12 months, while the severe detrimental 
effects of t-PA addition were evident after 1 month post t-PA inoculation. 
 
The Gouda cheese, manufactured with added t-PA, exhibited a reduced yield of 
almost 1.0% in comparison to the control Gouda cheese.  The t-PA Gouda 
exhibited a 3 fold increase in WSN:TN and a significant increase in free amino 
acids formed, as opposed to the control Gouda, indicating accelerated 
proteolysis in the t-PA Gouda cheese due to enhanced plasmin activity.  The 
residual rennet activity and starter culture proteolysis should be seen as a 
constant in both sets of Gouda cheeses manufactured in this study.  Hydrolysis 
of casein negatively affected the rheological properties of the rennet-induced milk 
gel in this experiment, increasing rennet coagulation time by 83%, moisture 
content in the final cheese by 10.48% and fat losses in the whey by 83%.  The 
results obtained are important to secondary cheese producers and will have 
serious financial implications, as increased proteolysis will have a negative 
impact on the production efficiency of cheese and product viability.  To illustrate 
this point, the loss in cheese yield and fat losses in the whey, based on the trial, 
was extrapolated to the production of cheese in a medium sized factory (100,000 
kg of cheese milk per day).  The financial loss in revenue could theoretically be 
calculated as follows (estimation based only on the loss of fat in the whey and 
reduced cheese yield): 
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CHEESE YIELD: 
 
100,000 kg milk at yield of 10.83%     = 10, 830 kg cheese 
100,000 kg milk at yield of 9.95%    = 9,950 kg cheese 
Total loss in kg cheese per day per 100,000 kg milk  = 880 kg 
Total loss in Rand value per day per 100,000 kg milk = 880 kg X R26,00/kg 
        = R 22,880 / day 
        = R 686,400 / month 
FAT LOSS IN WHEY: 
 
90,050 kg whey at 0.29% fat loss of (0.63% -0.34%) = 261.15 kg 
Total loss in Rand value per day per 100,000 kg milk = 261.15 X R38,00/kg 
        = R 9,923 / day 
        = R 297,705 / month 
 
TOTAL LOSS INCURRED PER MONTH  = R 984,105 / month 
 
The financial effect of inferior cheese in the marketplace is difficult to estimate, 
but some indicators could be an increase in product returns, shorter shelf-life of 
products, less profit on sales and a decrease in consumer demand. 
 
The main defects in the yoghurt produced with added t-PA were noted during the 
sensory analysis, which revealed that the t-PA yoghurt lacked freshness and also 
had a flat flavour in comparison to the control sample.  The panelists also 
recorded white spec formation in the t-PA sample as a defect, which resulted in a 
slight grainy or sandy texture, as well as syneresis (wheying-off) after a shelf-life 
of only 12 days.  The PA activity of the t-PA yoghurt was three times higher than 
the PA activity in the control sample, and no significant increase in plasmin 
activity was measured over the 30 day storage period, in both the t-PA and 
control samples.  There was a slight increase in the NCN and PP fractions (3-
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fold) of the t-PA yoghurt and a decrease in the CN in comparison to the control 
yoghurt.  
 
This study shows that the complex biochemical cascades present in bovine milk, 
have a profound influence on the final dairy products derived from this essential 
foodstuff.  It is therefore apparent that the elucidation of the role of the fibrinolytic 
system and its major components in bovine milk will lead to practical applications 
in the dairy industry; it will not only improve the quality of the products, but also 
the financial viability of the industry as a whole.  
 
This field of research is receiving attention internationally. The Food Science 
Department of Purdue University is currently investigating the use of Fourier-
transform infrared (FTIR) spectroscopy, in combination with statistical data 
analysis, to determine the plasminogen concentration in various dairy protein 
solutions.  Preliminary results are promising, as they have already succeeded to 
differentiate between plasmin and plasminogen in different dairy protein 
solutions.  It is clear that a physical technique such as FTIR spectroscopy has 
much to offer the dairy industry, as it provides the opportunity to investigate 
specific biochemical entities in a non-destructive manner. FTIR equipment is 
commercially available, easy to operate and is currently used for the rapid 
analysis of milk solids in milk and other dairy products.   
 
Future research of the fibrinolytic system in bovine milk offers exciting 
possibilities. Knowledge of the fibrinolytic system and its components in bovine 
milk can lead to the manipulation of these enzymes, by changing specific 
parameters such as the severity of heat treatment and the pH of milk during 
fermentation.  Manipulation of the fibrinolytic system could promote controlled 
proteolysis in cheese, which can shorten ripening times and enhance flavour 
development. In fluid milks and yoghurts, such knowledge can be used to prevent 
the negative effect that proteolysis has on the quality of the final products. 
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Chapter 8 
 
 
EXPERIMENTAL 
 
8.1. Origin of milk samples 
 
Raw bulk milk samples of morning and evenings milk of a mixed herd of 
Holstein and Jersey cows were collected from the Elsenburg Dairy Research 
Centre of the Department of Agriculture Stellenbosch, South Africa.  The 
average days in lactation of the cows were between 150 and 180 days (mid to 
late lactation).   
 
All samples were kept refrigerated at a temperature below 4°C and were 
tested within 48 hours of collection, unless otherwise specified. The milk was 
analysed to confirm whether it conforms to the normal specifications for raw 
bulk milk.  The following tests were conducted: Standard plate count (SPC), 
Coliform bacteria, somatic cell count (SCC), percentage fat, protein and 
lactose, freezing point, ethanol stability, pH and percentage titratable acidity 
(TA).  An additional clot boiling test was also done to confirm protein stability 
of the raw bulk milk. 
 
8.1.1. Standard Plate Count 
 
Preparation of samples: 
 
1. Thoroughly mix samples of raw milk. 
2. A 1:10 dilution (m/m) was prepared by adding 1 ml of the product to 9 
ml of sterile diluent or 11 ml of the product to 99 ml of diluent. 
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 Plating of samples: 
 
1. 1 ml of each of the dilutions was transferred in duplicate to sterile Petri 
dishes, beginning with the highest concentration and ending with the 
lowest. 
2. 10 ml of the standard plate count agar, which has been melted 
beforehand and cooled to 45°C +/- 1°C, were added to the petri dishes. 
3. The contents of each dish was thoroughly mixed using horizontal 
rotational movement while the medium is still fluid. 
4. Once the medium has set, the dishes were inverted and incubated at 
30°C +/- 1°C for 72+/-2 hours. 
5. At the end of the incubation the dishes were removed from the 
incubator and colony-forming units (CFU) were counted, with the aid of 
magnification, under uniform artificial illumination. 
 
Table 9.1:  Preparation of the phosphate buffer solution 
 
Diluent – Phosphate Buffer Solution  
Potassium dihydrogen orthophosphate 5.08 g 
Disodium hydrogen orthophosphate 13.63 g 
Distilled Water 2 litres 
 
Table 9.2:  Preparation of standard plate count agar 
 
Standard Plate Count Agar*  
Tryptone (pancreatic digestive product of casein) 5 g 
Yeast Extract 2.5 g 
Glucose 1 g 
Agar (bacterial grade) 15 g 
Distilled Water 1 litre 
Final pH of sterilised medium 7.0 ± 0.1 
*Sterilise for at least 15 minutes at 121°C. 
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8.1.2. Violet red bile (MUG) agar method for coliforms and Escherichia coli 
 
Preparation of samples: 
 
1. Thoroughly mix samples of raw milk. 
2. A 1:10 dilution (m/m) was prepared by adding 1 ml of the product to 9 
ml of sterile diluent or 11 ml of the product to 99 ml of diluent. 
 
Table 9.3:  Preparation of violet red bile agar 
 
Violet Red Bile Agar g.l-1
Brain Heart Infusion 7.0 
Peptone 4.0 
Lactose 9.0 
Bile Salts Number 3 1.5 
Neutral Red 0.03 
Crystal Violet 0.002 
MUG (4-methylumbelliferyl B-D-glucuronide) 0.1 
Sodium chloride 4.5 
Disodium phosphate 1.0 
Agar 13.0 
 
Plating of samples: 
 
1. Dilutions were prepared to obtain plates with colony counts of more 
than 10 and fewer than 150. Micro-organisms in the test samples were 
distributed as evenly as possible by inverting the sample containers 25 
times. When foam was formed, it was allowed to disperse. The interval 
between mixing and removing the test portion was not longer than 
three minutes. 1 ml of the test sample was removed with a sterile 
pipette and added to 9 ml of the diluent (or 10 ml of the test sample to 
90 ml of the diluent or 11 ml of the test sample to 99 ml of the diluent). 
The primary dilution was shaken thoroughly. In this way, a 10-1 dilution 
was obtained. 
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2. Further dilutions were prepared by transferring 1 ml of the primary 
dilution to another test tube containing 9 ml of sterile diluent by using a 
sterile pipette and avoiding contact between the pipette and the diluent. 
A fresh pipette was used for each dilution. Alternatively, 10 ml of the 
primary dilution was transferred to a bottle, containing 90 ml of the 
sterile diluent, or 11 ml of the primary dilution to 99 ml of the sterile 
diluent. Samples were mixed thoroughly by mixing mechanically for 5 
to 10 seconds to obtain the 10-2 dilution. When necessary, this 
procedure was repeated, using the 10-2 and further dilutions to obtain 
10-3, 10-4, etc., dilutions until the appropriate number of micro-
organisms has been obtained.  
3. 15ml of the VRB MUG agar was poured at 45°C +/- 1°C into each Petri 
dish.  The sample was mixed immediately after pouring by rotating the 
petri dish sufficiently to obtain evenly dispersed colonies after 
incubation. The samples were allowed to solidify on a cool horizontal 
surface. After complete solidification, about 4 ml of the VRB agar, at 
45°C +/- 1°C, was poured  onto the surface of the inoculated medium 
and allow to solidify.  
4. Plates were incubated in an adverted position at 30°C +/- 1°C for 24°C 
+/- 2 hours. 
5. Plates were examined under a 366 nm ultra violet light. All colonies, 
showing a blue fluorescence in the surrounding medium, were counted. 
Five or more fluorescent colonies are regarded as positive for 
Escherichia coli. Plates under normal light were examined and counted 
to obtain the coliform organisms. Dark red coloured colonies, with a 
diameter of at least 0.5 mm, are characteristic of coliform organisms.  
 
8.1.3. Percentage Fat, Protein, Lactose 
 
The % fat, protein and lactose in milk were detected using a Milkoscan 133B 
infra-red milk analyser from Foss Electric, Germany. 
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8.1.4. Somatic Cell Counts 
 
A Bentley Somacount 300 analyser of Bentley Industries, USA was used for 
the detection of SCC in the milk.   The Somacount utilise laser based flow 
cytometry for detection; ethidium bromide is mixed with the samples 
(automatically) to stain the DNA in somatic cells. The laser based counting 
section uses the fluorescence characteristics of the dye to count the cells one 
by one. 
 
8.1.5. Freezing Point  
 
The % water added in milk was detected by freezing point depression with an 
automatic Fiske cryoscope (Model 4D3), Fiske Associates, USA. 
 
8.1.6. Ethanol Stability Test 
 
1. Mix one volume of 70% (v/v) aqueous ethanol with one volume of milk.  
2. No signs of coagulation, the milk have passed the ethanol stability test. 
 
8.1.7. Titratable Acidity 
 
1. Pipette 9 ml of milk into a white dish. 
2. Add either 10 drops or 0.5 ml of a 1.6% phenolphthalein indicator 
solution in 50% ethanol to the milk. 
3. Titrate with 0.1 M NaOH solution until the first tinge of pink that persists 
for 30 seconds appears. 
4. To express the titratable acidity of the milk, as the percentage of lactic 
acid, divide by 10 the number of milliliters of 0.1 M NaOH used in the 
test. 
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8.1.8. The clot-on-boiling test  
 
1. Thoroughly mix the milk before sampling. 
2. Pour 5ml of milk into a test tube. 
3. Place the tube in boiling water. 
4. Ensure that the level of the boiling water is higher than the milk level. 
5. Stand the test tube of milk in the boiling water for five minutes. 
6. Remove the test tube from the water and tilt the tube almost 
horizontally without shaking the milk inside. 
7. Wait until a thin film is formed on the milk. 
8. The result is positive if all the milk clots or if floccules are seen to be 
adhering to the sides of the tube when it is returned to the vertical 
position. Colostrum in milk will result in a positive clot-on-boiling test 
result. The heat stability of the milk is also affected by other factors. 
 
8.2. Isolation and purification of PA from bovine milk 
 
8.2.1. Centrifugation, ultracentrifugation and precipitation 
 
A combination of centrifugation and ultracentrifugation steps were used in 
order to partially purify the PA.  The isolation and purification steps were 
modified from methods used by Politus et al. [74], Deharveng and Nielsen [22] 
and Yamauchi et al. [138].  All steps were conducted at 4°C unless otherwise 
specified. 
 
Raw bulk milk collected, that conformed to standard raw milk specifications, 
was centrifuged at 4000 X g for 30 minutes with a Beckman model J21-B 
centrifuge.  The fresh raw bulk milk was separated into a cream layer, a SCC 
pellet and the skim milk supernatant containing the casein and PA.   
 
The skim milk fraction was centrifuged at 100,000 X g for 1 hour with a 
Beckman L5-75 ultracentrifuge to isolate the milk serum (supernatant) from 
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the casein (pellet).  The SCC pellet (SP), containing PA, obtained after the 
initial centrifugation step of 4,000 X g for 20 minutes at 4°C, was washed 
three times with 0.01 M phosphate buffer containing 0.15 M NaCl (pH 7.2).  
The RSP1 pellet was then resuspended in 0.023 M phosphate buffer (pH 7.0) 
to yield at least 106 viable cells per millilitre.  Tryphan blue (5 µl of a 2.5 g.l-1 
solution) was added to 20 µl of the SSP fraction.  The proportion of cells, 
excluding the dye, was then counted and sonicated for 45 seconds.  The 
sonicated cell extract was then ultracentrifuged at 100,000 X g for 1 hour to 
remove the entrapped casein (pellet).  The SPP extracts (supernatant) was 
stored at –80°C for further investigation. 
 
In order to dissociate the PA from the casein micelle structure the casein 
pellet (CP1) was reconstituted to the original volume (5 ml) with 0.023 mM 
phosphate buffer (pH 7.0) and stirred overnight at 4°C (RCP1).  1 M of NaCl 
was added to the reconstituted casein pellet fraction (RCP1) and incubated for 
3 hours at 22°C and then ultracentrifuged at 100,000 X g for 60 min at 4°C.  
The resulting casein pellet (CP2a) was reconstituted to the original volume (5 
ml) with 50 mM Tris-HCl (pH 8.0) and the supernatant fraction (SUP3a) was 
then dialysed for 24 hours against 1000 volumes of 0.023 M phosphate buffer 
solution (pH 7.0) containing 0.2 M of boric acid pH 7.0 (pH of boric acid 
adjusted to 7.0 with 5 M KOH) and 20% DMF with one change of the external 
medium.  The function of the DMF is to dissociate any κ-casein still present in 
SUP2. 
 
8.2.2. Gelfiltration 
 
Sephadex G75 superfine gel was swollen in 20 mM of Tris-HCl buffer (pH 
8.0), and packed in a column (length 950 mm and a diameter of 16 mm).  The 
fractionation range for globular protein solutes are between the range of 
molecular weight of 3,000 to 80,000 Da.   
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The column was equilibrated at a flow rate of 7.0 ml per hour with 1 bed-
volumes of 50 mM Tris-HCl buffer (pH 8.0) containing 0.50 M of NaCl.  The 
column was calibrated by with molecular weight standards and the void (V0 – 
59.5 ml) and total volumes (Ve) were determined using a mixture of N-2,4-
DNP-glycine and dextran blue at concentrations of 2 mg.l-1.  A graph of Ve / V0 
of the molecular weight standards were plotted against their log Mr values 
(figure 8.1).  The PA containing fractions were loaded onto the column and 
were run at a flow rate of 6.0 ml.h-1.  The Ve of the PA was determined and 
subsequently the molecular mass of the PA could be derived from the graph. 
Absorbance was measured at 280 nm to determine elution of proteins. 
 
 
Table 8.1: Determination of the molecular mass of t-PA with Sephadex G75 
gelfiltration, V0 measured at 59.5 ml 
 
Protein Mr (Da) Elution 
volume  
Ve/V0 Log Mr 
Molecular weight standards 
BSA 68,000 56.20 0.94 4.83 
Ovalbumin 43,000 68.50 1.15 4.63 
Chymotrypsinogen 25,000 88.30 1.48 4.39 
Myoglobin 16,900 92.20 1.55 4.22 
Lysozyme 14,300 104.80 1.76 4.16 
PA containing samples 
t-PA 74,830 52.50 0.88 4.87 
u-PA 1 47,600 64.50 1.08 4.68 
u-PA 2 30,480 77.60 1.30 4.48 
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Figure 8.1: Log Mr versus the Ve/V0 to determine molecular mass of the 
purified PA by Sephadex G75 gelfiltration.  The protein standards used were 
BSA (66 kDa), Ovalbumin (43 kDa), Chymotrypsinogen (25 kDa), Myoglobin 
(16.9 kDa) and Lysozyme (14.3 kDa). 
 
8.2.3. Metal chelate (affinity) chromatography 
 
A Zn-chelating resin was prepared with chelating Sepharose 6B as per the 
manufacturer’s instructions (Pharmacia Biotech).  The resin was equilibrated 
with running buffer of 20 mM phosphate buffer containing 1 M NaCl, 0.01% 
(v/v) Tween 80 (pH 7.50).  After the equilibration the resin was mixed with the 
PA containing fractions and mixed on a shaker plate at 4°C for 3 hours.  The 
resin and protein mixture was then poured into the column (length 100 mm 
and a diameter of 25 mm).   
 
The column was washed at a flow-rate of 40 ml.h-1 with 4 volumes of running 
buffer.  An imidazole gradient of 0 – 0.1 M was then applied to the column and 
3 ml samples were collected.  After the gradient was applied an additional 75 
ml of 0.1 M imidazole buffer was used to wash the column to elute all the 
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remaining protein from the column, and 5 ml fractions were collected.  All the 
fractions, containing PA activity, were then pooled, and dialysed against 
deionised distilled water overnight at 4 °C.   
 
8.3. Colorimetric assay for PA activity 
 
The PA assay was determined spectrophotometrically, according to the 
method of Zachos et al. [8], using the synthetic substrate, D-Val-Leu-Lys-ρ-
nitroanalide (V0882, Sigma Aldrich; millimolar extinction coefficient of 5.57 
mM-1.cm-1).  Measurements were carried out on a Dynex Opsys MR microtiter 
plate reader. The reactions were measured by determining the change in 
absorbence at 405 nm due to the hydrolyses of the chromatogenic substrate 
D-Val-Leu-Lys-ρ-nitroanalide.  The chromatogenic substrate was cleaved at 
the Lys residue which yielded the free chromophore ρ-nitroanalide. 
 
Assays were performed in triplicate with 250 μl 100 mM Tris-HCl buffer (pH 
8.0) containing 50 μg.ml-1 plasminogen (P5661, Sigma Aldrich) and 0.6 mM 
D-Val-Leu-Lys-ρ-nitroanalide and 5 μl of a PA fraction.  White et al. [55] 
reported no influence of casein on PA activity, therefore no correction for 
turbidity was done for the fractions with casein present in this study.  The 
reaction mixtures were incubated at 37°C in a New Brunswick Scientific Co. 
G24 Environmental Shaker for 2 and 3 hours respectively, after which the 
absorbence was measured at 405 nm.  A sample without added plasminogen 
served as a control.   
 
The reaction was stopped by adding 100 μl of 30% (v/v) acetic acid to the 
samples.  The samples were centrifuged at 8,000 X g for 5 minutes before 
reading the absorbance at 405 nm.  A sample without added plasminogen 
served as a control.  The detection of the indigenous plasmin was subtracted 
from total plasmin activity.  The plasminogen activity used as substrate in the 
assay can be quantified as follows: one unit of plasminogen activity relates to 
a change of 0.1 in absorbency from α-casein at 275 nm in 20 minutes at 
37°C, pH 7.5 where urokinase is used as activator. 
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There was also distinguished between t-PA and u-PA by adding 20 μg fibrin 
and 20 mM amiloride to the PA-containing fractions.  In the presence of fibrin 
there will be an increase in t-PA activity and in the presence of amiloride a 
decrease in u-PA activity. Tissue type PA is not affected by amiloride and the 
activity of u-PA will not be enhanced by the addition of fibrin [139,140].   
 
8.4. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
 
8.4.1. Preparation of running and stacking gels 
 
The SDS-PAGE gel system of Life technologies was used for gel 
electrophoresis.  The system contains a set of premixed solutions containing 
all the chemicals needed for the preparation of any size or percentage 
continuous, gradient or discontinuous separation of proteins according to 
molecular weight.  The system consists of the following components: 40% 
(w/v) Acrylamide: Bisacrylamide (37.5: 1), Resolving gel buffer concentrate 
[1.5 M Tris-HCL, 0.4% (v/v), N, N, N, N-tetramethylethyldiamine (TEMED), 
0.4% (m/v) Sodium dodecyl sulphate (SDS), pH 9.0] and a stacking gel buffer 
[0.14 M Tris-HCL, 0.11% (v/v), TEMED, 0.11% (m/v) SDS, pH 6.8]. 
 
The concentrated solutions were prepared according to the prescribed 
method to yield a 10% polyacrylamide resolving gel and a 3.9% 
polyacrylamide stacking gel solution (refer to table 8.2). 
 
Freshly prepared ammoniumpersulphate solution (10% m/v) was added to the 
running gel mixture and directly thereafter the gel was poured.  A small 
volume of distilled water was added on top of the mixture and was discarded 
after the gel had polymerised (approximately 30 minutes for polymerisation).  
The stacking gel mixture was prepared, the ammoniumpersulphate solution 
(10% m/v) was added and the gel was poured on top of the polymerised 
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running gel.  A comb was inserted into the stacking gel to form the wells for 
sample application. 
 
Table 8.2: SDS – Polyacrylamide gel formulations for the resolving and 
stacking gels 
 
SDS-Polyacrylamide Gel Formulations 
Resolving Gel %(m/v) Stacking Gel % 
(m/v) 
Component, Volume (ml) 5.0% 7.5% 10% 12.5% 15.0% 3.9% 
40% Acrylamide: bis 5.1 7.7 10.3 12.8 15.4 1.0 
Resolving buffer 10.0 10.0 10.0 10.0 10.0 - 
Stacking buffer - - - - - 9.0 
Distilled water 24.5 21.9 19.3 16.8 14.2 - 
10% Ammoniumpersulphate 0.4 0.4 0.4 0.4 0.4 0.05 
Total volume (ml) 40.0 40.0 40.0 40.0 40.0 10.0 
 
8.4.2. Preparation of samples 
 
The samples (20 μl) were diluted with equal volumes of the treatment buffer 
(67.5 mM Tris-HCl, pH 6.8, 2% (m/v) SDS, 10% (v/v) glycerine and 5% (v/v) 
2-mercaptoethanol) and bromophenol (1 μg) as front marker.  The samples (1 
- 5 μg protein) were boiled for 2 minutes and allowed to cool to room 
temperature before they were loaded onto the gel. 
 
8.4.3. Gel electrophoresis of PA 
 
Electrophoresis buffer [25 mM Tris buffer, 0.25 M glycine, 0.1 % (m/v) SDS, 
(pH 8.3)] was added to the upper and lower chambers of the electrophoresis 
cell.  The wells of the cells were rinsed with the electrophoresis buffer before 
the samples were loaded.  After the samples were loaded a constant current 
of 18 mA was applied to the electrophoresis cell until the Bromophenol Blue 
reached the end of the running gel (approximately 90 minutes).  The gel was 
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removed to be stained or to elute the PA proteins or to use in immunoblotting 
experiments. 
 
8.4.4. Staining and destaining procedures 
 
The gel was stained for a minimum of 1 hour in a Coomassie blue solution 
[0.125% (m/v) Coomassie blue R250, 50% (v/v) methanol and 10% (v/v) 
acetic acid].  The staining solution was removed and the gel was destained in 
the first solution (50% methanol, 10% acetic acid, and 40% distilled water) for 
a maximum of 1 hour and then destained in the second solution (5% 
methanol, 7% acetic acid, and 88% distilled water) overnight. 
 
8.4.5. Elution of PA from preparative SDS-PAGE-gels 
 
For localisation of PA activity the electrophoretic lanes were cut into slices of 
approximately 5 mm and incubated overnight at 4°C in 0.1 M Tris-HCl (pH 
8.0) buffer containing 5.5 g Triton X100 per litre to remove the SDS.  After 2 
hours the buffer was discarded and the slices soaked in 0.5 ml fresh 0.1 M 
Tris-HCl (pH 8.0) buffer for 24 hours to elute the proteins.  The buffer 
containing t-PA protein (0.1 M Tris-HCl, pH 8.0 buffer) was dialysed against 
deionised distilled water for 24 hours at 4 °C.  The PA fraction was then 
lyophilised. 
 
8.4.6. Determination of molecular mass of purified bovine PA by SDS-PAGE  
 
A SDS-PAGE gel was prepared as described in paragraphs 8.4.1 - 8.4.3.  the 
PA fractions obtained from the centrifugation and ultracentrifugation steps, the 
Sephadex G75 column and the Zn chelating column were loaded on the gel 
together with 6 high molecular weight protein standards, namely 
phosphorylase B (94,000 Da), albumin (67,000 Da), ovalbumin (43,000 Da), 
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carbonic anhydrase (30,000 Da), trypsin inhibitor (20,100 Da) and a-
lactalbumin (14,400 Da).  A constant current of 18 mA was applied to the 
electrophoresis cell until the Bromophenol Blue reached the end of the 
running gel (approximately 90 minutes).  The gel was removed, stained and 
destained as described in paragraph 8.3.4.  The Rf values of the seven 
protein markers were calculated and a graph of the Rf values against the log 
Mr was drawn, from which the approximate molecular mass of the PA could 
be calculated (refer to table 8.3 and figure 8.2). 
 
Table 8.3: Determination of the molecular mass of PA with SDS-PAGE 
 
Protein Front (mm) Rf Log Mr Mr (Da) 
Standard Curve 
Phosphorylase B 10.0 0.127 4.97 94,000 
Albumin 22.0 0.278 4.83 67,000 
Ovalbumin 34.0 0.430 4.63 43,000 
Carbonic anhydrase 40.0 0.506 4.48 30,000 
Trypsin inhibitor 55.0 0.696 4.30 20,100 
α-lactalbumin 65.0 0.823 4.16 14,400 
Samples 
Plasmin 15.0 0.190 4.93 85,345 
t-PA 17.0 0.215 4.87 73,282 
u-PA1 31.0 0.392 4.70 50,119 
u-PA2 40.0 0.506 4.52 33,343 
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Figure 8.2: Determination of the molecular mass of purified PA with SDS-
PAGE. 
 
8.5. Isoelectric focusing (IEF) 
 
Isoelectric focusing electrophoresis was performed using a PhastGel IEF kit 
(Amersham Biosciences), pH 3-10. PhastGel IEF media are homogenous 
polyacrylamide gels (5% T, 3% C) containing Pharmalyte carrier ampholyte. 
Pharmalyte generates stable, linear pH gradients in the gels during the run. 
Proteins migrate under an electric field, essentially unhindered by the porous 
gel, to a point in the pH gradient that corresponds to their pI (isoelectric point). 
After the run the gel was stained using the silver staining method to enable 
visualisation of the different protein fractions. The calibration kit (pI 5.2-10.3) 
for pI determination consisted of β-lactoglobulin A (pI 5.20), carbonic 
anhydrase B (bovine) (pI 5.85), carbonic anhydrase B (human) (pI 6.55), 
myoglobin (acidic) (pI 6.85), myoglobin (basic) (pI 7.35), lentil lectin (acidic) 
(pI 8.15), lentil lectin (middle) (pI 8.45), lentil lectin (basic) (pI 8.65), 
trypsinogen (pI 9.30) and cytochrome C (pI 10.25).  
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The prepared gel was placed on the separation bed.  The sample well-stamp 
was covered with parafilm and 5 ml of sample pipetted into the well 
depressions, which is drawn into the applicator capillaries by capillary action. 
The sample applicators were then loaded near the cathode on the sample 
applicator arm.  Total running time was approximately 30 minutes for the gel.  
 
8.6. HPGPC analysis 
 
8.6.1. Molecular mass analyses of t-PA 
 
High performance gel permeation chromatography (HPGPC) of t-PA and 
standard protein markers was performed on a 0·75 × 60 cm prepacked TSK G 
3000 SW column (Sigma Aldrich).  The TSK G 3000 SW column contain 
silica-based, hydrophilic bonded phase packings that minimise interaction with 
proteins, thus the reason for being selected. Purified t-PA (200 μg) was 
analysed by HPGPC on the column equilibrated with 50 mM Tris-HCl, 100 
mM NaCl (pH 7.2). The same buffer was used to elute the protein at a flow 
rate of 0·4 ml.min-1. Absorbance was monitored at 280 nm.  
 
8.6.2. Amino acid analysis of t-PA 
 
A 100 μg lyophilised t-PA protein was added to 1 ml of 6 M HCl and sealed in 
an evacuated ampoule.  The acidified mixture was flushed with nitrogen while 
in an ultrasonic water bath, flame-sealed in a 5 ml ampoule, and transferred 
into a pre-heated oven at 110°C for 24 h.   Twenty μl of filtrate was transferred 
to a test tube and dried by blowing gently with nitrogen gas. Each dried 
sample was hydrated with 250 μl of 0.1 M HCl dilution buffer spiked with  
7.5 mM L-norvaline (Sigma Aldrich), filtered through a HV 0.45 μm pore size 
filter (Millipore), and loaded into an amino acid analyzer sample cartridge.  
Amino acids were derivatised with o-phthaldialdehyde and 2-mercaptoethanol 
(MCE).  The OPA reagent was prepared by combining 25 ml of 100 mM 
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sodium borate, 2.5 ml 20% (w/w) SDS, 40 mg OPA dissolved in 1 ml 
methanol, and 100 μl MCE, then adjusting the volume to 50 ml with water. A 
tetrahydrofuran/methanol solvent gradient [solvent A, tetrahydrofuran / 
methanol / 0.1 M sodium acetate, pH 7.2 (5:95:900, by vol.); solvent B, 
methanol] was used for the separation of amino acids with a flow rate of 2.2 
ml/min.  Samples were analysed by HPLC on a reverse phase C18 column. 
Effluent was monitored by fluorescence at an emission wavelength of 330 nm 
with excitation at 450 nm.  
 
Amino acid standard samples (AA-S-18 Sigma Aldrich) were prepared by 
mixing 80 µL of the 45 µmol / ml amino acid standard mixture with 20 µL of 10 
mM norvaline and analyzed directly by RP-HPLC, within 24 h from 
preparation.  
 
8.7. Brookfield viscosity 
 
Gel formation and apparent viscosity were measured with a Brookfield 
viscometer at 20°C (spindle 1 at a speed of 60 rpm) for UHT milk and at 4°C 
(spindle 3 at a speed of 60 rpm) for yoghurt.  Triplicate readings were taken 
directly in centipoise when the spindle had been rotating for 30 s. 
 
8.8. Kjeldahl analysis 
 
Protein analyses of the samples were done according to standard IDF 
procedure (IDF, 1964) by Kjeldahl analysis of the total protein (TP), non- 
protein nitrogen (NPN) and non-casein nitrogen (NCN).  Casein nitrogen (CN) 
was calculated as the difference between NCN and NPN.  All nitrogen results 
were expressed as protein equivalent using a conversion factor of 6.38 and 
were analysed in triplicate. The basic analytical procedure was as follows: 
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Total nitrogen (TN):  Sample is digested in 95-98% H2SO4, using CuSO4.5H20 
as catalyst with K2SO4 as boiling point elevator, to release nitrogen from 
protein and retain nitrogen as ammonium salt.  Concentrated 50% (w/w) 
nitrate-free NaOH is added to release NH3, which is distilled, collected in 
40g.l-1 H3BO3 solution, and titrated. 
 
Total protein nitrogen (TPN) and non-protein nitrogen (NPN):  Protein is 
precipitated from milk by trichloroacetic acid (TCA) solution.  Precipitation 
must be done in Kjeldahl flask or tube.  Final concentration of TCA in mixture 
is 12%.  The 12% TCA solution, which contains NPN components of a 
sample, is separated from protein precipitate by filtration.  Nitrogen content of 
protein precipitate and NPN filtrate is determined as in the TN method. 
 
The water soluble N (WSN) extracts were analysed according to the method 
of Kuchroo and Fox [163].  The N content of the extracts was determined by 
the Kjeldahl method; WSN was expressed as a percentage of TN.  
 
8.9. Spectrophotometric analysis at 280 and 507 nm 
 
In UHT and fermented milks, absorption of milk or whey serum, isolated from 
the samples at 280 nm, was tested, in order to detect the aromatic amino acid 
side chains of short peptides of hydrolysed casein molecules, according to the 
method of Richardson and Te Whaiti (1978) [105]. An increase in absorbence 
would indicate the presence of the liberated breakdown products (proteose 
peptones) of casein molecules in the serum. 
 
In Gouda cheese, total free amino acids were determined by a modified Cd-
ninhydrin reactive (CdN) method. The cadmium-ninhydrin method of 
Folkertsma and Fox [164] was used to quantify free amino acids produced 
during Cheddar cheese ripening. Lyophilized WSN extracts were 
reconstituted in distilled water (10%, w/v), and a 50 µl sample was diluted to 1 
ml with distilled water.  The 1 ml sample was then added to 2 ml of cadmium-
ninhydrin reagent (0.8 g ninhydrin (Sigma Aldrich) in 80 ml of 95% (v/v) 
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ethanol and 10 ml of glacial acetic acid, to which 1 g of CdCl2, (previously 
dissolved in 1 ml of distilled water), is added. The mixture was heated at 84°C 
for 5 min, cooled, and the absorbance was measured at 507 nm was.  The 
concentration of free amino groups in the mixture was expressed as mM 
Leucine equivalent.l-1 (mM Leucine equivalent.l-1) using a standard curve of D-
L-Leucine (Sigma Aldrich). 
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